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1. Introduction 
 
1.1. Problems of infectious diseases 
 
The optimism and clinical confidence associated with the development of antimicrobial 
agents from the 1940s onwards has been tempered by the emergence of new diseases, such as 
AIDS and infections associated with transplantation and cancer therapy, and by the 
widespread development of antibiotic resistance. Despite many advances, infectious diseases 
continue to account for about a quarter of all deaths worldwide (Mandell and Bennett, 2000). 
Indeed, the dramatic increase in drug-resistant microbes, combined with the lag in 
development of new antibiotics, the rise of megacities with severe health care deficiencies, 
environmental degradation, and the growing ease and frequency of cross-border movements 
of people and produce have greatly facilitated the spread of infectious diseases (Nicoll and 
Murray, 2002). Regaining the upper hand in the struggle against microbes requires 
multidisciplinary efforts which include expanding the use of vaccines to prevent infection 
(Mackay and Rosen, 2001), developing new antimicrobial agents (Byarugaba, 2004), 
improving surveillance for emerging microbial threats (Nicoll and Murray, 2002), teaching 
the correct use of antimicrobial therapy (Critchley and Karlowsky, 2004), developing 
adjunctive immunotherapies (Roilides and Pizzo, 1992), and conducting new basic research 
on the mechanisms of pathogenesis and drug resistance (Casadevall, 1996). 
In the early 20th century, antibody-based (serum) therapy was used to treat a variety of 
bacterial infections, including those cased by Corynebacterium diphtheriae, Streptococcus 
pneumoniae, Neisseria meningitides, Haemophilus influenzae, group A streptococcus, and 
Clostridium tetani (Casadevall and Scharff, 1994; 1995). By the 1930s, serum therapy was a 
standard treatment for lobar pneumonia. However, when antimicrobial chemotherapy was 
discovered in the mid-1930s, serum therapy for bacterial infections was rapidly abandoned. 
Antimicrobial chemotherapy had important advantages over serum therapy: it was more 
effective and less toxic. The immediate side effects of serum therapy included fevers, chills, 
and allergic reactions (Feinberg, 1936; Rackemann, 1942). Other disadvantages of serum 
therapy included the need to establish a precise diagnosis before selecting serum, lot-to-lot 
variation of serum, and the need for considerable physician production (Casadevall, 1996). In 
1975, hybridoma technology provided the means to generate unlimited amounts of 
monoclonal antibodies (MAbs) (Kohler and Milstein, 1975). In recent years, major advances 
have been made in the techniques used to generate human antibodies and humanize murine 
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monoclonal antibodies (Wright et al., 1992). The juxtaposition of three recent developments 
makes the reintroduction of antibody-based therapies an option for serious consideration. 
First, because of advances in technology, human antibody reagents can be synthesized; thus 
the toxicities traditionally associated with serum therapy can be avoided. Second, the 
emergence of new pathogens, the reemergence of old pathogens, and the increased prevalence 
of drug-resistant microorganisms have caused the effectiveness of existing therapeutic options 
to decline. Third, the difficulties involved in treating infections in immunocompromised 
patients suggest the need for adjunctive immunotherapy (Casadevall, 1996). However, both 
chemotherapy and immunotherapy are only therapeutic but not prophylactic. Indeed, the 
development of vaccines has been one of the most important contributions of immunology to 
medicine and public health. Based on stimulation of humoral and cellular immune responses 
against the corresponding pathogen, the field of vaccinology has experienced success in 
developing a long term prophylaxes for a variety of infectious disease agents by either 
historical use of traditional approaches of attenuated or inactivated microorganisms, protein 
subunits, toxoids or capsular polysaccharides (Hilleman, 2000; Makela, 2000) or recent 
introduction of  gene-based vaccines (Page, 2002). 
 
1.2. Vaccines  
 
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens (Mackay and 
Rosen, 2001). Vaccines are available against some of these agents and are being developed 
against almost all the other bacteria and viruses and about half of the parasites. The first 
successful human vaccine experiment carried out by Edward Jenner approximately 200 years 
ago demonstrated that inoculation of a boy with cross-reactive cow-pox virus protected him 
against two successive infections with small pox virus (Sharma and Khuller, 2001). Since 
then, the majority of vaccinologists have focused on the development of vaccines. The major 
breakthrough, occurring a hundred years later, was the preparation by Pasteur, of rabies 
vaccine, which is based on the intentional attenuation of the pathogen (Allen, 2002). 
This paved the way for the development of a big series of viral and bacterial vaccines. These 
conventional vaccines are based on the entire disease-causing microbial agent and consist of 
the killed or live attenuated organism that does not lead to infection but is capable of inducing 
protective immunity. They include also the detoxified toxins of some toxin secreting bacteria, 
which are effective in preventing the pathology of the bacterial infection (Loosmore et al., 
1990). The existing conventional vaccines have the ability to eradicate or drastically 
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diminishe incidence and morbidity of a large number of infectious diseases including major 
killers such as smallpox, polio and diphtheria (Mackay and Rosen, 2001). 
In spite of these tremendous achievements, there are several crucial drawbacks incurred by 
the current procedures for vaccine preparation. First, microbes that cannot be grown or can be 
grown only with difficulty in vitro pose a special problem to vaccine development. These 
include several viruses (HBV and HCV), bacteria like Mycobacterium leprae, and to a degree 
Chlamydia pneumoniae, and many parasites, of which the Plasmodia causing malaria are 
most important in this context (Makela, 2000). Second, the difficulty of ascertaining adequate 
killing or attenuation of the vaccine preparation, and the hazard which may be caused by 
exposure of both the vaccinees and those involved in vaccine production. This consideration 
is of particular consequences in case of fatal incurable diseases such as AIDS (Arnon and 
Ben-Yedidia, 2003). Third, the risk of reversion into their original pathogenic forms 
especially in immunocompromised individuals and infants. Moreover, it is possible that some 
live vaccine strains can be transmitted from the vaccinee to an unvaccinated individual 
(Hansson et al., 2000). 
New approaches are, therefore, being considered for vaccine development, which are not 
based on the entire organism. These include the use of recombinant DNA technology for the 
production of relevant microbial protective protein antigens in bacterial, yeast, plant or animal 
cells for vaccine preparation (Goldfarb et al., 1994; Diminsky et al., 1999) or production of 
live vaccines by introducing the relevant gene(s) into the genome of an adequate vector such 
as vaccinia virus (Oh et al., 2003) or Salmonella (Angelakopoulos and Hohmann, 2000). 
More recently, naked DNA vaccines strategy was applied. It consists of plasmid DNA into 
which the relevant gene(s) of the microbial agent can be inserted (Ulmer et al., 1993; Wang et 
al., 1993). In addition, the utilization of synthetic peptides which constitute the relevant 
protective epitopes of viruses, bacterial toxins or parasites, was used for eliciting neutralizing 
immune response towards the disease-causing agent (Tam, 1996; Tourdot et al., 1997). A 
novel means, called synthetic recombinant vaccines, based on synthetic oligonucleotides, 
which code for the relevant epitope(s) that are inserted into an appropriate vector, for the 
expression of this external epitope. This approach may allow the inclusion of more than one 
epitope in the desired vaccine (Klavinskis et al., 1989; Newton et al., 1989). Although 
vaccines are traditionally administered to healthy individuals to prevent infection, the rabies 
vaccine was used therapeutically more than a century ago to avoid deleterious effects on the 
nervous system after exposure to the virus (Wilde et al., 1989; 1996). Recently, attention has 
been given to the development of vaccines that can be used to stimulate immune defenses in 
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patient populations after they have been infected with a pathogen or even after they developed 
a disease (Seder and Hill, 2000; Sela et al., 2002; Vandepapeliere, 2002). Such therapeutic 
vaccines have also been referred to as ‘pharmaccines’ or ‘theraccines’ (Vandepapeliere, 
2002). Recently, the use of therapeutic vaccines has been extended to cover a variety of 
chronic, but not acute, diseases such as AIDS, tuberculosis, peptic ulcer, as well as different 
kinds of  cancer diseases and autoimmune diseases where a definite success in developing a 
drug/vaccine against multiple sclerosis and hopes for myasthenia gravis, lupus and diabetes 
(Sela et al., 2002).  
 
1.2.1. Virus-based vaccine vectors  
 
Vaccines based on live viruses have traditionally been highly effective and relatively easy to 
produce. For example, the elimination of smallpox was accomplished through mass 
vaccination with the live vaccinia virus, a mildly pathogenic animal virus related to smallpox. 
Live attenuated poliovirus developed by Sabin was also responsible for the drastic reduction 
of the disease all over the world. The live attenuated vaccines are well tolerated and 
immunogenic and led to effective vaccine against additional infectious diseases, e.g. yellow 
fever (Co et al., 2002), mumps (Cusi et al., 2001), and others. These vaccines are usually 
produced by attenuation of the pathogen by physical means or by selection of naturally 
occurring mutants that lead to infection with abortive replication of the pathogen, while 
retaining its immunogenicity (Polo and Dubensky, 2002). Using molecular biology and DNA 
manipulation methods, it has also been possible to express protective proteins in adequate live 
vectors and thus design live vaccines against various pathogens. Thus, the development of 
reverse genetics systems for the recovery of viruses from cDNA has made it possible to 
rapidly generate recombinant attenuated derivatives of these viruses by either point mutations 
or by attenuating hazardous sequences that are included in the vaccine (Skiadopoulos et al., 
2002). Live vaccines can be derived also using genetic engineering techniques since cloning 
procedures enable the generation of live viruses from plasmid DNA copies containing the 
whole virus genome. Vaccine candidates can thus be designed by site-directed mutagenesis, 
gene insertions or deletions and by generation of chimeric viruses (Agabov et al., 1998). In 
addition, engineered viruses may bear a phenotype that facilitates the immune response 
towards it, for example, expression of cytokines by recombinant RSV (Bukreyev et al., 2000). 
Gene-based delivery of antigens, and in particular application of virus-derived vectors, offers 
several potential advantages over traditional vaccine technologies. These include, most 
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notably, high-level production of authentic protein antigens directly within cells of the 
immunized host, potential adjuvanting effects from the viral delivery system itself and the 
possibility of efficient delivery of antigen directly to components of the immune system, such 
as antigen-presenting dendritic cells (DCs) (Polo and Dubensky, 2002; Makela, 2000). 
 
1.2.2. Bacterial-based vaccine vectors  
 
The potential of live, attenuated bacteria as vaccines and vectors has long been recognized 
and offers a number of advantageous in terms of convinience and immunogenicity compared 
with vaccines composed of inactivated organisms or antigen subunits. For example, simple 
modes of inoculation (e.g. oral) may confer protection following a single dose, presumably 
due to the limited ability of the vector to replicate in vivo. During the course of replication, the 
vector may potentially express many of the immunogens seen during natural infection, 
including mucosal immune responses that are not normally elicited by systemically 
administered vaccines. It is estimated that 90% of human infectious diseases are initiated at 
mucosal surfaces (Kraehenbuhl and Neutra, 1998). Attenuated bacteria may also be 
genetically engineered to express single or multiple heterologous antigens, providing potential 
protection against more than one pathogen. Finally, live bacterial vaccines can be inexpensive 
to manufacture (Trach et al., 1997; 2002) and practical for large-scale distribution (Lockman 
et al., 1999). 
Advances in the production of live attenuated bacteria expressing heterolougous antigens as 
vaccines have been greatly facilitated by the development of an increasing number of live 
vaccine vectors. The empirical development of early bacterial vaccines against typhoid fever 
(Salmonella typhi Ty21a) (Germanier and Furer, 1975) and tuberculosis (Mycobacterium 
bovis-BCG) (Guleria et al., 1996), for example, resulted in vaccines bearing randomly 
generated and undefined mutations. The progressive elucidation of microbial biosynthetic 
pathways hastened the development of second-generation vaccines and vectors that were 
rationally attenuated by the disruption of genes encoding known metabolic functions. 
Attenuated bacteria bearing mutations in biosynthetic genes, however, may be affected in 
their ability to colonize and replicate in vivo, diminshing their utility as vectors. To address 
the issue, highly atenuated strains bearing genes associated with virulence, such as phoP and 
virG, were created (Sansonetti et al., 1991; Homann et al., 1996). The effectivnes of 
virulence-attenuated mutants was based on the notion that such strains would replicate 
normally in vivo, producing superior vaccines and vector candidates. 
1. Introduction                                                                                                                           6                          
While a number of attenuated microorganisms show promise as potential vector plateforms, 
only a relative few have been evaluated in humans. In addition to issues of immunogenicity, a 
key concern associated with the use of live attenuated bacteria is safety (Trach et al., 2002). A 
vector should be safe for the vaccinated host and the environment as a whole, including 
unvaccinated contacts exposed to the vaccine vector. Bacterial vaccine vectors candidates that 
have been conducted for use in preclinical studies include attenuated strains of Salmonella, 
Shigella, Listeria, Mycobacterium and Vibrio. 
 
1.2.2.1. Listeria vector vaccines    
 
Listeriosis is an invasive infection caused by L. monocytogenes. Acquired immunity is 
multifactoral, involving phagocytes and several T-cell subpopulations (Kaufmann, 1993; 
Shan et al., 1995). Following invasion of the host through the gut, Listeria is found in large 
numbers in the cytosole of splenic APCs, such as macrophages, where the bacteria actively 
replicate. In the cytosole, Listeria antigens are processed by the host’s endogenous MHC 
Class I pathway and presented to CD8+ T-lymphocytes. The ability of L. monocytogenes to 
elicit protective CD8+ T-cell immune response in animals has spurred interest in developing 
the system as a live bacterial vector for use in humans. 
Although outbreaks of listeriosis are relatively uncommon, the organism may nevertheless 
cause death, particularly in people who are immunocompromised or pregnant. For these 
reasons, the development of Listeria vector candidates for use in humans has proposed with 
caution. One promising candidate is a L. monocytogenes auxotrophic mutant bearing deletions 
in alanin racemase (daI) and D-amino acid aminotransferase (dat), two genes required for the 
biosynthesis of bacterial cell walls (Thompson et al., 1998). This approach has the advantage 
of attenuating a virulent strain and reducing the potential of the mutant to revert to a wild type 
phenotype. Deletion of daI and dat resulted in a listerial strain that was highly attenuated in 
mice. While intravenous or intraperitoneal immunization of mice with a sublethal dose of the 
daI dat double-mutant failed to provide protection against virulent challenge, the addition of 
D-alanin to the inoculum was sufficient to allow the mutant to survive long enough to elicit 
protective CTL responses against lethal challenge. More recently, the first human safety study 
of a virulence attenuated L. monocytogenes vaccine (LH1196) was reported. The vaccine 
candidate was an orally-administered strain of L. monocytogenes bearing deletions in actA 
and plcB genes necessary for cell-to-cell spreading and escapes from the secondary vacuoles, 
respectively. Volunteers receiving up to 109 cfu shed vaccine organisms for approximately 4 
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days and showed no serious adverse effects, although two volunteers receiving higher vaccine 
doses manifested temporary elevation in selected liver enzymes following immunization 
(Angelakopoulos et al., 2002). All volunteers receiving the higher vaccine doses elicited 
cellular immune responses as shown by the production IFN-γ in ELISPOT assays. 
While the uses of attenuated Listeria in several applications have been described, the most 
promising results have been shown in situations where cellular immune responses are 
required. Recombinant Listeria secreting genetic fusions of Hly to lymphocytic 
choriomeningitis virus (LCMV) NP have been shown to elicit significant MHC Class I-
restricted immune responses in mice (Goosens et al., 1995). Immunized animals were 
protected against subsequent challenge with virulent strains of LCMV that establish chronic 
infection in unimmunized mice. Protection corresponded to the presence of NP118-126-specific 
CD8+ T cells. The effective use of Listeria vectors may also be dependent, however, upon the 
expression of heterologous antigens in appropriate intracellular compartments. This was 
suggested by results in mice immunized with a virulent strain of Listeria expressing either a 
secreted or a nonsecreted form of the LCMV NP118-126 epitope genetically fused to 
dihydrofolate reductase. Immunised animals elicted NP118-126 specific CTL responses of 
similar magnitude regardless whether the fusion protein was secreted or non-secreted. 
Furthermore, immunization of mice with either form of the fusion protein was equally 
efficient at eliciting the production of NP118-126-specific memory T- and provides protective 
immunity against LCMV challenge. In spite of these similarities, however, only mice 
immunized with Listeria expressing the secreted form of the NP118-126-DHFR fusion protein 
were protective against a lethal dose of Listeria whereas mice immunized with Listeria 
expressing the non-secreted form of the NP118-126-DHFR fusion protein showed no specific 
resistance to lethal challenge (Shen et al., 1996). These results demonstrate that infection with 
Listeria produces discordance between the production of immune CD8+ T cells to the 
passenger antigen and protection against the vector. 
The ability of L. monocytogenes to stimulate a vigorous CD8+ T cell response may also have 
potential as a therapy against some forms of cancer, since experimental evidence suggests that 
MHC Class I-restricted CD8+ lymphocytes may be a critical mediator of an effective 
antitumor response (Paterson and Ikonomidis, 1996). A recent study showed that a 
recombinant strain of L. monocytogenes inhibited tumor growth in a murine cancer model. 
Tumorogenic cells transduced with the influenza virus NP antigen were injected in mice to 
generate visible, subcutaneous tumors. Immunization of these mice with L. monocytogenes 
expressing NP inhibited tumor growth and ultimately stimulated the regression of 
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macroscopic tumors (Pan et al., 1995). Moreover; this NP-expressing Listeria vector was also 
capable of conferring CD8+ T-cell protection against a lethal challenge of renal carcinoma 
cells expressing NP. 
 
1.2.2.1.1. Listeria delivery of plasmid DNA 
 
The ability of L. monocytogenes to enter the host cell cytosole after phagocytosis and deliver 
plasmid DNA directly to the cytoplasm makes it an attractive DNA delivery candidate to 
induce cellular immune responses. An early vaccine candidate, L. monocytogenes ∆2, was 
constructed by deleting lecithinase activity, which significantly inhibited cell-to-cell spread by 
the bacterium (Dietrich et al., 1998). In an infected cell, ∆2 was designed to express in vivo 
controlled bacteriophage cytolysin that lysed the Listeria cell wall and released the plasmid 
DNA into the host cell cytosole. Cultured mouse macrophages infected with ∆2 expressing a 
fluorescent marker was evident in cultures three days post-infection. Bone marrow derived 
macrophages infected with ∆2 harboring an expression vector encoding a model epitope were 
able to stimulate an ovalbumin OVA 257-264-specific CTL clone to secrete IL-2.  
The use of attenuated Listeria for genetic immunization has several advantages over the direct 
injection of naked DNA, including oral administration, a natural tropism for APCs and the 
presence of recognized immunomodulatory components that may enhance the host’s immune 
response to a vectored antigen (Goosens et al., 1995).    
 
 1.2.3. Vaccines and T cells 
 
The ultimate goal of a vaccine is to develop long-lived immunological protection, whereby 
the first encounter with a pathogen is ‘remembered’, which leads to enhanced memory 
responses that either completely prevent reinfection or greatly reduce the severity of disease. 
Specialized cells known as memory T and B cells, and long-lived effector B cells (plasma 
cells), which constitutively secrete high-affinity ‘neutralizing’ antibodies, are the basis of 
immunological memory. The memory T-cell compartment consists of both CD4+ and CD8+ 
T-cells that can rapidly acquire effector functions to kill infected cells and/or secrete 
inflammatory cytokines that inhibit replication of the pathogen. Effector CD4+ T cells also 
help B-cell responses and enhance CD8+ T-cell development, through the activation of 
antigen presenting cells (APCs) or secretion of cytokines, such as interleukin-2 (IL-2), IL-4 
and IL-5. In some situations, protective immunity can be mediated by just one of the branches 
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of the immune system such as by antibodies or CD8+ T cells but for optimal control of 
pathogens, both the humoural and cellular immune responses need to be mobilized (Zajac et 
al., 1998). 
 
1.2.3.1. Stages of T-cell responses 
 
The path towards memory T-cell development continues to be delineated, but there are  
clearly three stages that T cells pass through as they differentiate into memory cells (Ahmed 
and Gray, 1996). The first stage, the ‘expansion’ phase, is initiated in the lymphoid tissues, 
where encounter with antigen induces naive T cells to clonally expand and differentiate into 
effector T cells, known as T helper (TH) cells or cytotoxic T lymphocytes (CTLs) for CD4+ 
and CD8+ T cells, respectively. Through the combined abilities of CD4+ and CD8+ effector 
T cells to secrete inflammatory cytokines and kill infected cells, a typical acute viral or 
intracellular bacterial infection can be resolved within days. Over the weeks that follow 
pathogen clearance, the majority (>90%) of effector T cells die, and this second stage is often 
referred to as the ‘death’ phase or contraction period which acts as a safeguard to prevent 
excessive immunopathology by limiting the duration of T cell responses. The surviving T 
cells enter the third stage, the ‘memory’ phase, in which the number of memory T cells 
stabilizes, and these cells are maintained for long periods of time.  
 
1.2.3.2. T-cell differentiation 
 
 Recent studies of CD8+ T cells have shown that the link between the commitment to clonal 
expansion and effector-cell differentiation is remarkably tight; the same duration of antigenic 
stimulation (2–24 hours) that drove naïve CD8+ T cells to proliferate was sufficient for them 
to commit to differentiate into effector cells that could secrete IFN-γ, tumour-necrosis factor 
(TNF) and IL-2, and kill infected cells (Mercato et al., 2000; Kaech and Ahmed, 2001; van 
Stipdonk et al., 2001). These data indicate that naïve CD8+ T cells are developmentally 
programmed to clonally expand and differentiate into CTLs after brief encounter with antigen. 
Even though CTL effector properties were acquired after as little as 2–24 hours of 
stimulation, it remains to be determined whether the quality of effector properties is affected 
by the duration of antigenic stimulation in vivo. It seems that T cells that are activated under 
different conditions, such as with heat-killed bacteria or in the presence of high concentrations 
of IL-2 or IL-15, might develop suboptimal and/or altered effector CD8+ T-cell functions 
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(Lauvau et al., 2001; Manjunath et al., 2001). The programmed development of CD8+ T cells 
has several advantages. First, it alleviates the need for prolonged confinement of CTLs to the 
lymphoid organs, which allows their migration to peripheral sites of infection and/or 
inflammation to remove infected cells. Second, it might also considerably affect the number 
of memory CD8+ T cells that are generated, because the size of the memory T-cell pool is 
directly correlated to that of the effector-cell population (Vijh and Pamer, 1997; Busch et al., 
1998; Murali-Krishna et al., 1998). In several models of acute viral and bacterial infection, 
the number of effector CD8+ T cells peaks 2–3 days after the infectious pathogen is cleared. 
If each CD8+ T-cell division was regulated strictly by antigen contact, the number of effector 
CTLs would peak earlier and reach a lower maximum, and consequently, less memory CD8+ 
T cells would be generated (Kaech et al., 2002b). 
A similar type of developmental program might also drive the differentiation of activated 
CD4+ T cells, but the formation of effector CD4+ T cells might be influenced to a greater 
extent than for CD8+ T cells by extrinsic factors, such as the duration of antigen exposure and 
the types of cytokines that are present (Kundig et al., 1996; Iezzi et al., 1998; 1999; Jelley-
Gibbs et al., 2000; Langenkamp et al., 2000). Unlike naive CD8+ T cells, which commit to 
effector and memory T-cell development within 24 hours of stimulation, naive CD4+ T cells 
required more than 48 hours of continual antigenic stimulation to commit to the formation of 
polarized TH1 or TH2 effector phenotypes in vitro (that is, the secretion of IFN-γ or IL-4, 
respectively). Even after 48 hours, a large proportion of the CD4+ T cells did not develop 
effector properties (that is, they were non-polarized) (Iezzi et al., 1999). Nonpolarized CD4+ 
T cells produced IL-2, but little or no IFN-γ or IL-4 (Langenkamp et al., 2000; Iezzi et 
al.,2001). So, it seems that naive CD8+ T cells commit to effector-cell differentiation more 
readily than CD4+ T cells. As described above, this might result from the apparent differences 
between CD4+ and CD8+ T cells in their activation requirements or the rates at which their 
thresholds for activation are reached.  
 
1.2.3.3. T cell migration 
 
As naïve T cells differentiate into effector cells, their migration patterns are altered. Effector 
T cells have a reduced potential for homing to lymph nodes owing to decreased expression of 
lymph-node-homing receptors, such as CC-chemokine receptor 7 (CCR7) and L-selectin 
(CD62L) and a greater capacity to migrate to inflamed tissues owing to increased expression 
of chemokine receptors such as CCR5 and CCR2. The expression pattern of CD62L on 
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activated T cells is triphasic and seems to be regulated by the duration of antigenic 
stimulation. Initially, TCR stimulation induces the rapid shedding of CD62L from the T-cell 
surface by proteolytic cleavage, but within 24–48 hours, CD62L is re-expressed (Chao et al., 
1997). However, if TCR stimulation continues, the locus that encodes CD62L becomes 
transcriptionally silenced and surface expression of CD62L becomes fixed at a low level for 
an extended period of time (Chao et al., 1997; Oehen and Brduscha-Riem, 1998; Teague et 
al., 1999).  
After ~24 hours of antigenic stimulation, the levels of CD62L and CCR7 remained high on 
activated CD4+ T cells, and these cells retained lymph-node-homing properties, whereas 
migration to peripheral sites, such as the peritoneum and lungs, was inefficient (Iezzi et al., 
2001). However, if the exposure to antigen was sustained over several days, the T cells lost 
surface expression of these receptors and trafficking to the lymph nodes was markedly 
reduced (Langenkamp et al., 2000; Sallusto et al., 1999; Iezzi et al., 2001).  
 
1.2.3.4. Lineage of memory T cells 
 
The precise lineage by which memory cells arise remains unresolved (Murali-Krishna et al., 
1998; Sprent and Surh, 2002). Conventionally, two models have been proposed for the 
generation of memory cells. The first is the linear differentiation model, which predicts that 
memory cells are the progeny of effector CTLs that escape activation induced cell death 
(AICD) (Jacob and Baltimore, 1999; Opferman et al.,1999; Hu et al.,2001) as the activated 
CD8+ T cells seem to be programmed to develop into memory T cells, because CD8+ T cells 
that were stimulated briefly (~24 hours), proliferated and differentiated into CTLs without 
further antigenic stimulation but surprisingly, these cells continued to develop into long-lived, 
protective memory CD8+ T cells (Mercado et al., 2000; Kaech and Ahmed, 2001). Therefore, 
the instructive program that guides effector CD8+ T-cell development is sufficient to guide 
the formation of memory CD8+ T cells termed “effector memory T cells”. 
The other view is that memory cells can directly arise from naive cells without passing 
through an effector-cell stage (non-linear differentiation), for example when naive T cells 
receive weak antigenic stimulation towards the end of an immune response and these memory 
cells are referred to as “central’memory T cells” (Langenkamp et al., 2000; Iezzi et al., 2001; 
Lauvau et al., 2001; Manjunath et al., 2001).  If naive cells come under the influence of IL-15 
shortly after activation, they differentiate into central memory-like cells. On the other hand, if 
they encounter sufficiently high doses of IL-2, they differentiate into fully fledged effector 
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cells. Thus, effector differentiation is not required to generate central memory cells, at least in 
vitro. Moreover, if differentiated effector cells, generated either in vitro or in vivo, are 
cultured in IL-15, they too can revert to memory-like cells (Manjunath et al., 2001). The 
difference between memory cells generated with IL-15 from naive cells vs. those generated 
from effector cells is that while the former express (CD62L) L-selectin and CCR7, the latter 
have lost these markers indicating that memory cells generated from naive cells resemble 
central memory cells while those generated from effector cells resemble effector memory 
cells. Therefore, it is important to consider that memory T-cell development might occur in a 
non-linear fashion and that it can result in qualitatively different memory T-cell subsets 
(Langenkamp et al., 2000; Campbell et al., 2001). Different priming conditions, for example, 
the duration of antigenic stimulation and the type of cytokines present might affect the 
formation of these subsets (Kaech et al., 2002a). 
 
1.2.3.5. Immunological characters of naive versus memory T cells  
 
Comparisons between naive and memory T cells have begun to reveal the physiological basis 
for the heightened recall responses of memory T cells. First, as a consequence of clonal 
expansion during the primary infection, experiments in mice have shown that there can be a 
substantial increase (~1000-fold) in the precursor frequency of antigen-specific T cells in 
immune animals compared with naive animals (Busch et al., 1998; Murali-Krishna et al., 
1998; Whitmire et al., 1998; Bousso et al., 1999). Second, as naive T cells differentiate into 
memory cells; their gene-expression profile is reprogrammed by changes in chromatin 
structure and the profile of active transcription factors (Agarwal and Rao, 1998). For example, 
the genes that encode interferon-γ (IFN-γ) and cytotoxic molecules, such as perforin and 
granzyme B, are not expressed in naive CD8+ T cells, but are constitutively expressed in 
effector and memory CD8+ T cells (Yang et al., 1998; Bachmann et al., 1999; Teague et al., 
1999; Veiga-Fernandes et al., 2000; Grayson et al., 2001). Although the synthesis of these 
proteins occurs in an ‘on–off’ fashion that is regulated by antigen contact, elevated levels of 
the messenger RNA transcripts endow memory CD8+ T cells with the capacity to produce 
larger quantities of these proteins more rapidly than naive T cells (Slifka et al., 1999; 
Badovinac et al., 2000; Kaech and Ahmed, 2001). Third, memory CD8+ T cells express a 
different pattern of surface proteins that are involved in cell adhesion and chemotaxis from 
naive T cells, which allows memory T cells to extravasate into non-lymphoid tissues and 
mucosal sites (Moser and Loetscher, 2001). This enables memory T cells to survey peripheral 
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tissues where microbial infections are generally initiated. Fourth, memory T-cell populations 
are maintained for a long time due to homeostatic cell proliferation, which occurs at a slow, 
yet steady, pace. Interestingly, the rate of this homeostatic cell division must equal the rate of 
cell death, because the number of memory CD8+ T cells remains relatively constant over time 
(Murali-Krishna et al., 1998; Homann et al., 2001). So, it is the increased number of antigen-
specific T cells, and their faster responses, anatomical location (that is, near the sites of 
microbial entry) and longevity that collectively explain how memory T cells confer long-term 
protective immunity. 
 
1.3. Interactions of Listeria monocytogenes with mammalian host cells and tissues 
 
Listeria monocytogenes is a ubiquitous, rapidly growing, gram-positive bacterium with an 
unusually broad ecological niche and host range. Infection of humans and animals has been 
traced to contaminated foods and can lead to serious, often fatal disease. In humans, disease is  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1. Schematic representation of the cell infectious process by L. monocytogenes and the bacterial 
factors involved. Adapted from Tilney and Portnoy (1989). 
 
 
most common among pregnant women, newborns,  and  immunocompromised individuals 
(Schlech, 2000). These clinical features are due to the unique properties of L. monocytogenes 
to be able to cross three barriers, the intestinal barrier, the fetoplacental barriers and the blood 
brain barrier (Cossart and Lecuit, 1998). Bacteria cross the intestinal barrier, and via the 
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lymph and blood proceed to the liver and spleen where the infection is normally stopped by 
the non-specific defenses of the host, in particular neutrophils. In the immunocompromised 
host, bacteria multiply  in  the  hepatocytes  and  finally  reach  the  brain  and  the  placenta.  
Listeria  is  thus a bacterium  able to  infect many  cell types  and  tissues  where  it is  always 
intracellular due to its capacity to trigger its own phagocytosis in cells which are normally 
nonphagocytic (Cossart, 2002). The different phases of Listeria infection in eukaryotic host 
cells were shown schematically in Fig.1.1. Entry into mammalian cells is mediated by at least 
two bacterial factors: internalin A (InlA) and B (InlB). Escape from the vacuole requires 
expression of listeriolysin O (LLO), a pore-forming toxin which in some cells can function 
synergistically with or be replaced by a phosphatidylinositol-specific phospholipase C (PI-
PLC). Intracellular movement requires expression of ActA, and lysis of the two-membrane 
vacuole is performed by a lecithinase (PLC-B). PI-PLC is synthesized in an active form 
whereas PC-PLC is produced as an inactive precursor. A bacterial zinc-dependant 
metalloprotease and a host cell cysteine protease are required to cleave off part of the 
precursor and activate the phospholipase (Marquis et al., 1997). 
 
1.3.1. Entry into cells 
 
Host  cell  infection  begins  with  the  internalisation  of  the  bacteria  either  by  
phagocytosis in the case of macrophages or induced phagocytosis (invasion) in the case of 
normally non-phagocytic cells. Bacterial invasion starts by the interaction with the plasma 
membrane which progressively enwraps the bacterium. This process usually refers to as the 
‘zipper’ mechanism in contrast to the ‘trigger’ mechanism used by Salmonella or Shigella 
(Finlay and Ruschkowski, 1991; Isberg and Tran Van Nhieu, 1994; Adam et al., 1995; 
Swanson and Baer, 1995; Mengaud et al., 1996). Following internalization, bacteria reside 
within membrane-bound vacuoles for about 30 min before lysing the membrane. However, 
significant levels of internalization by non-professional phagocytic cells is often mediated by 
one or more bacterial surface proteins, collectively named internalins, of which internalin A 
and B are the best characterized (Braun and Cossart, 2000). Internalin A promotes binding 
and internalization by E-cadherin, the human receptor for internalin A, whereas internalin B 
binds to the Met receptor tyrosine kinase and mediates internalization via PI3-kinase 
activation (Cossart, 2001). As evidenced by the residual level of entry of a ∆inlAB mutant, 
other mechanisms of entry exist. InlA and InlB are two members of the internalin multigene 
family which contains five other members; InlC, InlC2, InlD, InlE and InlF and it was 
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anticipated that these genes could also play a role in entry, but this does not seem to be the 
case (Engelbrecht et al., 1996; Domann et al., 1997; Dramsi et al., 1997). A recent report 
indicates that ActA, the protein involved in actin polymerization, could also participate in 
invasion (Alvarez-Dominguez et al., 1997). 
 
 1.3.2. Escape from a vacuole 
 
Upon phagocytosis by macrophages, there are a number of possible fates awaiting a 
bacterium (Duclos and Desjardins, 2000). In the case of L. monocytogenes, internalized 
bacteria are either killed or escape into the cytosol. Mutants that fail to escape from a vacuole 
may survive in tissue culture cell lines, but do not grow (Lety et al., 2002). The pore-forming 
protein listeriolysin O (LLO) is largely responsible for mediating escape from the vacuole, 
and is consequently an essential determinant of pathogenicity (Vazquez-Boland et al., 2001b). 
Mutants lacking LLO fail to escape from a vacuole in most cells, and synthesis of LLO by 
other organisms such as Bacillus subtilis is sufficient to mediate escape from a vacuole 
(Bielecki et al., 1990). Thus, it is clear that the role of LLO is to mediate vacuolar escape 
from a phagosome and from a secondary vacuole formed upon cell-to-cell spread (Gedde et 
al., 2000). In addition to LLO, L. monocytogenes secretes two phospholipases C (PLCs) that 
contribute to escape: a phosphatidylinositol- specific PLC (PI-PLC) and a broad-spectrum 
PLC (PC-PLC) that is synthesized as a proenzyme activated by a secreted L. monocytogenes 
metalloprotease (Vazquez-Boland et al., 2001b). Mutants lacking both PLCs show a marked 
defect in vacuolar escape, and in human epithelial cells such as HeLa cells, PC-PLC and 
metalloprotease mediate escape from a vacuole in the absence of LLO (Marquis et al., 1995). 
The precise mechanism by which L. monocytogenes escapes from a vacuole is not clear but is 
consistent with the following model: upon phagocytosis, the L. monocytogenes containing 
vacuole acquires markers of a maturing endosome/ phagosome and acidifies to an average pH 
of 5.9 (Alvarez-Dominguez et al., 1997; Beauregard et al., 1997). Agents, such as 
bafilomycin that block acidification, inhibit vacuolar perforation and bacterial escape (Conte 
et al., 1996; Beauregard et al., 1997; Glomski et al., 2002). It was proposed that LLO 
insertion into the phagosomal membrane has two functions: one is to dissipate the pH gradient 
and thereby halt the maturation of the phagosome, and the other is to act as a channel for the 
passage of proteins from the vacuole (Portnoy et al., 2002). The bacterial phospholipases 
and/or host vacuolar constituents then pass through the channel and act on the vacuole, 
leading to its dissolution.  
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1.3.3. Compartmentalization of LLO activity 
 
LLO is one of 23 members of the cholesterol-dependent family of cytolysins (CDCs) secreted 
by gram-positive bacteria (Billington et al., 2000). The best characterized of the CDCs are 
perfringolysin O (PFO) and streptolysin O (SLO), which are normally secreted by 
extracellular pathogens and presumably act on cells from outside. Replacement of LLO with 
PFO in L. monocytogenes results in a strain that is able to escape from a vacuole, albeit at a 
reduced efficiency, but that kills the infected cells from within (Jones and Portnoy, 1994). 
Thus, LLO is apparently unique in that it acts in a vacuole, but does not kill the host cell upon 
growth in the cytosol. The properties of LLO as a vacuole-specific lysin can be exploited to 
deliver macromolecules to the cytosol of macrophages either by incorporation of LLO into 
acid sensitive liposomes or by expression of recombinant proteins in Escherichia coli 
expressing LLO (Lee et al., 1996; Higgins et al., 1999). A PEST-like motif has been 
identified recently close to the N-terminus of mature LLO protein (Rechsteiner and Rogers, 
1996; Decatur and Portnoy, 2000; Lety et al., 2001). Two different hypotheses were evolved 
explaining the role of PEST-like sequence in compartmentalization of LLO activity. The first 
was postulated by Decatur and Portnoy (2000) who found that removal of the PEST-like 
sequence does not affect LLO activity or vacuolar escape, but results in a strain that is 
extremely toxic to infected host cells suggesting that this motif may target eukaryotic proteins 
for phosphorylation and/or degradation by the proteasome, and may generally represent sites 
of protein-protein interactions (Decatur and Portnoy, 2000; Lety et al., 2001). In contrast, 
Charbit A. and co-workers were recently confirmed that the PEST-like sequence allows 
efficient disruption of the phagosomal membrane and the ∆PEST mutant remained trapped 
within phagosomes of bone marrow-derived macrophages (Lety et al., 2001). However, both 
of them have agreed with that the deletion of this motif did not affect the secretion and 
haemolytic activity of LLO but abolished in vivo bacterial virulence. Moreover, a recent study 
was postulated the absence of correlation between the PEST score in the N-terminus of LLO 
and the susceptibility of the protein to protease degradation (Lety et al., 2002).  
LLO is unique among the CDCs in that it has a pronounced acidic pH optimum. Mutation of a 
single LLO residue (L461T) results in an increase in LLO activity at neutral pH and leads to a 
100-fold loss in virulence (Glomski et al., 2002). This mutation does not affect escape of L. 
monocytogenes from a vacuole, but causes premature permeabilization of infected host cells 
after about five bacterial generations. Thus, the acidic pH optimum of LLO as well as the 
PEST-like sequence restricts LLO activity to a vacuolar compartment. Surprisingly, 
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transcription and synthesis of LLO continues in the host cytosol (Bubert et al., 1999; Moors et 
al., 1999). However, a number of other potential mechanisms may be in place to prevent 
toxicity to the infected host. For example, PC-PLC secretion is acid dependent and occurs 
preferentially in host vacuoles (Marquis and Hager, 2000), although this is yet to be 
documented for LLO.  
 
1.3.4. Growth in the cytosol 
 
Intracellular pathogens can be broadly divided into those that grow within a modified vacuole 
of the host cell (Duclos and Desjardins, 2000) and those like L. monocytogenes that grow in 
the host cytosol. There is compelling evidence to suggest that the cytosol is a favorable 
environment for bacterial growth: Bacillus subtilis expressing LLO or E. coli precoated with 
LLO can escape from a vacuole and grow in the cytosol of tissue culture cell lines (Bielecki et 
al., 1990; Monack and Theriot, 2001). However, it was recently shown that an L. 
monocytogenes hexose phosphate transporter was virulence-regulated and necessary for 
growth on glucose-6-phosphate and optimal cytosolic growth (Chico-Calero et al., 2002). 
Thus, although nonpathogens can grow in the cytosol under some circumstances, 
intracytosolic bacteria have clearly evolved specific mechanisms to enhance intracellular 
growth. In addition most intracytosolic bacterial pathogens like L. monocytogenes have 
evolved mechanisms of actin-based motility to spread from cell to cell (Goldberg, 2001). 
When free in the cytosol, L. monocytogenes replicates and induces the polymerization of host 
actin filaments and uses the force generated by actin polymerization to move, first 
intracellularly and then from cell to cell. These filaments rearrange within 2 h into long comet 
tails left behind in the cytosol while the bacteria move ahead at a speed of approximately 0.3 
mm/second (Tilney and Portnoy, 1989; Dabiri et al., 1990; Theriot et al., 1992). Remarkably, 
a single bacterial protein, ActA, is responsible for mediating actin nucleation; actin based 
motility, and is necessary for pathogenicity. ActA-minus mutants escape normally from 
vacuoles, but grow in the host cytosol as microcolonies and do not spread from cell to cell or 
form plaques in tissue culture cell monolayers (Tilney and Portnoy, 1989). The ActA protein 
provides multiple binding sites for host cytoskeletal components, thereby acting as a scaffold 
to assemble the cell’s actin polymerization machinery (Cameron et al., 2000). It was then 
clear that ActA was sufficient to induce actin polymerisation and movement. However, since 
bacteria dropped in pure actin do not polymerize actin, it became obvious that ActA was a 
recruiting factor that allowed actin to polymerize. While a deletion analysis was providing 
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evidence that the N-terminal part of ActA, called ActA-N (the first 233 amino acids) was 
sufficient for its activity on the bacterial surface (Lasa et al., 1995), the first ActA ligand was 
identified (Chakraborty et al., 1995). It is a protein called VASP (for vasodilator phospho-
protein). VASP is a substrate for cGMP-dependent kinases and is found in locations where 
actin is polymerizing, in particular at the leading edge of locomoting cells. VASP is also a 
ligand of profilin, an actin-sequestering protein which can also induce actin polymerisation by 
binding, as an actin-profilin complex to the actin filament barbed ends. It was then shown that 
VASP binds to the central part of ActA which is dispensable, establishing that VASP together 
with the central part of ActA stimulates a process that is really generated in the N-terminal 
part of ActA. ActA-N contains a dimerisation site (Mourrain et al., 1997). The key 
experiment was performed by the group of Mitchison that succeeded to fractionate cell 
extracts and demonstrate that the critical factor for the polymerisation process is a protein 
complex which when added to bacteria and actin can induce an “actin cloud” around the 
bacteria (Welch et al., 1997). This Arp2/3 complex contains seven proteins of which two are 
actin-related proteins which may act as the two first monomers in the actin nucleation process. 
Recent experiments have shown that purified ActA-N in the presence of purified Arp2/3 
complex can stimulate actin polymerisation and also branching of the actin filaments. The 
interesting discovery that came afterwards is that in mammalian cells, the normal ligands of 
the Arp2/3 complex are proteins of the Wasp/NWasp/ Scar family (Machesky and Insall, 
1998). These proteins upon a signal, such as interaction of a ligand with its receptor, may bind 
to a GTP-bound small GTPase at the plasma membrane and can then recruit the Arp2/3 
complex which itself becomes activated and able to polymerize actin into a branched filament 
network. Thus ActA and Wasp family proteins are both activators of the actin nucleator 
Arp2/3 complex. The parallel between ActA and Wasp family proteins also lies at the level of 
the primary structure. It thus appears that the bacterial ActA mimics mammalian Wasp 
proteins (Skoble et al., 2000; Boujemaa-Paterski et al., 2001). An important study was the in 
vitro reconstitution of Listeria motility which requires in addition to actin and Arp2/3 
complex, cofilin, capping protein, alpha-actinin and also VASP and profilin which accelerate 
the movement (Loisel et al., 1999).  
 
1.3.5. Cell to cell spread 
 
When moving bacteria contact the plasma membrane, they induce the formation of bacterium 
containing protrusions. Contact between these protrusions and neighbouring cells results in 
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the internalization of the protrusion. In the newly infected cell, the bacterium is surrounded by 
two plasma membranes which must be lysed to initiate a new cycle of multiplication and 
movement. Lysis of the double membrane is mediated by a phospholipase C synthesized by L. 
monocytogenes called phosphatidylcholine-specific phospholipase C (PC-PLC). Thus, once 
Listeria has entered the cytoplasm, it can disseminate directly from cell to cell, circumventing 
host defences such as circulating antibodies and complement. This ability to disseminate in 
tissues by cell-to-cell spreading provides an explanation for the early observation that 
antibody is not protective and that immunity to Listeria is T cell-mediated (Cossart and 
Lecuit, 1998). 
 
1.3.6. The virulence gene cluster of L. monocytogenes 
 
Most of the genes coding for the virulence factors which are discussed above are clustered on 
a 10 kb region of the chromosome. This virulence locus consists of three transcriptional units 
(Fig. 1.2.).  The  central  position  is  occupied  by  the  hly  monocistron ,  encoding  a  pore-  
 
 
 
Fig.1.2. Schematic representation of the virulence gene cluster (vgc) of L. monocytogenes (italic), its 
corresponding proteins, and its regulation by prfA. The direction of transcription is indicated by 
arrows. 
 
forming listeriolysin O (Cossart et al., 1989; 2001). Downstream from hly and transcribed in 
the same orientation is a 5.7-kb operon comprising three genes: mpl,  actA  and  plcB,  
encoding a zinc  metalloenzyme, a surface  protein  ActA, a  zinc-dependent phospholipase C 
respectively (Vázquez-Boland et al., 1992). Upstream and divergent from hly lies the plcA-
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prfA operon that encodes plcA, a phosphatidylinositole-specific phospholipase C. The second 
gene encodes the prfA protein which is a member of the CAP/FnR family of transcriptional 
activators and has a critical helix-turn-helix motif similar to that of CAP (Sheehan et al., 
1996). All known virulence genes, in addition to prfA protein itself, are under the either 
absolute or partial control of the pleiotropic activator protein PrfA (Mengaud et al., 1991; 
Chakraborty et al., 1992).  Therefore, prfA, like hly and actA, is absolutely indispensable for 
Listeria pathogenicity. PrfA is the only virulence activator identified to date in Listeria and is 
the main switch of a regulone comprising virulence-associated loci scattered throughout the 
listerial chromosome, including members of the internaline multigene family (Goebel et al., 
2000). A number of environmental and growth-phase dependent signals modulate expression 
of the virulence regulon via PrfA. The activating signals include high temperature (37 °C) 
(Leimeister-Wächter et al., 1992), stress conditions (Sokolovic et al., 1990), sequestration of 
extracellular growth medium components by activated charcoal (Ripio et al., 1996), contact 
with host cells (Renzoni et al., 1999) and the eukaryotic cytoplasmic environment (Bubert et 
al., 1999; Freitag and Jacobs, 1999; Moors et al., 1999; Renzoni et al., 1999). This model 
predicts a regulatory mechanism involving allosteric activation of PrfA by a putative low 
molecular weight cofactor, the levels of which would depend on the environmental conditions 
sensed (Ripio et al., 1997; Vega et al., 1998). PrfA activation leads to the synthesis of more 
PrfA protein by positive feedback, mediated by a PrfA-dependent promoter, which governs 
the synthesis of a bicistronic plcA-prfA mRNA (Vega et al., 1998; Mengaud et al., 1991). 
This 10 kb virulence region is, however, absent from the non-pathogenic species such as L. 
innocua, L. welshimeri and L. gray but is present, with the same genetic structure and at an 
identical position, in the chromosome of L. ivanovii (Gouin et al., 1994; Chakraborty et al., 
2000). In contrast to well-characterized pathogenicity islands, the Listeria virulence gene 
cluster is rather small and has the same GC content as the rest of the chromosome (Cossart 
and Lecuit, 1998). The inlAB operon is located in another region. InlAB was the first 
identified internalin locus to be identified which was discovered by screening a bank of 
transposon mutants for defective internalization in epithelial cell monolayers (Gaillard et al., 
1991). Since then, a number of other internalin loci have been found in L. monocytogenes and 
L. ivanovii, and there is evidence that they are also present in nonpathogenic species such as 
L. innocua (Gaillard et al., 1991). All these loci form a multigene family exclusive to Listeria, 
encoding proteins with a characteristic domain containing a variable number of leucine-rich 
repeats (LRRs). There are two subfamilies of internalins. One consists of large proteins (70–
80 kDa) which are attached via their C-terminal regions to the bacterial cell wall. This group 
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is exemplified by the inlAB-encoded InlA and InlB polypeptides and includes at least six 
other members (inlC2, inlD, inlE, inlF, inlG and inlH), all found in L. monocytogenes 
(Dramsi et al., 1997; Raffelsbauer et al., 1998). The other group includes proteins generally 
much smaller in size (25–30 kDa), which lack the C-terminal cell-wall anchor region and are 
released into the extracellular medium. The prototype is InlC (or IrpA) from 
L. monocytogenes (Engelbrecht et al., 1996; Domann et al., 1997) but the remaining members 
of this group (i-InlC, i-InlD, i-InlE, i-InlF and i-InlG) have all been identified in L. ivanovii 
(Engelbrecht et al., 1998; González-Zorn et al., 2000). The known internalin loci usually 
comprise from two up to several inl genes, forming ´internalin islets´. The only exceptions are 
the inlC and inlF genes, which lie alone in the L. monocytogenes chromosome (Vazquez-
Boland et al., 2001a). 
 
1.3.7. Listeriosis model of systemic infections  
 
L. monocytogenes is a food-borne pathogen (Farber and Peterkin, 1991). Although ingestion 
of these bacteria is likely to be a very frequent event, given their ubiquitous distribution and 
the high frequency of contamination of raw and industrially processed food, L. 
monocytogenes is an uncommen cause of severe illness in the general human population. Host 
susceptibility plays a major role in the presentation of clinical disease upon exposure to L. 
monocytogenes. Human infection with L. monocytogenes typically occurs in 
immunocompromised individuals (Schuchat et al., 1991), justifying its classification as an 
opportunistic pathogen. In immunocompetent people, infection with L. monocytogenes may 
be accompanied by flu-like symptoms, and spontaneous resolution is common. Groups at risk 
are neonates, the elderly, as well as the adults with illness that compromise the immune 
system like chronic liver disease and AIDS. Pharmacologically immunocompromised adults, 
such as transplant recipients or patients suffering from autoimmunity, and adults treated with 
chemotherapy due to cancer are also concerned (Lorber, 1997). In these individuals, L. 
monocytogenes can cause severe invasive infections, which frequently end in a fatal course of 
meningoencephalitis. An additional frequent form of invasive listeriosis is septicemia (Lorber, 
1997). However, recent epidemiological studies have provided compelling evidence that a 
febrile gastroenteritis syndrome may be the main clinical manifestation of L. monocytogenes 
infection, which is also found in immunocompetent adults upon ingestion of high doses of 
bacteria (Salamina et al., 1996; Dalton et al., 1997; Aureli et al., 2000). 
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Another form of clinical presentation is foetomaternal listeriosis (Klatt et al., 1986). This 
results from invasion of the foetus via the placenta and develops as chorioamnionitis. Its 
consequence is abortion or the birth of a baby with generalized infection, a clinical syndrome 
known as granulomatosis infantiseptica and characterized by the presence of 
pyogranulomatous microabscesses disseminated over the body and a high mortality. The 
infection is usually symptomatic in the mother or may present as a mild flu-like syndrome. 
The pathogenesis of listeriosis in humans is still poorly understood. Most of the available 
information is derived from interpretation of epidemiological, clinical, and histopathological 
findings or by extrapolation of observations made in experimental infections in animals, 
particularly in the mouse model which has long been used as a tool to study a rapidly 
appearing CD8+ T cell-dependent immune response (Mackaness, 1962). As contaminated 
food is the major source of infection, the gastrointestinal tract is thought to be the primary site 
of entry of L. monocytogenes into the host. The clinical course of infection usually begins 
about 20 h after the ingestion of heavily contaminated food in cases of gastroenteritis (Dalton 
et al., 1997), whreas the incubation period for the invasive disease is generally much longer, 
around 20 to 30 days (Linnan et al., 1988; Riedo et al., 1994). 
Before reaching the intestine, the ingested bacteria have to withstand the adverse environment 
of the stomach. A significant number is probably destroyed by the gastric acidity (Schlech et 
al., 1993). The portal of entry and the mechanism of intestinal translocation used by L. 
monocytogenes are controversial (Marco et al., 1997; Jensen et al., 1998). However, recent 
data favours the view that the translocation of L. monocytogenes is a passive non-specific 
process with no preference for enterocytes or M cells (Pron et al., 1998) but with, however, a 
preferential site of early multiplication in the phagocytic cells underlying the Peyer’s patches. 
This result is in agreement with the early observation that bacteria survive and even replicate 
in resident phagocytes of the lamina propria (Mackaness, 1962). 
Following translocation, bacteria, via the lymph and the blood, reach the spleen and liver. In 
the latter organ, most of the bacteria are killed by the Kupffer cells, though a fraction reachs 
the hepatocytes, the principal site of bacterial replication in the liver (Cousens and Wing, 
2000), where they induce apoptosis with concomitant release of chemoattractants which leads 
to an influx of neutrophils (Conlan and North, 1991; Rogers et al., 1996). These phagocytic 
cells ingest bacteria or apoptotic hepatocytes and contribute to the rapid clearing of the 
infection before a complete sterilization is achieved by the immune response. The step of 
bacterial multiplication in the liver appears critical for the establishment of a ‘successful’ 
infection (Cossart and Lecuit, 1998). 2 to 4 days after infection, influx of neutrophils 
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gradually changes to infiltrating macrophages and T lymphocytes to form the characteristic 
granulomas (Mandel and cheers 1980; Heymer et al., 1988). These granulomas are the 
histomorphological correlate of cell-mediated immunity and presumably act as the true 
physical barriers that confine infectious foci (portnoy, 1992). Between day 5 and day 7 post-
infection, bacteria start to disappear from mouse organs until their complete clearance as a 
result of activated macrophages and a specific immune response primarily involving CTLs 
and a Th1-biased CD4+ T cell response (Harty et al., 1992; Geginat et al 1998; Gregory and 
Liu 2000). 
Although it may be hazardous to extrapolate these data to human listeriosis, the scenario of 
the human infection is believed to begin by ingestion of contaminated food (Schlech et al., 
1983). Bacteria then reach the gastrointestinal tract and cross the intestinal barrier. In the 
cases of the immunocompromised host or the pregnant woman, bacteria multiply 
unrestrictedly in the hepatocytes from which they further disseminate haematogeneously to 
the brain and placenta (Cossart and Lecuit, 1998). 
 
1.4. Host immune response to Listeria infection  
1.4.1. The innate response to Listeria infection 
 
The innate immune response to Listeria involves a coordinated interaction between many cell 
types and the production of numerous cytokines. These responses have been most clearly 
studied in SCID (severe combined immunodeficient) mice, devoid of B and T cells, which 
allow for the dissection of these innate responses. These components are necessary in 
immunocompetent mice to control infection prior to the development of T cell immunity 
(Edelson and Unanue, 2000).  
Neutrophils play a key role in the early control of Listeria growth, appearing at sites of 
infection within the first 24 hours. The importance of neutrophils was demonstrated by 
several investigators using monoclonal antibodies to deplete these cells from the host during 
infection (Rogers and Unanue, 1993; Czuprynski et al., 1994a; 1994b). Mice depleted of 
neutrophils succumbed to an early lethal infection, with large bacteria-laden foci in the liver 
parenchyma. Rogers et al. demonstrated that Listeria infection of hepatocytes both in vitro 
and in vivo resulted in apoptosis of the hepatocytes and in the release of neutrophil 
chemoattractants (Rogers et al., 1996). Neutrophils migrating into the liver removed apoptotic 
hepatocytes through release of proteases and destroyed the released bacteria through surface 
phagocytosis. Indeed, activated neutrophils can produce a variety of cytokines (IL-1b, IL-6 
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and TNF-α), chemokines [macrophage inflammatory protein 1a (MIP-la), MIP-1b and MIP-
2], and other soluble factors (leukotriene B4) that modulate the activities of both resident and 
immigrating cell populations (Seebach et al., 1995). 
Recent experiments indicate that the initial elimination of Listeria taken up in the liver is not 
solely a function of immigrating neutrophils; Kupffer cells also play a prominent role. Mice 
depleted of Kupffer cells by pretreatment with liposome-encapsulated dichloromethylene 
diphosphonate exhibited an approximate 75% decrease in the number of Listeria recovered in 
the liver 10 min post-infection (Gregory and Wing, 1998). These findings suggest that the 
majority of Listeria initially recovered in the liver is bound to Kupffer cells. Experiments 
demonstrating reduced blood clearance in mice pretreated i.v. with sugars or neoglycoproteins 
suggest that clearance in at least some cases is mediated by the interaction of lectins expressed 
by Kupffer cells and carbohydrate residues on the surface of the bacteria (Ofek and Sharon, 
1988). In addition to playing a major role in blood clearance, Kupffer cells are a significant 
factor in host resistance to both primary and secondary listerial infections of the liver (Pinto et 
al., 1991; Samsom et al., 1997). Kupffer cells can inhibit the proliferation of Listeria in the 
liver directly by phagocytosing and killing the organisms, or indirectly by promoting the 
biological response of other cell populations. Indeed, Kupffer cells can express intercellular 
adhesion molecule 1 (ICAM-1; CD54) and vascular cell adhesion molecule 1 (VCAM-1; 
CD106), and produce a variety of soluble factors such as interleukin 1b (IL-1b), IL-6, tumor 
necrosis factor a (TNF-α), nitric oxide and leukotrienes: all of which can promote the 
infiltration, localization, and/or antimicrobial activity of neutrophils (Decker, 1990; Essani et 
al., 1995). A similar role in trapping blood-borne pathogens was evaluated in macrophages 
located in the marginal zone of the spleen (Aichele et al., 2003). 
Also critical during early infection is the interaction between Listeria organisms, 
macrophages and NK cells (Unanue, 1997a). Infection of macrophages with Listeria (or 
exposure to heat-killed Listeria) results in macrophage production of TNF-α and IL-12, two 
key cytokines of the innate immune system. These two cytokines together synergize to cause 
NK cell secretion of IFN-γ. In combination with TNF-α, IFN-γ  leads to full macrophage 
activation. Activated macrophages display increased levels of class II MHC molecules and 
become listericidal through the production of free radicals (Bancroft et al., 1991; Beckerman 
et al., 1993). Macrophage activation is clearly necessary for immunity to Listeria, as 
pharmacologic inhibition of nitric oxide production or the gene targeting of inducible nitric 
oxide synthase and NADPH oxidase results in the inability of mice or macrophages to control 
infection (Beckerman et al., 1993; Shiloh et al., 1999). Recently, a report has also 
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demonstrated that splenic CD8α+ dendritic cells produce IFN-γ in response to Listeria 
infection in the absence of NK cells, potentially serving as an alternative source of IFN-γ  
(Ohteki et al., 1999). It should also be stated that the cytokines IL-1 and IL-6 play a necessary 
role during the early immune response to Listeria infection. Their role has been associated 
with the neutrophil response (Unanue, 1997a; 1997b). Just recently a novel cytokine, Eta-1 
(osteopontin), has been shown to play a role during the very early phase of listeriosis (Ashkar 
et al., 2000). Thus, there exists during the early phase of the infection interplay among IL-1, 
IL-6, Eta-1, TNF-α and IL-12. Like macrophages, dendritic cells have the ability to 
phagocytose L. monocytogenes at the early stages of infection and produce a variety of 
proinflammatory cytokines like TNF-α, IL-1, IL-6. and IL-8 as well as IL-12 and IL-18 
production (Guzman et al., 1995; van Deuren et al., 1995; Kolb-Maurer et al., 2003) .  
Beside its role as a natural killer cell activator, IL-12 is a major Th1-promoting factor 
(Macatonia et al., 1995; Gorak et al., 1998). IL-12, in combination with IL-18, induces IFN-
γ production by T cells. Both IL-12 and IFN-γ are required for the generation of protective 
Th1 immune responses against the intracellular bacteria (Yang et al., 1997; Sugwara, 2000). 
A critical role for IL-18 has recently been described in L. monocytogenes infected mice 
(Neighbors et al., 2001). Infection was greatly exacerbated by a monoclonal antibody against 
the IL-18 receptor. Moreover, IL-18 was required for the subsequent release of nitric oxide 
from the macrophage in response to L. monocytogenes infection. IL-18-dependent NO 
production may be a major mechanism of bacterial clearance. 
 
1.4.2. The adaptive response to Listeria infection 
1.4.2.1. The T cell response 
 
The adaptive immune response to Listeria is dependent on the presence of T lymphocytes. 
Because the organism is present in both phagosomes and the cytosol of professional antigen-
presenting cells during infection, epitopes derived from Listeria proteins are presented by 
MHC class I and class II molecules as well as by the class Ib molecule H2- M3 (Pamer et al., 
1991; Safley et al., 1991; Sanderson et al., 1995; Sijts et al., 1996; Busch et al., 1997;  Darji 
et al., 1998). Presentation of Listeria antigens (often bacterial secreted proteins) primes both 
CD4+ and CD8+ T cells. This results in the full clearance of organisms from the host and 
provides a pool of memory T cells capable of a more rapid secondary immune response to the 
bacteria. Listeria-specific CD4+ and CD8+ T cells can both independently provide resistance 
to infection although the effector mechanisms used in each case are still not fully elucidated. 
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It is clear that both CD4+ and CD8+ T cells are activated in an Ag-specific fashion following 
infection with L. monocytogenes (Harty et al., 1996). However, a large body of evidence 
involving specific T cell subset depletion (Mielke et al., 1989) and experiments performed in 
mice deficient in CD4+ and/or CD8+ T cells (Roberts et al., 1993; Kaufmann and Ladel, 
1994; Ladel et al., 1994) indicates that CD8+ T cells are the most effective mediators of 
antilisterial immunity. 
 
1.4.2.1.1. CD8+ T cell effector mechanisms 
  
Activated CD8+ T cells are capable of elaborating a diverse array of effector functions. 
Following Ag-specific stimulation, CD8+ T cells produce a broad range of cytokines 
including IFN-γ and TNF-α (Douglas et al., 1998). The ability of activated CD8+ T cells to 
carry out in vitro cytolysis is well documented. Following ligation of the TCR-αβ by the 
appropriate MHC class I-peptide complex, the CD8+ T cell induces its target to undergo 
programmed cell death (PCD) (Mielke et al., 1989). Two independent pathways account for 
the majority of in vitro target cell lysis by CD8+ T cells (Kagi et al., 1994). One is a perforin-
dependent pathway, mediated by granzymes, which are serine proteases found in the 
cytoplasmic granules of activated CD8+ T cells that gain access to the cytoplasm of the target 
cell and induce PCD by activation of the caspase cascade. Although the mechanism(s) by 
which perforin and granzymes are involved in cytolysis remain controversial (Froelich et al., 
1996; Shi et al., 1997), the dependence of some cytolytic activity on perforin is clear (Kagi et 
al., 1994; Kojima et al., 1994; Lowin et al., 1994; Walsh et al., 1994). The other pathway by 
which CD8+ T cells are capable of efficient in vitro cytolysis is dependent upon interactions 
between CD95 ligand (CD95L, Fas ligand) on the activated CD8+ T cell and CD95 on the 
target cell. Ligation of CD95, in some cell types, leads to intracellular signaling events that 
also activate the caspase cascade and induce PCD (Nagata, 1997). 
 
1.4.2.1.2. H2-Kd-restricted recognition by T cells 
 
Four major Listeria-derived epitopes of CD8+ T cells presented by H2-Kd have been 
identified. Attempts to quantitate the presentation of these peptides by infected cells have 
been made. Two of the peptides derive from p60, a constitutively secreted protein of Listeria: 
p60 (residues 449-457) is presented at a high density by infected cells but is subdominant 
based on the size of the T cell population specific for this peptide; in contrast a stronger T cell 
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response is specific for p60 (residues 217-225), even though this epitope is presented at a 
lower level. A third epitope derives from LLO (residues 91–99); although presented in 
smaller amounts than the p60 epitopes, it dominates the T cell response. The fourth epitope is 
from a secreted metalloprotease, mpl (residues 84–92). A major contribution in understanding 
the response to Listeria has been made by following the development of the CD8+ T cell 
response to these four peptides, an accomplishment made by Eric Pamer’s laboratory (Busch 
et al., 1998; 1999) using the MHC tetramer approach developed by Davis and Altman 
(Altman et al., 1996). 
Pamer’s group developed four tetramers that were shown to recognize CD8+ T cells specific 
for the Listeria-derived epitopes described above. Following primary infection, the T cell 
populations specific to each epitope increased albeit in different amounts. The largest number 
of cells was specific to LLO91–99, reaching about 1.4% of all CD8+ cells in the spleen at day 7 
post-infection, while the response to the subdominant epitopes (p60 449–457 and mpl 84–92) were 
about 0.05%. The T cell response to the p60 217–225 epitope was intermediate, at 0.25%. 
These responses all declined noticeably by day 35. A secondary challenge resulted in the 
expansion of all of these T cell populations but cells specific for the two major epitopes 
proliferated most dramatically: 17% of all CD8+ spleen cells recognized LLO91–99, while 
about 4% were specific to p60217–225. The T cell populations again contracted after the 
secondary infection was resolved; however they persisted at a level higher than that seen after 
the initial primary infection. Therefore, the burst and subsequent decline of the response to 
each epitope occur in parallel, despite the wide range in the size of the T cell populations 
specific for these four epitopes. A point to be noted in the overall studies from Listeria is the 
lack of correlation between the quantity of MHC–peptide display by the antigen-presenting 
cell and the magnitude of the T cell response. This could indicate that a number of regulatory 
mechanisms are present or that the magnitude of the response is dependent on the existing 
TCR repertoire prior to stimulation (Busch et al., 1998; 1999).  
 
1.4.2.1.3. H2-M3-restricted recognition by T cells 
 
Other antigenic components in the anti-Listeria response are the bacterial peptides presented 
by H2-M3. Presentation of peptides by this molecule requires the presence of N-formyl-
methionine at their amino termini. Consequently, it was expected that bacteria-derived 
peptides could be selected by this special class I molecule and presented to T cells. Several 
Listeria-derived peptides presented by H2-M3 have been identified (Gulden et al., 1996; Lenz 
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et al., 1996; Princiotta et al., 1998). A recent paper (Kerksiek et al., 1999) followed the T cell 
response to one of these peptides by using MHC tetramer technology. An important finding 
was that these T cells expanded rapidly during primary infection, peaking at days 5 –7 post-
infection. In comparison, the response to the LLO91–99 peptide (presented by Kd) peaked on 
days 7–9. Surprisingly, however, the H2-M3-restricted T cell response to a secondary 
infection was rather small compared with the vigorous recall response to the LLO peptide 
described previously.  
 
1.4.2.2. Role of humoral immunity in Listeria infection 
 
In the past few years provocative studies showing the role of antibody in protection against 
some intracellular pathogens have been reported, most notably to Cryptococcus neoformans 
(Yuan et al., 1995). Protective mAbs were shown to recognize the capsular polysaccharide of 
the organism, with protection depending on epitope specificity and isotype of the mAb (Yuan 
et al., 1995; Nussbaum et al., 1997).  
The human humoral immune response directed against proteins of Listeria monocytogenes 
have been examined in both healthy individuals and listeriosis patients. Two major targets for 
an antibody response were found in individuals that did not suffer from listeriosis: 
listeriolysin O (LLO) and internalin-related protein (IrpA). In contrast, the humoral response 
in listeriosis patients appears to be more heterogeneous and included LLO, IrpA, InlB, and 
ActA as major targets (Grenningloh et al., 1997) indicating that these proteins can be used to 
probe for and identify listerial infections in patients and, in particular, to assess the incidence 
of innocuous infection by pathogenic listeria in the general population. 
There are at least four potential mechanisms for antibody mediated protection against 
intracellular pathogens: firstly opsonization of the pathogen when it is present in the 
extracellular space, leading to complement activation and/or increased phagocytosis; secondly 
binding to key surface molecules on the pathogen, preventing entry into host cells; thirdly 
neutralization of toxins elaborated by the pathogen in the extracellular environment; fourthly 
antibody action at an intracellular location inside of a pathogen-containing phagocyte (Cossart  
and Lecuit, 1998). It should be noted that on some occasions polyclonal antisera can fail to 
have a protective effect whereas a mAb of a defined specificity and isotype can be shown to 
provide protection. That is to say, natural infection may not result in the production of 
protective antibodies. This means that studies employing serum transfers (as was the case for 
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Listeria) should not be taken as evidence that no role exists for antibody in the context of a 
particular organism. 
Two recent reports (Edelson et al., 1999; Ochsenbein et al., 1999) have demonstrated a 
surprising role for natural antibodies and for anti-LLO antibody in the context of Listeria 
infection. Ochsenbein et al. showed that naive C57BL/6 mice possess low but detectable 
levels of Listeria-specific natural IgM in their serum (reactive to Listeria surface components 
at a titer of 1:16) although there was no detectable Listeria-specific IgG (Ochsenbein et al., 
1999). Mice lacking antibody production (µMT mice) as expected did not have this natural 
anti-Listeria IgM and the early dissemination of Listeria was characterized in these antibody-
deficient mice compared with wild-type counterparts after a high dose intravenous infection.  
Recent work of Edelson et al; has involved antibody neutralization of the Listeria pore-
forming toxin LLO. Mice were passively treated with mouse anti-LLO mAb and then infected 
with Listeria. Antibody treatment resulted in significantly lower bacterial titers in the spleen 
and liver at both six hours (titers were 1 log lower) and two days (2–3 logs) post-infection; 
increased survival after a lethal challenge also resulted (Edelson et al., 1999). Increased 
survival was also seen in SCID mice, indicating that the antibody could work in the absence 
of B and T cells although antibody-treated SCID mice still developed a chronic Listeria 
infection, demonstrating the need for T cells for full Listeria clearance. Protection by mAb 
depended on toxin neutralization, as a non-neutralizing mAb did not affect Listeria resistance. 
Authors suggested that LLO was neutralized either extracellularly or within the phagosomes 
of infected cells. However, older studies in which anti-Listeria serum was taken following 
infection or immunization with killed bacteria and then transferred to naive animals did not 
demonstrate protection against Listeria infection (Osebold and Sawyer, 1957; Mackaness, 
1962; Cheers and Ho, 1983). The ability of mAb to provide resistance over serum antibody 
has been explained to be due to a low abundance of serum Ab to protective Ags, or as a result 
of serum Ab being of an inappropriate isotype to mediate resistance (Edelson et al., 1999). 
 
1.5. Cholesterol-binding cytolytic protein toxins 
 
Cholesterol-binding cytolysins (CBCs) are a large family of 50- to 60-kDa single-chain 
proteins produced by 23 taxonomically different species of gram-positive bacteria from the 
genera Streptococcus, Bacillus, Clostridium, Listeria and Arcanobacterium (Billington et al., 
2000). Apart pneumolysin, which is an intracytoplasmic toxin, all the other toxins are secreted 
in the extracellular medium. Among the species producing CBCs, only L. monocytogenes and 
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L. ivanovii are intracellular pathogens which grow and release their toxins in the phagocytic 
cells of the host. CBCs are lethal to animals and highly lytic toward eukaryotic cells, 
including erythrocytes. Their lytic and lethal properties are suppressed by sulfhydryl-group 
blocking agents and reversibly restored by thiols or other reducing agents. These properties 
are irreversibly abrogated by very low concentrations of cholesterol and other 3-
hydroxysterols (Alouf, 2000). Membrane cholesterol is thought to be the toxin-binding site at 
the surface of eukaryotic cells. Toxins molecules bind as water-soluble monomers to the 
cholesterol-containing lipid bilayer of eukaryotic cells. Upon binding they oligomerize into 
arc- and ring-shaped structures comprising about 50–80 toxin molecules followed by the 
generation of large oligomeric transmembrane pores (15–30 nm diameter) leading to cell lysis 
(Bhakdi et al., 1985; Bayley, 1997; Rossjohn et al., 1998; 1999; Shepard et al., 1998; Alouf 
and Palmer, 1999; Gilbert et al., 1999; Mitchell, 1999). The exception to this is found in the 
Listeria monocytogenes CBC, listerolysin O, which lyses phagosomal membranes but not the 
cell membrane due to its low pH activity optimum at around pH 5.5 (Geoffroy et al., 1987). 
As for other bacterial membrane-damaging proteins, a key function of CBCs is likely to 
enable access to free iron in host cells for bacterial growth purposes. In many cases cytolysin 
production is upregulated by low environmental iron (Alouf, 2000).  
Thirteen structural genes of the toxins have been cloned and sequenced to date. The deduced 
primary structure of the proteins shows obvious sequence homology particularly in the C-
terminal part and a characteristic common consensus sequence containing a unique Cys 
residue (ECTGLAWEWWR) near the C-terminus of the molecules (except pyolysin and 
intermedilysin) known as the Trp-rich loop and shown to be involved in cholesterol and 
membrane binding (Nakamura et al., 1995; Rossjohn et al., 1998; Jacobs et al., 1999). 
However, another Cys residue outside this undecapeptide and closer to the C-terminus occurs 
in ivanolysin. Genetic replacement of the Cys residue in the consensus undecapeptide by 
certain amino acids demonstrated that this residue was not essential for toxin function. Other 
residues in the undecapeptide have been mutagenized, particularly the Trp residues. One of 
these Trp appeared critical for lytic activity (Alouf, 2000).  
 
 
1.5.1. Pneumolysin  
 
Pneumolysin (PLY) is an important virulence factor from the pathogenic bacterium S. 
pneumoniae. The pneumococcus is responsible for many serious diseases such as bacterial 
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meningitis, pneumonia and otitismedia which cause significant mortality and morbidity of 
human populations worldwide. Various pneumococcal proteins allow efficient propagation of 
bacterium within the host, including pneumolysin (PLY), hyaluronatelyase (SpnHL) 
(Jedrzejas et al., 1998a; 1998b; Li et al.,2000) and pneumococcal surface protein A (PspA) 
(Jedrzejas et al., 2000). 
Pneumolysin is a 53-kDa protein produced by all clinical isolates of the pathogen (Paton et 
al., 1986; 1993). Unlike other pneumococcal antigen, this molecule is not surface exposed. It 
is a cytoplasmic enzyme that is released due to the action of surface pneumococcal autolysin. 
The virulence properties of pneumolysin are therefore directly dependent on the action of 
autolysin. Pneumolysin has several distinct functions, especially in the early pathogenesis of 
pneumococcal infection. The enzyme is cytotoxic to ciliated bronchial epithelial cells, slows 
ciliary beating in organ culture, and disrupts tight junctions and the integrity of the bronchial 
epithelial monolayer (Steinfort et al., 1989; Rayner et al., 1995). Due to pneumolysin 
function, the ability of ciliated bronchial cells to clear mucus from the lower respiratory tract 
is reduced, which facilitates the spread of pneumococcal infection. In addition, pneumolysin 
interactions with alveolar epithelial cells and pulmonary endothelial cells probably cause 
alveolar edema and hemorrhage during pneumococcal pneumonia. Pneumolysin action during 
pneumococcal infection disrupts the alveolar-capillary boundary, which produces an alveolar 
flooding providing nutrients for bacterial growth and facilitates penetration through the 
epithelium into the pulmonary interstitium and ultimately into the blood stream (Rubins and 
Janoff, 1998). The virulence and multiple function of pneumolysin, especially in early stages 
of infection by pneumococci, are crucial to the pneumococcal colonization of a host 
(Jedrzejas, 2001). For pneumolysin, its membrane pore assembly consists of 30 to 50 
monomeric pneumolysin molecules with the assembly diameter of 35 to 45 nm (Rubins and 
Janoff, 1998). 
Although the structure of PLY is not known, it is expected to be similar to the structures of 
CBC molecules from other bacterial organisms that have been structurally elucidated by X-
ray crystallography. Of these CBC molecules, the structure of perfringolysin (PFO) from 
Clostridium perfringens probably is the most similar to that of PLY, based on the high 
sequence similarity of 60% (Feil et al., 1996; Rossjohn et al., 1997). The PFO molecule was 
divided into four domains. Three domains are arranged in a row, giving an elongated shape. 
Domain 3 is covalently connected to the N terminal domain 1 and packed laterally against 
domain 2. Membrane interaction of the monomer appears to be mediated by domain 4, while, 
oligomerization involves several sites scattered throughout the sequence. The Trp-rich region 
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around the conserved Cys residue within domain 4 is assumed to conformationally adapt to 
cholesterol, and domain 3 is envisaged to move across the “hinge” by which it is connected to 
domain 1 (Jedrzejas, 2001). 
 
1.5.1.1. Immunomodulatory effects of pneumolysin 
 
Cholesterol binding cytolysins were shown to possess, at its sublytic doses, a regulatory 
activity in target cell networks. As mentioned before, Listeriolysin O elicits IL-1, IL-6, IL-10, 
IL-12, TNF-α (Nishibori et al., 1996), chemokines (IL 8, monocyte  chemotactic protein-1) 
expression, adhesion molecules (ICAM-1, E-selectin), NF-κB nuclear translocation (Kayal et 
al., 1999) and induction of apoptosis of mouse dendritic cells (Guzman et al., 1996). On the 
other hand, the immunomodulatory effects of pneumolysin are reflected by the stimulation of 
human IL-1 and TNF-α release in vitro (Hackett and Stevens, 1992; Houldsworth et al., 
1994) and in vivo (Shanley et al., 1996); and complement activation (Bhakdi and Tranum-
Jensen, 1985). Pneumolysin binds to immunoglobulin Fc fragment, leading to classical 
complement pathway activation in absence of pneumolysin-directed antibodies. Activation 
could divert complement away from intact bacteria and thereby leading to inflammation. 
Pneumolysin also shares limited sequence homology to C-reactive protein involved in acute-
phase response to infection or injury (Mitchell et al., 1991; Paton et al., 1984). 
Moreover, the cytotoxic effects of pneumolysin can directly inhibit phagocyte and immune 
cell function, which leads to suppression of the host inflammatory and immune responses. 
Low concentrations of pneumolysin are able to inhibit human neutrophil and monocyte 
respiratory bursts, chemotaxis, bactericidal activity, and production of lymphokines and 
immunoglobulins (Rubins and Janoff, 1998). The striking effects of pneumolysin on the host 
cell upon exposure to S. pneumoniae were recently investigated with the aid of cDNA 
microarrays to identify genes which are responsive to S. pneumoniae in a pneumolysin-
dependent and -independent fashion in THP-1 human monocytic cell line. Of 4133 genes 
evaluated, 142 were found to be responsive in a pneumolysin-dependent fashion, whereas 40 
were found to be responsive independent of pneumolysin. Genes that were up-regulated in 
cells exposed to the virulent type 2  S. pneumoniae strain relative to those exposed to the 
isogenic strain, which does not express pneumolysin included genes encoding proteins such as 
mannose binding lectin-1, lysozyme, α-1 catenin, cadherin-17, caspases 4 and 6, macrophage 
inflammatory protein-1β (MIP-1 β), interleukin 8 (IL-8), monocyte chemotactic protein 3 
(MCP-3), IL-2 receptor-β (IL-2R-β), IL-15 receptor-α (IL-15R-α), interferon receptor-2, and 
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prostaglandin E synthase. Down-regulated genes included those encoding complement 
component receptor 2/CD21, platelet-activating factor acetylhydrolase, and oxidized low-
density lipoprotein receptor 1 (OLR1). Pneumolysin-independent responses included down-
regulation of the genes encoding CD68, CD53, CD24, transforming growth factor β2, and 
signal transducers and activators of transcription 1 (Rogers et al., 2003). Recent report showed 
that pneumolysin is recognized by Toll-like receptor 4 which mediates innate immune 
response to pneumococcal infection (Malley et al., 2003). 
 
1.6. Regulation of iron uptake and storage in L. monocytogenes  
 
The essential nature of iron for virtually all organisms is a double-edged sword that requires a 
careful balancing act to ensure survival. On the one hand, iron is a required cofactor of many 
enzymes involved in the maintenance of basic metabolic functions such as electron transport. 
On the other hand, interaction of free oxygen with iron leads to the Fenton reaction, which 
results in the production of oxygen radicals that can cause severe damage to the majority of 
cellular biomolecules (Touati, 2000). Due to these two opposing phenomena, it is perhaps no 
surprise that organisms have developed tightly regulated systems for both uptake and 
sequestration of iron. Within the context of mammalian systems this is accomplished in part 
through the action of iron binding molecules such as transferrin, heme and lactoferrin (Otto et 
al., 1992; Nuijens et al., 1996). In addition to protecting cells from the harmful effects of 
oxygen radicals, the ability to sequester iron also limits bacterial growth within the 
mammalian host. This is evidenced by extensive epidemiological data suggesting that there is 
a strong link between the iron status of the host and susceptibility to a number of bacterial 
pathogens (Wanachiwanawin, 2000; Collins, 2003). In light of the requirement for iron and 
the stiff competition for this nutrient, it is no surprise that successful pathogenic 
microorganisms have developed intricate systems that allow them to acquire and store iron 
within the bacterial cell. In fact, genes that encode factors involved in these processes are 
often considered to be virulence factors and have been the subject of intense study by 
numerous groups (Braun, 2001). Intrinsic to the ability to acquire iron is the fact that 
microbes must also be able to sense and respond to changing iron concentrations within the 
environment. This is crucial to help maintain the homeostatic relationship between having 
enough iron to grow and avoiding iron toxicity. In a number of organisms, this regulation is 
accomplished by the ferric uptake regulator (Fur) protein (Crosa, 1997). Found in both gram-
negative and gram-positive bacteria, Fur functions by binding to promoter regulatory 
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elements, called Fur boxes, in an iron-dependent manner. Typically, Fur-regulated promoters 
are repressed under iron-replete conditions and derepressed under iron-depleted conditions. 
Moreover, it is critically important for infecting bacteria to have the ability to store iron 
intracellularly while in an iron-rich environment and utilize the stored iron under iron 
depleted conditions. Micro-organisms have developed two types of iron storing proteins: 
ferritins and bacterioferritins (Andrews, 1998). The former contain iron, whereas the latter 
contain heme. Amongst prokaryotes, ferritins have been isolated from Bacteroides fragilis 
(Rocha et al., 1992), Escherichia coli (Hudson et al., 1993), Helicobacter pylori (Frazier et 
al., 1993) and Campylobacter jejuni (Wai et al., 1995, 1996). In addition, ferritin-encoding 
genes have been found in the genomes of Haemophilus influenzae, Clostridium 
acetobutylicum, Thermotoga maritima, Archaeoglobus fulgidus, Mycobacterium tuberculosis 
and Vibrio cholerae (Andrews, 1998). However, the complete genome sequences of Bacillus 
subtilis, Methanococcus jannaschii and Mycoplasma pneumoniae do not contain a ferritin-
encoding gene. This indicates that the iron storage system varies amongst bacterial species. 
Evidence to demonstrate the contribution of ferritin to protection against oxidative stress has 
also been provided by analysis of a ferritin-deficient mutant of Cam. jejuni (Wai et al., 1996). 
In E. coli, however, a mutation in the ferritin-encoding gene (ftnA) confers no sensitivity to 
oxidative stress on the cell (Abdul-Tehrani et al., 1999). 
In eukaryotes, Ferritins are polymers of 24 identical or similar subunits forming a spherical 
protein shell where up to 4500 iron atoms can be sequestered (Harrison and Arosio, 1996; 
Polidoro et al., 2002). They mainly composed of two subunit types, termed H and L. The 
ferritin H subunit has a potent ferroxidase activity that catalyses the oxidation of ferrous iron, 
whereas ferritin L plays a role in iron nucleation and protein stability (Orino et al., 2001). An 
unusual dodecameric ferritin has been isolated from the gram-positive bacterium Listeria 
innocua (Bozzi et al., 1997). L. innocua ferritin is an oligomeric, spherical protein complex 
containing up to 50–100 iron atoms per oligomer and the functional properties of an authentic 
ferritin (Ilari et al., 2000). It binds and incorporates iron as an authentic ferritin, although its 
sequence and structure are related to the DNA-binding proteins designated DNA-binding 
proteins from starved cells (Dps) that are expressed by bacteria under conditions of oxidative 
or nutritional stress (Almiron et al., 1992; Pena and Bullerjahn, 1995; Yamamoto et al., 
2000). The apoferritin shell of L. innocua does not contain 24 subunits like all ferritins, but is 
characterized by the dodecameric assemblage described for the Dps protein from E. coli 
(Bozzi et al., 1997; Grant et al., 1998). Each subunit contains one high affinity iron-binding 
site that resembles known ferroxidase sites (Ilari et al., 2000). The way of iron incorporation 
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by the dodecameric ferrirtin in Listeria innocua was recently investigated (Stefanini et al., 
1999). The polypeptide chain that assembles into the unusual dodecameric shell of Listeria 
innocua apoferritin lacks the ferroxidase centre characteristic of H-type mammalian chains, 
but is able to catalyse both Fe (II) oxidation and nucleation of the iron core. A cluster of five 
carboxylate residues, which correspond in part to the site of iron core nucleation typical of L-
type mammalian ferritins, has been proposed to be involved in both functions. Interestingly, 
the iron ligands in Listeria ferritin are conserved in the Dps proteins and belong to the group 
of amino acids forming the so-called DNA-binding signature, an observation in line with the 
recently reported iron binding capacity of a neutrophil-activing dodecameric protein from H. 
pylori (Tonello et al., 1999). At variance with the Dps proteins, Listeria ferritin does not 
appear to bind DNA (Bozzi et al., 1997). Hebraud M. and Guzzo J. have recently reported 
that the main cold shock protein of Listeria monocytogenes belongs to the family of ferritin-
like proteins. Its N-terminal sequence shared a complete sequence identity with a Listeria 
innocua non-heme iron-binding ferritin.  The purification of this protein revealed a native 
molecular mass of about 100-110 kDa which indicates a polypeptide composed of six 18 kDa-
subunits (Hebraud and Guzzo, 2000). As a part of the Listeria spp. genome project, the 
ferritin gene ( fri) has been identified at 970,638 bp in the 3,010,209 bp L. innocua 
chromosome and at 979,044 in the 2,944,528 bp L. monocytogenes chromosome (Glaser et 
al., 2001). 
 
1.7. Aim of this work 
 
In the first part of this study, due to the need for highly purified cytolysins in performing 
several biological and immunological assays, listeriolysin O (LLO) and pneumolysin (PLY) 
were expressed in the non-pathogenic species Listeria innocua followed by their purification 
by ion exchange chromatography.  
In the second part,  a novel Listeria monocytogenes ferritin (Frm) was identified as a target of 
the humoral response following infection of mice with pathogenic Listeria monocytogenes but 
not with the non-pathogenic Listeria innocua. A Listeria monocytogenes ∆frm mutant lacking 
the entire frm gene was generated in order to simplify identification of the role of this novel 
protein during Listeria infection as well as in mediating protection against reactive oxygen 
intermediates (ROI).    
In the third part, the suitability of some Listeria mutants to be used as live vaccines against 
the corresponding virulent pathogen or as a carrier for introducing heterologous antigen into 
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animals and humans was investigated. Two categories of mutants were tested, the first 
includes the isogenic Listeria monocytogenes mutant strains that harbour either a specific 
deletion within the actin nucleator gene (actA) and/or multiple deletions within the actA and 
phosphlipase B (plcB) genes. The second category includes a recombinant of the non-
pathogenic Listeria innocua harbouring the complete virulence gene cluster (vgc) from the 
wild type Listeria monocytogenes. The attenuation of these mutants, their ability to survive in 
mouse listeriosis model and to induce a protective as well as inflammatory T- cell mediated 
immunity was tested.   
In the fourth part, the question if replacement of  listeriolysin O (LLO) with another related 
cholesterol-binding cytolysin can maintain the listerial capacity to escape the host cell vacuole 
and gain access into the cytosole as well as to induce a protective antilisterial immunity was 
addressed. In this respect, prokaryotic shuttle vector harbouring the coding region for 
pneumolysin downstream from the hly promoter and regulated by prfA was constructed and 
transformed into the isogenic Listeria monocytogenes deletion mutant EGD-e∆hly. The ability 
of the mutant to express and secret pneumloysin into the extracellular environment, its 
intracellular survival both in vitro and in vivo as well as induction of humoral and cellular 
responses to this mutant was examined.    
Finally, the role of the putative PEST-like sequence in listeriolysin O in mediating induction 
of protective antilisterial immunity was analysed by studying the intracellular survival of L. 
monocytogenes mutant, lacking the PEST like sequence, both in vitro and in vivo as well as its 
ability to induce production of an effector and protective cellular antilisterial response. 
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2. Materials and Methods  
 
2.1. Bacterial strains and plasmid vectors 
 
Bacterial strains as well as plasmid vectors used during this work are shown in tables 2.1. and 
2.2. respectively with their specific features as well as their resources and/or references. 
 
 
Table 2.1. Bacterial stains. 
Strain Genotype/phenotype Resource/Reference 
Escherichia coli: 
INVαF' F' endA1, recA1, hsdR17(rk-,mk+), supE44, thi-1, 
gyrA96, relA1, F80lacZ∆ M15, ∆ (lacZYA-
argF)U169.  
Life technologies co.,  
Karlsruhe 
 
DH5αTM F-Φ80∆lacZ∆M15,∆(lacZYA-argF)U169,deoR 
recA1,endA1,hsdR17(rk-,rk+),phoA,supE44,λ-thi-1, 
gyrA96, relA1. 
Life technologies co.,  
Karlsruhe 
 
XL2-Blue RecA1, endA1, hsdR17, SupE44, thi-1, gyrA96, 
relA1, lac [F1 lacIqZ∆M15 Tn10 (TetR) Amy 
CamR]. 
Stratagene co.,  
Amsterdam; Holland 
 
Listeria monocytogenes: 
EGD-e Serotype 1/2a Mackaness, 1962 
 
EGD-e∆hly2 Deletion of amino acids 61 to 420 coding 
nucleotides in hly gene. 
Guzman et al., 1995 
 
EGD-e∆actA2 Deletion of amino acids 31 to 425 coding 
nucleotides in actA gene. 
Chakraborty et al., 
1995 
EGD-e∆actA 
∆plcB 
Deletion of amino acids coding nucleotides starting 
from aa 31 in actA to aa 264 in plcB. 
Darji et al., 2003 
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Strain Genotype/phenotype Resource/Reference 
Listeria innocua 
L. innocua Serotype 6a NCTC 11288 Francis and Stewart, 
 1997 
L. innocua + 
pUvBBAC::vgc  
Serotype 6a NCTC11288 harboring a 6, 6 kb 
fragment encoding the prfA virulence gene cluster 
(prfA-plcA-hly-mpl-actA-plcB) of L. 
monocytogenes on a BAC-based shuttel vector 
(pUvBBAC). 
Hain et al., unpublished 
 
Table 2.2.  Plasmid vectors. 
APR = Ampicillin resistant, KmR  = Kanamycin resistant, EmR = Erythromycin resistant, CmR = 
Chloramphenicol resistant, MCS = multiple cloning site, origin (ori) = origin of replication, ts = 
temperature sensitive. 
 
Plasmid Features 
Antibiotic 
resistance 
Reference 
pCR®2.1-
TOPO® 
lacZα,M13-andT7-Primer binding 
position,MCS,colE1-Origin 
ApR, KmR Invitrogen co., 
Groningen; Holland 
 
pERL3 lacZα,MCS,ermC,ColE1-origin,pAMβ1-
origin 
EmR Leimeister-Wächter et 
al.,1990 
 
pERL3-503 prfA and hly genes from L. 
monocytogenes in pERL3 
EmR Darji et al., 1995 
pAUL-A LacZa`,MCS,ermC,pMPa-origin,orits from 
pE194 
EmR Chakraborty et al.,  
1992 
 
pSOG304 Shuttel vector E. coli-L. monocytogenes, 
ErmC  from pE194,ColE1 from 
LITMUSTM, pIP501-Replicon without 
copR, prfA gene from L. monocytogenes 
EmR Otten S., unpublished 
pSOG306  promoter and signal peptide of hly gene 
from L. monocytogenes in pSOG304 
EmR Otten S., unpublished 
 
pPL2 Shuttel vector E. coli-L. monocytogenes, 
MCS,ComC ,col p15A ori,RP4 oriT,U153 
integrase, L. monocytogenes p60 promoter
CmR Lauer, et al. 2002 
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Plasmid properties 
Antibiotic 
resistance 
Reference 
pUvBBAC 
Shuttel BAC-based Gm+ve/Gm-ve vector , 
MCS, LacZα, single-copy mini-F replicon 
in Gm-ve host, low-copy pIP501 replicone 
in Gm+ve host, lox-sites for chromosomal 
integration of BAC-recombinant 
 
EmR,CmR Hain et al., 
unpublished 
 
 
 
In this work, the Escherichia coli host for pCR®2.1-TOPO®, pERL3-503, pSOG304, as well 
as pSOG306 plasmid vectors was INVαF' while DH5αTM  and XL2-Blue was the host for 
pAUL-A and pPL2 plasmid vectors respectively. 
 
2.2. Chemicals and biochemicals 
 
Standard chemicals purchased from Amersham Pharmacia Biotech (Freiburg), Boehringer 
Mannheim (Mannheim), Life Technologies (Karlsruhe), Merck (Darmstadt), New England 
Biolabs (Schwalbach), Roth (Karlsruhe), Serva (Heidelberg) und Sigma-Aldrich 
(Deisenhofen) were used during this work. Synthetic oligonucleotides were purchased from 
Sigma-ARK scientific (Steinheim).  Enzymes for restriction digestion from New England 
Biolabs and MBI Fermentas (St. Leon-Rot) as well as Taq-Polymerase from Life 
Technologies were used. 
 
2.3. Culture media, supplements, buffers and solutions 
2.3.1. Culture media 
 
E. coli strains were grown in Luria-Bertani (LB) medium (Sambrook et al., 1989). LB 
medium consists of: 
1.0 % [w/v] tryptone                                        10 g 
0.5 % [w/v] yeast extract                                   5 g 
0.5 % [w/v] NaCl                                               5 g            (H2O ad 1000 ml) 
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L. monocytogenes EGD-e, L. innocua wild type strains as well as  its mutant derivatives were 
grown in Brain Heart Infusion (BHI) medium containing 37.0 g  brain heart infusion (Difco 
co., Augsburg) in 1.0 l H2O. For preparing LB and BHI agar medium, 1.5% [w/v] 
bacteriological agar (Life Technologies, Karlsruhe) was added. For detecting the hemolytic 
activity of L. monocytogenes and E. coli strains, enterohemolytic washed blood agar plates 
from Oxoid co. (Wesel) were used. 
L. monocytogenes were grown in minimal medium (Premaratne et al., 1991) containing 
glucose as a defined carbon source. Minimal medium is composed of: 
 
Salt component A (see below)                             100 ml 
Salt component B (see below)                               10 ml 
13 mM ferric citrat                                                 20 ml 
20% [w/v] glucose                                                 50 ml 
1 mg/ml Amino acids solution                               10 ml 
5 mg/ml L-cysteine                                                 20 ml 
30 mg/ml L-glutamine                                            20 ml 
10 mg/ml Riboflavin (Vitamin B2)                         50 µl (in 1 N formic acid) 
10 mg/ml Thiamine (Vitamin B1)                         100 µl 
10 mg/ml (+)-Biotin                                                 50 µl (in 0.1 N NaOH) 
1 mg/ml DL-6.8-Thioctic Acid:                                 5 µl (in 70% [v/v] Ethanol) 
H2O                                                                 ad 1000 ml 
                                                                                            
Salt component A: 
KH2PO4                                                                   6.56 g 
Na2HPO4.7 H2O                                                   30.96 g 
H2O                                                                   ad 100 ml 
Salt component B: 
MgSO4.7 H2O                                                         4.09 g 
H2O                                                                   ad 100 ml 
Amino acids solution: 
L-Arginine                                                                0.1 g 
L-Isoleucine                                                              0.1 g 
L-Leucine                                                                 0.1 g 
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L-Methionine                                                          0.1 g 
L-Valine                                                                  0.1 g 
H2O                                                                  ad 100 ml 
All components were autoclaved separately and/or sterile filtered. Amino acids solution were 
stored at 4°C, vitamins at -20°C while all other components were kept at RT. Cysteine and 
glutamine solutions must be freshly prepared due to its oxidative instability. 
 
For production of competent E. coli cells, E. coli were grown in SOB-medium (Inoue et al., 
1990):     
 
2.0% [w/v] tryptone                                                5.0 g 
0.5% [w/v] yeast extract                                       1.25 g 
10 mM NaCl                                                       0.145 g 
2.5 mM KCl                                                        0.045 g 
10 mM MgCl2.6 H2O                                              0.5 g 
10 mM MgSO4.7 H2O                                         0.615 g 
H2O                                                                  ad 250 ml 
 
The SOC-Medium in which E. coli cells are suspended after managing the transformation 
contains 20 mM of D- glucose in addition to the components of the SOB medium.   
 
2.3.2. Media supplements 
 
For inoculation of culture media by antibiotic resistant strains, the following antibiotics were  
added: Ampicillin (stock solution 100 mg/ml in 50% (v/v) ethanol, end concentration 100 
µg/ml), erythromycin for selecting plasmid-containing E. coli strains (stock solution 50 
mg/ml in 96% (v/v) ethanol, end concentration 300 µg/ml), erythromycin for selecting 
plasmid-containing L. monocytogenes strains (stock solution 5 mg/ml in 96% (v/v) ethanol, 
end concentration 5 µg/ml) and chloramphenicol (stock solution 5 mg/ml in 70% (v/v) 
ethanol, end concentration 8 µg/ml for selecting plasmid-containing L. monocytogenes strains 
or 20 µg/ml for selecting plasmid-containing E. coli strains). For production of 
electrocompetent L. monocytogenes cells, penicillin was used (Stock solution 10 mg/ml in 
50% [v/v] ethanol, end concentration 10 µg/ml). For killing the extracellular bacteria after  
monolayer eukaryotic cell line infection in case of  invasions or plaque-assays, gentamicin 
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was used (Stock solution  50 mg/ml in H2O, end concentration 20 µg/ml or 10 µg/ml in soft 
agar into the over layer of eukaryotic cells respectively).  
In E. coli strains containing plasmids  harbouring the multiple cloning site (mcs) in the lacZα 
gene, the medium must contain 5-Bromo-4-chlorindoxyl-β-D-galactoside (XGal; Stock 
solution  20 mg/ml in Dimethylformamid, end concentration 15 µg/ml) for detecting the 
successful insertion of the desired gene in the mcs region of the plasmid. 
 For production of electrocompetent Listeria, bacteria were grown in BHI medium containing 
0.5M D-sucrose. For electroporation purpose, BHI medium with 0.5M D-sucrose was used. 
 
2.3.3. Buffers and solutions 
 
TE Buffer: 
          
              10 mM Tris.HCl (pH 8.0) 
              1.0 mM EDTA                            
 
GES-Reagent: 
               
              60 g      guanidiniumthiocyanate 
              0.5 M   EDTA                                                             20 ml 
              10% [w/v]   sodium-N-lauroylsarcosinate                    5 ml 
              H2O                                                                       ad 100 ml 
              Sterile filter with 0.45 µm-Filter and  
              keep at room temperature away from light .                       
 
50X TAE-Puffer: 
                
              242.3 g                   Tris 
              57.1 ml                   96% [v/v] acetic acid 
              100 ml                    0.5 M EDTA (pH 8,0) 
              H2O                       ad 1000 ml                       
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5X loading buffer (for agarose gel electrophoresis): 
                                      
              25.0% [w/v]            ficoll Type 400 
              0.25% [w/v]            bromphenol blue 
              in TE buffer 
 
DNA standard marker: 
 
The 1 Kb Plus DNA Ladder TM (delivered from Life Technologies, Karlsruhe as aliquots of 
1µg/µl) was diluted to be used at an end concentration of 50 ng/µl as follows: 
 
               1 Kb Plus DNA Ladder TM                    20 µl 
               5X loading buffer                                100 µl 
               TE  buffer                                       ad 400 µl 
 
From this dilution, 10-12 µl were loaded onto the agarose gel.  
The ladder contains a total of twenty bands; ten bands ranging in size from 3000 bp to 12000 
bp in 1000-bp increments while the other ten bands ranges in size from 100 to 2000 bp. 
 
CCMB80 solution: 
               
               CaCl2.2H2O                                            11.8 g 
               MnCl2.4H2O                                             4.0 g 
               MgCl2.6H2O                                             2.0 g 
               Potassium acetate                                   0.98 g 
              Glycerin (sterile)                                    100 ml 
               H2O                                                 ad 1000 ml 
 
10X  PCR buffer: 
                                                                                                                               End conc.: 
             1 M Tris.HCl (pH 8.3)                              200 µl                                  200 mM 
             1 M MgCl2                                                  20 µl                                    20 mM 
             1 M KCl                                                     250 µl                                  250 mM 
             10% [v/v] tween 20                                      50 µl                               0.5% [v/v] 
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             10 mg/ml    gelatin                                       100 µl                                 1 mg/ml 
             H2O                                                        ad 1000 µl 
 
10X  PBS: 
            
           NaCl                                                                   80 g 
           KCl                                                                    2.0 g 
           Na2HPO4                                                          6.1 g 
           KH2PO4                                                            2.0 g 
           H2O                                                         ad 1000 ml  (pH 7.4 with 1M NaOH) 
                                        
2X sample buffer (SDS-PAGE): 
 
         100% [v/v] glycerin                                         2.0 ml 
         10% [w/v]  SDS                                               1.0 ml 
         100% [v/v] β-Mercaptoethanol                        0.2 ml 
         0.5 M Tris.HCl (pH 6.8)                                0.29 ml 
         0.2% [w/v] bromphenolblue                          0.15 ml 
         (in 0.1 M Tris.HCl [pH 7,5]) 
         H2O                                                                  6.9 ml 
 
Polyacrylamide resolving gel (10 or 12%):                  
       
       1.5 M Tris.HCl (pH 8.8)                                       5 ml 
        Rotiphorese® Gel 30                             6.45 or 8.4 ml 
        10% [w/v] SDS                                                 0.2 ml      
        TEMED                                                              10 µl       
        25% [w/v] APS                                                   60 µl      
        H2O                                                       8.15 or 6.2 ml 
 
Polyacrylamide stacking gel (5.7 %): 
 
      0.5 M Tris.HCl (pH 6.8)                                      2.5 ml 
      Rotiphorese® Gel 30                                            1.9 ml 
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      10% [w/v] SDS                                                    0.1 ml 
      TEMED                                                                3.5 µl 
      25% [w/v] APS                                                      40 µl 
      H2O                                                                      5.4 ml 
 
10X SDS-running buffer: 
 
    Tris                                                                          30.3 g 
    Glycine                                                                     144 g 
    SDS                                                                            10 g 
    H2O ad                                                                  1000 ml 
 
Coomassie blue (for protein staining): 
 
    0.2%[w/v] coomassie R250 
    10% [v/v] acetic acid (96% [v/v] glacial acetic acid) 
    10% [v/v] ethanol 
    H2O ad 1000 ml 
 
Destaining solution for  SDS-PAGE: 
 
   10% [v/v] acetic acid (96% [v/v] glacial acetic acid) 
   40% [v/v] methanol 
   H2O ad 1000 ml 
 
Overnight destaining solution for  SDS-PAGE: 
 
   5% [v/v] acetic acid (96% [v/v] glacial acetic acid) 
   7.5% [v/v] methanol 
   H2O ad 1000 ml 
 
10X  Blot buffer: 
     
     Tris                                                                              58 g  
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   Glycine                                                                        29 g 
   SDS                                                                            3.7 g 
   H2O                                                                   ad 1000 ml 
 
10X  TBS: 
    
   Tris                                                                           24.2 g 
   NaCl                                                                            80 g 
   H2O                                                                 ad 1000 ml (pH 7.6 with HCl) 
 
1X  TBS-T: 
 
   100 ml        10X TBS 
   0.1% [v/v]   tween 20 
   H2O ad       1000 ml 
 
Blocking solution (for immunoblotting assay): 
 
   Skimmed milk                                                              5 g            
   1X TBS                                                                   100 ml 
 
BCIP-solution: 
 
   0.1 M glycine (pH 10) 
   1 mM ZnCl2 
   1 mM MgCl2 
   1 mg/ml 5-Brom-4-chlor-3-indolylphosphat-p-toluidine (BCIP) 
 
Sodium phosphate loading buffer for protein purification 
(cation exchange chromatography): 
    
    0.05M NaH2PO4                              pH 6.2 (with 0.05 Na2HPO4) 
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Sodium Phosphate elution  buffer for protein purification 
(cation exchange chromatography): 
   
   0.05M NaH2PO4                             pH 5.6    (with 0.05 K2HPO4)            
   1M NaCl  
Tris-HCl loading buffer for protein purification 
(anion exchange chromatography): 
 
   0.05M Tris                                      pH 7.5        (with 37% HCl) 
 
Tris-HCl elution  buffer for protein purification 
(anion exchange chromatography): 
   0.05M Tris                                      pH 7.5       (with 37% HCl) 
   0.5M NaCl 
 
Mowiol solution: 
   Mowiol                                           2.4 g 
   Glycerin 100 %(v/v)                      4.8 ml                 
   H2O                                                6.0 ml  → keep the mixture at room temperature 
   0.2M  Tris.HCl (pH 8.5)                12.0 ml→10 min at 50°C; 15 min at 5000g, 
                                                          take the supernatant, store at 4°C    
 
Diethanolamine buffer for ELISA: 
   MgCl2                                           10mg 
   Diethanolamine                            10ml 
   H2O         to                                 100ml          pH 9.8  (with37% HCl) 
 
Erythrocytes lysis buffer: 
 
   Tris                                           2.06 gm 
   NH4Cl                                       7.49 gm 
   H2O        to                             1000.0 ml        pH 7.2  (with37% HCl) 
     
FACS buffer: 
 
  FCS (100%)                       2.0 ml 
  PBS (1X)                                   98.0 ml 
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2.4. Bacterial storage 
 
To keep the bacteria for the routine use over a short period of time, bacteria were inoculated 
onto fresh agar plates every 4 to 8 weeks, incubated at 37°C, then stored at 4°C. E. coli 
species were grown on LB plates while Listeria strains were grown on BHI plates. In case of 
antibiotic resistance as a result of plasmid transformation, E. coli and L. monocytogenes were 
grown on LB and BHI agar plates supplemented with the corresponding antibiotics. 
For longer-term storage, 1.0 ml bacterial culture was mixed with 0.5 ml sterile 100 % (v/v) 
glycerin in a 2 ml cryotubes (Nalge Nunc, Hamburg), freezed in fluid nitrogen and 
subsequently stored in -80°C.    
 
2.5. Bacterial growth conditions 
 
 For the most purposes as for example plasmid DNA or chromosomal DNA isolation, 
infection assays, E. coli and L. monocytogenes were grown in 10 ml medium in 100 ml 
conical flasks at 37 °C with shaking at 180 rpm either in a water bath (Infors, Bottmingen, 
Swiss) or on a shaking apparatus (GFL co., Burgwedel) placed in a 37 °C incubation room. In 
case of all in vitro and in vivo infection experiments, subcultures were performed by 1:50 
dilution of overnight culture (200 µl) in a fresh medium (10 ml) followed by further 
incubation at 37 °C for 2-3 hours corresponding to the  bacterial exponential growth phase. 2 
ml of bacterial culture were transferred to a sterile 2.0 ml reaction tube, spinned down at 8000 
rpm for 2 minutes. The bacterial pellet was saved, resuspended in 2.0 ml sterile PBS and 
spinned down again. This washing step was repeated twice. The pellet was resuspended in 
PBS and the bacterial concentration was calibrated by measuring its optical density at 
wavelength of 600. Further dilutions were prepared in PBS to obtain required numbers of 
bacteria for infection (for details, see section 2.9.6.1). 
 
2.6. Bacterial growth measurement 
 
The optical density of bacterial culture was measured with a spectrophotometer (Ultrospec 
3000; Amersham Pharmacia Biotech, Freiburg).1.0 ml of bacterial culture or suspension was 
added in a disposable microcuvet and the optical density was measured at a wave length of 
600 nm. In case of optical density over 0.6, bacterial culture must be 1:10 diluted with the 
respective buffer or culture medium before measurement. 
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2.7. Molecular biological and molecular genetics methods 
 
Chromosomal as well as plasmid DNA isolation, restriction enzyme analyses and 
amplification by PCR were performed according to standard protocols (Sambrook et al., 1989; 
Ausubel et al., 1990; McClure et al., 2000). 
 
2.7.1. DNA isolation 
27.1.1. Plasmid DNA isolation from E. coli  
 
It took place by means of the GFXTM micro plasmid prep kit (Amersham pharmacia biotech. 
co., Freiburg) following instructions of the manufacturer. 3.0ml of bacterial culture were 
divided into two halves, centrifuged after each other for 1 minute at 13000 rpm in a 1.8ml 
reaction tube and treated according to the manufacturer instructions submitted for a 2-3 ml 
bacterial culture. Plasmid DNA was eluted with 50 µl 10 mM Tris.HCl (pH 8.5). If the 
plasmid DNA was intended to be used in sequencing reaction, double distilled H2O (pH 7.5) 
was used in elution. Plasmid DNA can be stored at -20 °C. 
 
2.7.1.2. Chromosomal DNA isolation from gram-positive bacteria  
 
  Chromosomal DNA was isolated from Listeria monocytogenes and Streptococcus   
pneumonia following the protocol of Pitcher et al. (1989) as follows: 
1.5 ml bacterial culture was spinned down in 1.8 ml reaction tube for 4 minutes at 1500 g. The 
supernatant was flicked out and the pellet was washed with 0.85% (w/v) NaCl solution, 
centrifuged at 15.000 g for 5 minutes, then suspended in 100 µl TE buffer containing 50 
mg/ml lysozyme  and finally incubated in a thermomixer (Eppendorf, Hamburg) at 37°C and 
1200 rpm for 30 minutes. 1.0µl Dnase-free Rnase (Boehringer Mannheim co., Mannheim) 
was added to the pellet, then incubated for 5 minutes at room temperature (RT) before mixing 
with 500µl GES-reagent by inverting the reaction tube 5 times. After 5 minutes incubation at 
RT followed by 2 minutes on ice, 250µl ice-cooled 7.5M ammonium acetate was added for 
protein precipitation. After 10 minutes incubation on ice, the reaction tube was inverted 5 
times for mixing. The DNA was extracted by adding 500µl phenol/chloroform/isoamyl 
alcohol (25:24:1) to the reaction tube. The reaction tube was inverted gently for 15 minutes, 
then centrifuged for another 15 minutes at 18.000g and 4°C. The upper aqueous layer was 
removed with a pipette and placed in a new microfuge tube. DNA was precipitated by adding 
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0.5 volume of 2-propanol followed by careful horizontal turning of the tube, careful and slow 
inverting and finally strong shaking so that the chromosomal DNA could be rolled up to a 
well visible coil. The received DNA coil would be a pellet through 5 minutes centrifugation at 
18.000 g and 4°C. The DNA pellet was washed five times, each with 1.0 ml 70% (v/v) 
ethanol and then centrifuged. Thereafter, the DNA pellet was vacuum dried for 5-10 min and 
resuspended in 100µl of filtered TE buffer. The DNA was dissolved by incubating the 
samples overnight at 37oC. The chromosomal DNA was stored at 4oC. According to the 
described method, 10µg of chromosomal DNA could be obtained from 1.5 ml of stationary 
grown bacteria. 
 
2.7.2. Enzymatic treatment of DNA 
2.7.2.1. DNA digestion with restriction enzymes 
 
In order to digest plasmid DNA for fragment isolation or further cloning, DNA quantities 
between 100 ng and several micrograms in a volume of 15 to 100 µl would be incubated for 1 
to 4 h with the respective restriction enzymes (about 5 to 25 Units per µg). The restriction 
digestion took place in the manufacturer enzyme specific reaction buffer. In case of restriction 
digestion with two restriction endonucleases working in two different buffer systems, the 
digested DNA would be purified after the first digestion by means of the QIAquick PCR 
Purification Kits (Qiagen co., Hilden) then incubated with the second enzyme. 
 
2.7.2.2. Ligation of a DNA fragment with a DNA vector     
In general, a 1:3 (vector: insert) ratio is recommended for the ligation reaction. The ligation is 
carried out in presence of  three ingredients in addition to water: Two or more fragments of 
DNA that have either blunt or compatible cohesive ends (the vector and the insert), a 1X 
buffer containing ATP which is provided as a 10X concentrate, and the T4 DNA ligase (Life 
Technologies co., Karlsruhe). The volume of the ligation mixture depends on the DNA 
concentration ranging from 15-40µl using 1-2 units from the T4-ligase for 50ng-2µg of DNA. 
The optimal incubation conditions for T4 DNA ligase is overnight at 16°C. 
2.7.3. Agarose gel electrophoresis 
Agarose gel electrophoresis is employed to check the progression of a restriction enzyme 
digestion, to quickly determine the yield and purity of a DNA isolation or PCR reaction, and 
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to size fractionate DNA molecules, which then could be eluted from the gel. Prior to gel 
casting, dried agarose is dissolved in 1X TAE buffer by heating. 0.5µg/ml ethidium bromide 
was included in the warm gel solution to enable fluorescent visualization of the DNA 
fragments under UV light. The warm gel is poured into a mold (made by wrapping clear tape 
around and extending above the edges of an 18 cm x 18 cm plastic plate), which is fitted with 
a well-forming comb. The percentage of agarose in the gel varied between 0.8-1.2 percent 
[w/v] depending on the expected size(s) of the fragment(s). Agarose gels are submerged in 1X 
TAE electrophoresis buffer in a horizontal electrophoresis apparatus. The DNA samples are 
mixed with 5X gel tracking dye (1:1 v/v) and loaded into the sample wells. Electrophoresis is 
usually carried out at 150 - 200 mA for 30-60 minutes at RT, depending on the desired 
separation. When low-melting agarose is used for preparative agarose gels, electrophoresis is 
carried out at 100-120 mA for 30-60 minutes, again depending on the desired separation. 1 kb 
plus DNA LADDERTM (Life Technologies co., Karlsruhe) size markers were co-
electrophoresed with DNA samples for fragment size determination. After electrophoresis, the 
gel is placed on a UV light (254nm) box and a picture of the fluorescent ethidium bromide-
stained DNA separation pattern is taken with the aid of a gel documentation system of 
Cybertech CSI (Cybertech co., Berlin) and a video copy processor (P68E; Mitsubishi Electric, 
Ratingen). If the DNA would be eluted from the gel for size fractionation purposes, the 
amount of time at which the DNA is exposed to the UV transilluminator has to be minimised 
because the UV mutagenises the DNA at a measurable rate. A clean scalpel blade is used to 
cut around the band of interest. The transilluminator is switched off and the white light is 
switched on. The band is carefully removed from the gel and placed on the glass. It is 
recommended to trim off as much empty agarose as possible. The excised band is transferred 
into a 1.8 ml microfuge tube. 
2.7.4. Extraction of DNA fragments from the agarose gel 
QIAquick gel extraction kit (Qiagen co., Hilden) following producer’s instructions was used. 
DNA is eluted with 20-30µl 10mM Tris.HCl (pH8.5) and can be stored at –20 °C for further 
use. 
2.7.5. Quantification of DNA concentration 
For cloning or sequencing purposes, the amount of DNA must be firstly measured using the 
Nanodrop ND-1000 spectrophotometer (G. Kisker GbR¸ Steinfurt). 1µl of the DNA sample is 
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pipetted directly onto the measurement surface. Using surface tension, a column is drawn 
between the ends of two optical fibers to establish the measurement path. DNA measurement 
took place at a wave length 260 nm and the amount of DNA is given as ng/µl. 
 
2.7.6. Transformation 
2.7.6.1. Transformation in E. coli 
2.7.6.1.1. CCMB80 method 
Chemically competent E. coli is prepared following the protocol of Hanahan et al. (1991). 20 
ml LB medium was inoculated with E. coli INVαF' strain and incubated overnight at 37°C. A 
1 ml overnight culture was inoculated in 50 ml SOB-medium and incubated at 25-30°C until 
the optical density at 550nm was approximately 0.3. The culture was chilled for at least 10 
min on ice. In the following steps, the cell suspension should be kept on ice as much as 
possible. The cell suspension was centrifuged for 10 min at 3.000 rpm (Sorvall GSA rotor, 
GMI co., Minnesota; USA) at 4°C. The pellet was gently resuspend in 17 ml ice-cold 
CCMB80 buffer and incubated for 20 minutes on ice then centrifuged for 15 minutes at 3000 
rpm (Sorvall GSA rotor) at 4°C. Again, the pellet is gently resuspended in 4.2 ml ice-cold 
CCMB80 buffer. The cell suspension is aliquoted at 200 µl per cryotube (Nalge Nunc co., 
Hamburg). The cell suspension is shock-freezed in liquid nitrogen and tubes are stored at 
80°C where they will be competent for at least 6 months. For transformation, competent E. 
coli  are thawed out on ice. 100-200µl of  competent E. coli  are gently mixed  with the  DNA 
preparation (usually 10pg to 10ng DNA) in a 1.8ml microfuge tube, incubated on ice for 30 
minutes and heat shocked at 42 °C for 90 seconds. The transformation mixture is added to 
800 µl SOC medium and incubated at 37 °C with shaking at 180-200 rpm for 1-3 hours 
depending on the antibiotic selection marker in the transforming DNA. If the transforming 
DNA has a phenotypic expression of ampicillin or chloramphenicol resistance, one hour will 
be enough for incubating the transformed E. coli but in case of erythromycin resistance, the 
incubation time will be extended to 3 hours. Finally, 50-200 µl of the transformed bacteria 
will be plated out on suitable selection media and incubated for 1-2 days at 37°C. In case of 
pPL2 and pAUL-A transformation, it is recommended that plates have to be incubated 
overnight at 30 °C due to its temperature sensitivity. 
 
2.7.6.2. Transformation in L.monocytogenes by electroporation 
 
Electrocompetent L. monocytogenes was prepared following the protocol of Park and Stewart  
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(1990). A single colony of L. monocytogenes or its isogenic mutants was inoculated in 10 ml 
BHI. The bacterial culture was grown overnight with shaking at 180 rpm and 37 °C. 2.0 ml is 
inoculated into 200 ml 0.5 M sucrose containing BHI in 1 L flask and incubated with shaking 
at 180 rpm and 37 °C for 2-3 hours till reaching OD600 of about 0.2.  200 µl of 10mg/ml 
penicillin G stock solution is added and bacteria were further incubated for 2 hours. Bacteria 
were spinned down at 5000 rpm for 10 minutes at 4°C (Sorvall GSA-rotor) and the 
supernatant was decanted. At this time point, bacteria must be kept on ice during work. The 
bacterial pellet was resuspended in 20 ml ice cold HEPES buffer (1 mM HEPES [pH 7.0], 
0.5M sucrose) and centrifuged at 6000 rpm and 4°C for 10 minutes. The pellet was again 
resuspended in 10ml HEPES buffer and centrifuged at 6000 rpm and 4°C for 15 minutes. This 
step was repeated three times. In the last time, the supernatant was decanted and the bacterial 
pellet was mixed thoroughly with 500 µl glycerin containing HEPES buffer (1mM HEPES 
[pH 7.0], 0.5M Sucrose, 10% [v/v] glycerin). The bacterial suspesion is aliquoted as 50 µl cell 
suspension in 1.8 ml cryotubes (Nalge Nunc co., Hamburg), shock-freezed in a liquid nitrogen 
and kept at –80°C. Electroporation took place by mixing 50µl of thawed electrocompetent 
bacteria with 1-10µl (containing 1-2µg) of plasmid preparation. The mixture was pipetted in a 
pre-cooled electroporation cuvette (0.1 cm slit; Invitrogen, Groningen; Holland). The  
electroporator is set at 1 KV, 400 ohms, 25 µFD. Cuvette was placed and pulsed. The time 
constant for electroporation is usually about 5 minutes. Immediately 1 ml pre warmed 0.5M 
sucrose containing BHI was added and bacteria was incubated for 1-3 hours, depending on the 
antibiotic selection, at 37°C and 180 rpm. 100-250 µl of bacterial suspension are plated out on 
selective media for 1-2 days at 37°C. 
 
2.7.7. Polymerase chain reaction (PCR) 
2.7.7.1. Amplification of DNA fragments for further cloning 
The DNA fragment, to be cloned in a vector, has to be amplified to an amount sufficient to be 
cloned with a minimum nucleotide mismatch. This can be done with the aid of the expandTM 
high fidelity PCR system (Boehringer Mannheim co., Mannheim) which increase both the 
yield and accuracy of the PCR product (Mullis et al., 1986). It contains the Pwo-DNA-
polymerase proofreading enzyme which increases the fidelity of PCR threefold over Taq 
DNA Polymerase. It prevents truncated products from mis-incorporated nucleotides as well as 
limiting primer degradation by the 3' to 5' exonuclease activity of the proofreader. According 
to the producer’s instructions, the volume of of PCR preparation for DNA fragment smaller 
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than 1kb is smaller than that of DNA fragment bigger than 1kb.The dNTP-mixture used in the 
hifi PCR preparation was prepared from stock solution of 100mM dNTP set (Life 
technologies co., Karlsruhe). The concentration of each nucleotide in the dNTP-mixture is 
5mM while its end concentration in the PCR preparation is 200µM. The end concentration of 
each primer in the PCR preparation is 30nM. 1-2µl of isolated chromosomal DNA(100ng-
1µg) is used as a template. It is common to use 0.2ml "thin walled" tubes (Biozym Diagnostic 
co, Hess. Oldendorf) for polymerase chain reactions. These tubes transmit the temperature 
changes faster.  PCR took place in thermocyclers Gene Amp PCR system2400 (Perkin Elmer 
co., Langen).  
The amplified DNA has to be purified from buffer, primers and other proteins prior to cloning 
or restriction digestion. The purification is done by means of QIAquick PCR purification kits 
(Qiagen co., Hilden) according to the manufacturer’s instructions. The DNA is eluted with 
20-30µl of 10mM Tris.HCl (pH 8.5). After purification, 3-5µl DNA can be tested with 
agarose gel electrophoresis for the right size of the PCR amplified DNA. 
Usually , the amplified DNA fragment is subcloned in  PCR®2.1-TOPO®  vector with the aid 
of TOPOTM TA Cloning® kit (Invitrogen co., Groningen, Holland) and transformed in E. coli 
INVαF'. Now, the DNA insert in the new constructed PCR®2.1-TOPO® derivative is available 
for further restriction digestion and cloning in other vectors. Sometimes, the amplified DNA 
fragment can be used directly in further restriction digestion and ligation in the desired vector. 
2.7.7.2. Amplification of DNA fragments for testing the recombinant clone 
After cloning a DNA fragment in the desired vector by ligation or in the PCR®2.1-TOPO®  
vector by topoisomerisation, PCR analysis is performed to confirm the identity of the right 
clone using  forward and reverse primers possessing sequences complementary either to those 
of the vector lying up-and down stream from the DNA insert or to  the sequences at the 5` and 
3`ends of the DNA insert. One colony of the transformed bacteria is picked by means of a 
tooth pic and placed in a 0.2ml reaction tube (Biozym Diagnostic co., Oldendorf).  50µl of 
PCR preparation is added in the tube as follows: 
                                                                                                           End conc.: 
10X PCR buffer                                        5.0 µl                                    1X  
5 mM dNTPs                                             2.0 µl                                    200 µM 
20 µM forward primer                               0.5 µl                                    200 nM 
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20 µM reverse primer                                0.5 µl                                    200 nM 
Taq-Polymerase (5 U/µl)                         0.25 µl                                   1.25 U/50 µl 
H2O                                                     ad 50.0 µl 
 
The thermostable Taq polymerase was obtained from Life Technologies (Karlsruhe). 
The temperature program of PCR reaction was adjusted as follows: 
 
1)   2 min                                                    94°C 
2)   20 sec                                                   94°C 
3)   30 sec                                                   55°C 
4)   90 sec                                                   72°C 
5)   3 min                                                    72°C 
6)   ∞                                                            4°C 
Steps 2) to 4) are repeated 25 times. The PCR product is tested for the right size through 
agarose gel electrophoresis.   
 
2.7.8. Construction of a site-directed insertion mutation 
 
The isogenic deletion mutants were produced by means of chromosomal integration of a 
pAUL-A vector containing a portion of the desired gene coding sequence (Chakraborty et al., 
1992; Schäferkordt and Chakraborty, 1995). The pAUL-A vector is a plasmid containing a 
temperature sensitive origin of replication from plasmid pE194, lacZa` multiple cloning site 
surrounded by transcriptional terminators and erythromycin resistance marker expressed in 
both E. coli and Listeria sp. Two fragments from the chromosomal DNA, one is (often about 
1000bp) upstream and the other (often about 500 bp) downstream from the gene of interest 
were amplified with high fidelity PCR followed by PCR product purification and restriction at 
the 3` end of the upstream fragment as well as the 5`end of the downstream fragment with the 
same endonuclease. Thereafter, the two restricted fragments were ligated together and the 
ligation product lacking the gene of interest was amplified with high fidelity PCR and 
restricted at its 5` and 3` ends with specific endonucleases.  The pAUL-A plasmid was 
isolated from E. coli DH5α and restricted with the same endonucleases followed by ligation 
with the PCR amplified and restricted chromosomal DNA fragment. The ligation mixture was 
transformed into E. coli INVαF' followed by overnight incubation at 30°C. Recombinants 
were identified as Lac_ (white coloured) colonies and the plasmid DNA was analysed by PCR 
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analysis using the forward primer for the upstream fragment and the reverse primer for the 
downstream fragment to identify the insert with the right size followed by DNA sequencing to 
identify plasmids carrying the correct insert. These plasmids were isolated from E. coli 
INVαF' and electroporated into L. monocytogenes EGD-e followed by overnight incubation at 
30°C. Again, PCR analysis was performed with grown EGD-e colonies to confirm the 
presence of plasmids carrying the right size of insert. Integration of the plasmid was achieved 
by streaking out the PCR positive colonies onto BHI plates containing 5µg/ml erythromycin 
and overnight incubation at 42°C. At this temperature, pAUL-A can not multiply but will 
integrate into the chromosomal DNA by homologous recombination disrupting the whole 
gene in the chromosomal DNA with its insert possessing the deleted gene sequence. Several 
transformants were purified by re-streaking colonies onto BHI plates containing 5µg/ml 
erythromycin and further incubation at 42°C. Colonies were tested by PCR analysis using 
universal primers of pAUL-A (M100/M101), which bind few nucleotides up and downstream 
of the multiple cloning site of  pAUL-A, to identify integration of pAUL-A into the 
chromosomal DNA. The absence of the band corresponding to the insert indicates a 
successful integration. A weak band refers to incomplete integration. So, re-streaking must be 
continued for further few days till complete integration is achieved. The homologous 
recombination between the chromosomal and pAUL-A DNA sequences is accomplished by 
two-step gene replacement procedure. The plasmid is first integrated in the chromosome 
corresponding to the site on the plasmid that was cleaved by a restriction endonuclease. 
Homologous recombination results in two copies of the gene, separated by the plasmid 
sequences. The second step involves homologous crossing over in the repeated DNA segment 
to loop-out the plasmid, along with the intact gene. In other words, the wild-type 
chromosomal allele can be replaced by the mutant allele from pAUL-A. To exice  pAUL-A  
that carry either the wild type or the mutant gene out of the bacterial cell, PCR positive 
colonies were overnight incubated in BHI containing 5µg/ml erythromycin at 30°C. At the 
next day, the bacterial culture was 1:1000 diluted and further incubated at the same conditions 
till reaching OD600 of 0.3-0.5 followed by further 1:20 dilution in BHI containing 10µg/ml 
erythromycin and incubation for 2.5 hours at 30°C. Addition of 200µg/ml ampicillin and 
overnight incubation at 30°C gives selection for bacteria that already lost pAUL-A to live 
over bacteria that still containing pAUL-A. Several dilutions from the bacterial culture (10-1 
_10-5) were plated out on BHI plates without erythromycin and overnight incubated at 30°C. 
The colonies that grow only on BHI plates but not on those containing 5µg/ml erythromycin 
were selected for PCR analysis using the forward primer for the upstream fragment and the 
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reverse primer for the down stream fragment to find out if the homologous recombination 
managed to exchange the wild type with the mutant gene. Colonies that carry the mutant gene 
underwent sequencing analysis to confirm the correct insert sequence. 
 
2.7.9. DNA sequencing 
 
Identification of nucleotides sequence of a DNA fragment was carried out using a strength of 
grouping cycle sequencing with the aid of thermosequenase fluorescent labelled primer cycle 
sequencing kit and ALFexpress (both purchased from Amersham Pharmacia Biotech co., 
Freiburg) following the manufacturer’s instructions. For each sequencing reaction 1µl  of 
Cy5-labelled primer(1-2pmol) was combined with 6µl of the tested DNA fragment (0.5µg)  
and added to each of four labelled microfuge tubes containing 2µl of  G,C,T or A dNTPs and 
introduce the four sequencing reaction mixtures to the thermocycler pre-programmed as 
follows:    
                             1) 5 min.                           95°C 
                             2) 30 secs.                        98°C 
                             3) 40 secs.                        60°C 
                             5)  5 min                          60°C 
                             6)  ∞                                  4°C 
 
 
Steps 2)  and 3) were repeated 25 times. Addition of 5µl stop buffer to each reaction tube 
could stop the reaction. 
 
2.7.10. Computer programs 
 
Nucleotides sequences were processed with the aid of “ Heidelberg Unix Sequence Analysis 
Resources”(HUSAR) program and the lasergene  99-sequence analysis system (DNA STAR, 
Inc; purchased from GATC Biotech, Konstanz). Figures of plasmid and new clones were 
created with the aid of “Clone Manager 5” while graphics and pictures were processed with 
the aid of Corel Draw (Scientific and Educational Software co., Durham; USA). Different 
statistical  data were converted to figures using Sigma plot 2000 (SPSS Inc., Chicago; USA). 
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2.7.11. Primers 
 
All primers used in this work either for purpose of amplification or sequencing was combined 
in the following list: 
 
Table 2.3. A list of primers used either in DNA amplification or in sequencing. Sites for restriction     
                 digestion are underlined                
                
Primer Nucleotide sequence (5`→3`) Restriction 
site 
hly-gene for 5’- AATTCCCTCGAGCCTCCTTTGATTAGTATATTC –3’ XhoI 
hly-gene rev 5’- AGCCACCTACAACTAGTCTGACAGAGAG  -3’ SpeI 
hly-P for 5’- CTTGACTAGAGGGTACCTCC-3’ KpnI 
PEST rev 5’-CTGAAGCAAAGCATATGTCTGC-3’ NdeI 
PEST for 5’-AAGACGCATATGGAAAAGAAACACG-3’ NdeI 
hly∆PEST rev 5’-TATGGATCTCGAGTCAGATATTC -3’ XhoI 
ply-gene for AGGTAGCATATGGCAAATAAAGCAG NdeI 
ply-gene rev CCCTGTATCTCGAGGAATTGG XhoI 
Lmo-fri for1 TTGTTCTCTCGGATCCGTTGACAAGGTTTCTTTATC BamHI 
Lmo-fri rev 1 AAATTCCTTTGCGGCCGCTGAGTTGATTGTTTTC NotI 
Lmo-fri for 2 CAAACATATCGCGGCCGCCAAAGCATTCTTAGGAAAA
GC 
NotI 
Lmo-fri rev 2 GTTTTTGGTTCAAGCTTGATTTTCCAGTCGTGGTC HindIII 
fri for CCTGAAAGCGGTGAGCTCAATTTTCCATA SacI 
fri rev CATTTATTTGCTTGGTCGACTACCTCGATATTC SalI 
M100 GTAAAACGACGGCCAGT / 
M101 CAGGAAACAGCTATGAC / 
 
2.8. Protein biochemical methods 
2.8.1. Protein isolation from Listeria species 
2.8.1.1. Proteins in bacterial supernatant 
 
A fresh colony of Listeria sp. was inoculated in 250-300 ml conical flask containing 50 ml 
BHI and incubated at 37°C and 180 rpm till reaching OD600 of 1.0. The bacterial culture was 
transferred into 50 ml reaction tube. Bacteria were removed by centrifugation for 20 minutes 
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at 2.800g and 4°C. The culture supernatants were carefully aspirated and transferred into a 
fresh tube. Supernatant proteins were precipitated overnight by the addition of 10% (v/v) 
trichloroacetic acid (TCA) at 4°C on ice. The supernatant was centrifuged for 20 minutes at 
6.200g and 4°C. The precipitated proteins were suspended in Tris.HCl (pH 8.8) and stored at 
–20°C. 
 
2.8.1.2. Somatic soluble antigens 
 
Bacteria were cultured overnight in 20ml BHI broth and transferred to 50 ml reaction tube. 
The supernatant was removed by centrifugation for 5 minutes at 8000 rpm and RT. Bacterial 
pellet was washed twice with PBS, and subsequently subjected to ultrasonication. 1g (wet 
weight) of bacterial cells was suspended in 10 ml of PBS and sonicated (87.5% output, degree 
7 on a sonifier [Model S-125; Branson Sonic Power Co., Danbury, Conn; USA]) 6 times for 1 
minute followed by 1 minute incubation on ice per time to avoid elevation of temperature. 
The sonicated suspension was centrifuged at 39000g for 50 minutes, and the supernatant was 
filter sterilized (pore size 0.45µm [Millipore co. Eschborn]), aliquoted and stored at –20°C. 
 
2.8.2. Protein analysis 
2.8.2.1. SDS-Polyacrylamide Gel Electrophoresis 
 
Two glass plates (one notched and the size of both is 10 x 10cm.) were attached together 
using fixed spacers and a one-piece profiled silicone rubber seal and fixed with clamps. The 
assembly was kept to stand upright using clamps as supports. Resolving gel was prepared in 
0.25 M Tris.HCl pH 8.8 with a final concentration of 10 or 12% depending on the molecular 
weight of the separated proteins. The gradients of the resolving gel were mixed gently 
ensuring no air bubbles form and subsequently poured carefully into glass plate assembly. 
The gel was overlayed with water to ensure a flat surface and to exclude air and left one hour 
to dry. Water was decanted before adding the stacking gel. Stacking gel was prepared in a 
final concentration of 5.7% in 0.125 M Tris.HCl pH 6.8, mixed and poured carefully onto the 
top of set resolving gel, comb was inserted and allowed to set for 30 minutes to dry. The 
assembled glass plates were fitted in a gel casting stand (Biometra co., Göttingen). The comb 
was removed and the gel casting stand was filled with 1X SDS running buffer so as to 
completely cover the gels. Protein samples were mixed with 2X sample buffer (3:1 v/v), 
heated at 95°C for 5 minutes and loaded into the wells in the stacking gel by layering them 
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under the running buffer using a micropipet. The gel casting stand was covered with the 
protection cover and connected to the power supply with a voltage of 150v and a current of 
200mA for 60-80 minutes. As a molecular weight marker, 5.0µl of a pre-stained SDS-PAGE 
standard marker (Bio-Rad co., Philadelphia; USA) possessing a wide molecular weight range 
covered by broad range pre-stained standards ranging from 6.0 to 200.0 kDa was also loaded. 
The gel was covered with Coomassie blue staining solution, sealed in plastic box and left on a 
shaker for 2 to 3 hours at RT with agitation. The stained gel was destained with destaining 
solution with agitation. 
 
2.8.2.2. Immunoblotting (Western blot) 
2.8.2.2.1. BCIP immunodetection procedure 
 
After separation of proteins by the SDS-PAGE electrophoresis, the gel was transferred on a 6 
x 9 cm piece of PVDF transfer membrane (Millipore co., Eschborn) previously soaked in 100 
% (v/v) methanol. Both gel and PVDF membrane were sandwiched between two Whatmann 
3MM papers (Biometra co., Göttingen) previously soaked in 1X blot buffer. The assembled 
gel with membranes were carefully transferred into FastblotTM B44 semidry blotting system 
(Biometra co., Göttingen) in a manner that the electric current passes from the cathod  through 
the gel and then through the PVDF membrane to the anode. The blot casting was connected to 
the standard power pack supply P25 (Biometra co., Göttingen) and blot running parameters 
were adjusted to voltage of 200v and a current of 250mA per gel for 45 minutes. The blotted 
nitrocellulose membrane was blocked in freshly prepared 5% skimed milk in 1X TBS buffer 
for 2 hours at RT with constant agitation. The primary antibody was diluted to the 
recommended concentration in a fresh TBS containing 0.2% tween 20 (TBS/T). The 
nitrocellulose membrane was soaked in the primary antibody solution and incubated for 1 to 2 
hours at RT or overnight at 4ºC with agitation. The primary antibody used in this work may 
be  monoclonal or polyclonal antibodies (Table 2.4.) as well as natural antisera isolated from 
mice previously infected with Listeria monocytogenes or its derived mutants.  The 
nitrocellulose membrane was washed five times for 3 to 5 minutes each with TBS/T. The 
nitrocellulose membrane was incubated in TBS/T solution containing a 1:1000 diluted 
secondary antibody for 30-60 minutes at RT. For a mouse monoclonal antibody, alkaline 
phosphatase conjugated goat-anti-mouse IgG was used while for a rabbit polyclonal antibody, 
alkaline phosphatase conjugated goat-anti-rabbit IgG (Dianova co., Hamburg) was used. The 
nitrocellulose membrane was washed five times for 3 to 5 minutes each with TBS/T. 
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Detection of proteins was performed using BCIP solution as an enzyme substrate. As soon as 
the protein bands were detected, membrane was washed 4-5 times with water and left to air 
dry. 
 
2.8.2.2.2. Enhanced chemiluminescence (ECL) immunodetection procedure 
 
This method is more sensitive than that using BCIP as a substrate. So, it is often used for 
detection of minor amounts of proteins. The sequence of procedure was the same as that 
mentioned above with some differences; the secondary antibody used in this technique was 
either horseradish peroxidase-conjugated goat-anti-mouse or anti-rabbit IgG (1:1000 diluted). 
After the last wash, the membrane was transferred to a clean glass plate and covered with a 
membrane of 10 ml of developing solution (ECL from Amersham International, Piscataway; 
USA) for 2 minutes. The excess of developing solution was drained and  membrane was 
wrapped in Saran Wrap (Dow chemical co. South Carolina ;USA), fixed in an x-ray film 
cassette with the proteins facing up and exposed to an x-ray film (Kodak co. ,Stuttgart, 
Germany)  in a dark room for few seconds or up to several minutes. 
 
Table 2.4. A list of first antibodies used in Immunoblotting during this work 
Detected  protein(s) Type of antibody Dilution in TBS-T 
LLO (Listeriolysin O) monoclonal (mouse ab) 1:15000 
PLY (Pneumolysin) monoclonal(mouse ab) 1:15000 
monoclonal(mouse ab) 1:15000 Frm ( Ferritin-like protein 
from L. monocytogenes ) polyclonal (rabbit ab) 1:10000 
 
2.8.3. Protein Purification 
 
Bacterial cytolysins were hyper-expressed in L. innocua through co-expression of the positive 
regulatory factor prfA in the plasmid vector in conjunction with the structural cytolysin gene 
(Darji et al., 1995). One bacterial colony was inoculated in 20 ml BHI overnight with shaking 
at 180 rpm and 37ºC. 10 ml of the overnight bacterial culture was used to inoculate one liter 
of minimal medium in a 3 liter volume conical flask. The bacterial culture was incubated 
without shaking at 30ºC for 48 hours. The bacterial pellet was removed by centrifugation at 
6000 rpm for 30 minutes at 4ºC in a floor F6-6X 250ml Sorvall centrifuge (GMI, Minnesota; 
USA). The supernatant was concentrated by transferring at 4ºC to Amicon stirred cell series 
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8000 (Millipore co., Eschborn) with a cut-off point of 30 kDa  and allowed to be concentrated 
to about 25 ml. In case of cation exchange chromatography used for purification of 
listeriolysin O, the concentrated supernatant was patch absorbed with Q-sepharose (pharmacia 
co., Freiburg), pre-equilibrated with loading buffer (20mM sodium phosphate, pH6.2) for 60 
minutes. The non-absorbed fraction was centrifuged, filtered by 0.45µm Millipore filter and 
transferred through a super loop, which allows introduction of larger sample volumes into a 
pressurized fluid system, to a HiPrep™ 26/10 desalting column intended for desalting and 
buffer exchange using Äkta explorer which is a high-performance chromatography system (all 
tools and components used in connection with ÄKTA explorer were purchased from  
Pharmacia biotech AB, Uppsala; Sweden) and UNICORN™ control system version 3.0 
provided with a program for  protein desalting. Proteins were eluted from the desalting 
column with the loading buffer that used in the ion exchange chromatography in order to 
carry the same charge as the loading buffer. Purification of the desired protein from 
supernatant fluids was achieved by ion exchange chromatography. Separation in ion exchange 
chromatography depends upon the reversible adsorption of charged solute molecules to 
immobilized ion exchange groups of opposite charge. In cation exchange  chromatography, 
pH of the loading buffer (sodium phosphate loading  buffer) must be lower than the isoelectric 
point of the desired protein by at least 0.5 units while must be higher with the same value 
when applying to anionic exchanger (Tris.HCl loading buffer). Resource S column was used 
as a cation exchange column while Resourse Q was used as an anion exchange column 
depending on the isoelectric point of the separated protein. With the aid of Äkta explorer and 
UNICORN™ control system version 3.0 provided with a program for ion exchange 
chromatography, the column was firstly equilibrated with the loading buffer at a flow rate of 
4ml/min followed by introduction of the sample. The protein of interest was bound with the 
oppositely charged chromatographic medium leaving the other proteins carrying the same 
charge to elute out of the column. When the elution buffer start to drop in the column, 
conditions were then altered by increasing salt concentration so that the bound substances 
were eluted differentially and collected in a fraction collector with the solution eluting from 
the column being monitored by an absorbance device for measuring the protein concentration 
in the effluent. The quantity of the isolated protein in mg/ml could be determined by 
measuring the effluent at OD280 and dividing the optical density value by 1.25. Also, the 
haemolytic activity of the purified cytolysin could be identified qualitatively and 
quantitatively by the aid of hemolysin titre test. The cytolysin was stored in aliquots at –80ºC. 
Under these conditions, they were stable for more than 6 months. 
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2.8.4. Screening of hemolytic activity 
 
With the aid of hemolysin titre test, the haemolytic activity of a protein can be identified by 
measuring the magnitude of lysis of (1% v/v) sheep erythrocytes suspension (Young et al., 
1986). 1 ml of defibrinated erythrocytes (Oxoid co., Wesel) was diluted with gentle mixing in 
9 ml of 1X PBS (pH 5.6 or pH 7.0) in 15 ml reaction tube followed by centrifugation for 5 
minutes at 2900 rpm and 4ºC. The supernatants was gently decanted and the washing step was 
repeated once. 100 µl from the washed erythrocytes was added to 9.9 ml of 1X PBS (pH 5.6 
or pH 7.0) containing 10 mM DTT. In case of measuring the haemolytic activity in bacterial 
culture supernatant, the supernatant was separated from bacteria by centrifugation at 14000 
rpm for 2 minutes. The test was carried out in 96-well microtiter plates with tapered (v-
shaped) well base. 50µl of 1X PBS (pH 5.6 or pH 7.0) was added to each of the 12 well of the 
row except the first well where 100 µl of the protein suspension was added.  1:2 serial dilution 
was carried out in the next 11 wells by gentle mixing of 50 µl from the protein suspension in 
the first well with the 50µl of 1X PBS (pH 5.6 or pH 7.0) in the second well followed by 
mixing 50 µl from the second well with that in the third and so on till reaching the end of the 
row where 50 µl from the last well was flicked out. A negative control sample (100 µl of 1X 
PBS [pH 5,6 or pH 7.0]) and a positive control sample (100 µl of distilled water) were 
included in all tests. 50 µl of washed defibrinated (1% v/v) sheep erythrocytes suspension was 
added to each well followed by incubation for 1-3 hours at 37ºC and 5%CO2. The non-lysed 
erythrocytes would aggregate and the intact erythrocytes could be seen as a pellet on the base 
of plate wells. To measure the haemolytic activity of a purified protein, 100µl of the purified 
protein was added in the first well followed by 1:2 serial dilutions in 1X PBS as previously 
discussed. To quantify the haemolytic activity, the number of wells containing lysed 
erythrocytes was counted. The hemolytic units were expressed as the reciprocal dilution of 
toxin that is required for 50% lysis of erythrocytes compared to the lysis obtained by distilled 
water. 
 
2.9. Cell culture 
2.9.1. Eukaryotic cell lines 
 
Infection assays were carried out in a variety of eukaryotic cell lines of different types and 
derived from several sources (Table 2.5.). Furthermore, the P3-X63-Ag8-653 myeloma cell 
line was included in production of monoclonal antibodies (Table 2.5.). 
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Table 2.5. Eukaryotic cell lines used in this study 
Cell line Cell Type Organ Source Catalog. Nr. 
HeLa Epithelial Uterus Human DSMZ ACC 57 
J774A.1 Monocytes / Mouse DSMZ ACC 170 
L-929 Fibroblasts subcutaneous tissue Mouse DSMZ ACC 2 
P3-X63.Ag8–653 Myeloma cells / Mouse DSMZ ACC 43 
P3-X63.Ag8–653 * Myeloma cells / Mouse DSMZ ACC 43 
* X63.Ag8–653 myeloma cell line transfected with BCMG-Neo vector harbouring  mouse IFN-
γ cDNA.  
 
2.9.2. Cell culture media and supplements 
 
DMEM:                                   Dulbecco’s Modified Eagle Medium; with sodium pyruvate, 
                                                1 g/l  glucose and pyridoxine (Life Technologies co.) 
MEM:                                      Minimum Essential Medium; with Earle's salts; L-glutamine 
                                                (Life Technologies, Karlsruhe co.) 
RPMI 1640:                             RPMI 1640; with L-glutamine, and 2.0 g/l NaHCO3 
                                                (PAN Biotech, Aidenbach co.) 
FCS:                                       100% Foetal Calf Serum (Sigma-Aldrich, Deisenhofen co.) 
L-Glutamine:                          100X; 29.3 mg/ml in normal saline, 200 mM (PAA  
                                                Laboratories, Linz; Österreich) 
NEA:                                       Non-essential amino acids (100X) (Biochrom co., Berlin) 
Hanks’ salt solution:              Hanks’ salt solution (1X); w/o Ca2+, Mg2+, w/o Phenol Red 
                                               (Biochrom co., Berlin) 
Trypsin/EDTA:                      Trypsin/EDTA (1X) (PAA Laboratories, Linz; Österreich) 
2X MEM:                               Modified Eagle Medium (2X); with L-glutamine, w/o phenol 
                                                red (Life Technologies co.) 
2% [w/v] Agar:                      Agar, cell culture tested (Sigma-Aldrich co.), 2% [w/v] in                           
                                               H2O 
Neutral red:                            Neutral red solution (Sigma-Aldrich co.) 
 
 
HeLa cells were grown in MEM , J774A.1 were grown in DMEM , and L929 cells as well as 
X63.Ag8–653 myeloma cell line were grown in RPMI 1640. To prepare a complete medium, 
all media were supplemented with 10 % (v/v) foetal calf serum, and 2mM L-glutamine and 
2. Materials and Methods                                                                                                          65                       
5x10-5 M 2-mercaptoethanol. MEM was additionally supplemented with 1% (v/v) non-
essential amino acids (NEA). HAT selection medium is prepared by supplementing a 500 ml 
complete RPMI 1640 medium with 2 % (v/v) of 50X HAT (Gibco # 21060-017). X63.Ag8–
653 cells producing IFN-γ  were grown in complete RPMI medium supplemented with 
10µg/ml G418 as a selection antibiotic (Life technologies co., Karlsruhe). 
In Plaque assay, the infected monolayer of L-929 cells was incubated in MEM medium 
containing the following components: 
 
2X MEM                                 12.9ml 
100% [v/v]  FCS                       1.5ml 
100X NEA                                0.3ml 
100X L-glutamine                    0.3ml 
2% [w/v]  Agar                        15.0ml 
2.0 ml from this mixture were applied to each well. 
            
         2.9.3. Counting the eukaryotic cells using a microscope counting chamber 
 
For cell culture applications that require the use of cell suspensions it is necessary to 
determine cell concentration. A device used for cell counting is called a counting chamber 
(Becton Dickinson co., Frankfurt/Main). To prepare the counting chamber, the mirror-like 
polished surface is carefully cleaned with lens paper. The coverslip is also cleaned. Coverslips 
for counting chambers are specially made and are thicker than those for conventional 
microscopy since they must be heavy enough to overcome the surface tension of a drop of 
liquid. The coverslip is placed over the counting surface prior to putting the cell suspension. 
The cell suspension was 1:10 diluted in a sterile trypan blue solution (Sigma-Aldrich co., 
Munich),which can stain only the living cells, and 10µl of diluted cell suspension was 
introduced into one of the V-shaped wells by means of a 10µl pipet (Eppendorf co., 
Hamburg). The suspension was allowed to be drawn into the chamber by capillary action. 
Care should be taken not to overfill or underfill the chamber. The opposite chamber was filled 
in the same manner. The charged counting chamber is then placed on the microscope stage 
and the counting grid is brought into focus at low power. The counting chamber consists of 
sixteen 1 mm squares divided into smaller squares. Each square represents a volume of 10-4 . 
The whole cells in the sixteen squares were counted. To determine the number of cells per ml, 
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the total number of cells counted in all squares was multiplied by 104 and by the dilution 
factor (10). 
2.9.4. Culture of eukaryotic cells 
The eukaryotic cells were cultured in 15ml of its suitable medium in rounded cell culture 
dishes (Nalge Nunc co., Hamburg) and incubated at 37ºC in presence of 5% CO2 (Steri-Cult 
incubator, Forma scientific/Labotect, Göttingen) for 3 to 4 days when the cells are about 80% 
confluent. Then, the cells are detached from the surface by trypsinization. The cells were 
washed twice with 5ml Hanks’ salt solution (Biochrom AG co., Berlin) followed by addition 
of 1.0ml Trypsin/EDTA and incubated for 5 minutes at 37ºC. 500µl of detached cell 
suspension was reseeded in a new cell culture plate containing 15ml of fresh corresponding 
medium. If cells were intended to be used in an infection assay or a plaque assay, the 
Trypsin/EDTA cell suspension was taken, one day before performing the assay,  in 15 ml of 
the corresponding medium, counted using a microscope counting chamber and adjusted to 
105cells/ml. Cell suspension was seeded in 24-well plate (1ml/well) for invasion assay or 6-
well plate (2ml/well) for plaque assay. 
 
2.9.5. Storage of eukaryotic cells 
 
In order to keep the eukaryotic cells viable for a long time, cells were washed with Hanks’ 
salt solution followed by addition of 1 ml Trypsin/EDTA and incubated for 5 minutes at 37ºC. 
Cells were detached from the plate surface by trypsinization. The cells were counted and the 
number was adjusted to 106/ml. 1ml aliquots of cell suspension was added separately in  15ml 
conical tubes (BD bioscience co., Heidelberg) and washed with 10ml of its corresponding 
medium by centrifugation for 10 minutes at 1100rpm and 37ºC. The medium was removed 
while the cell pellet was resuspended in  500µl of FCS containing 8% dimethyl sulfoxide 
(DMSO) in 2ml-cryotubes (Nalge Nunc co., Hamburg) and kept in a freeze box (Nalge Nunc 
co., Hamburg) with 250ml 2-propanol overnight at -80ºC. At the next day the cryotubes were 
transferred into a tank of liquid nitrogen for long period storage. When needed, the cryotube 
was taken out from the N2 tank, thawed at 37ºC and added to 15ml of its corresponding 
medium in a cell culture plate and incubated at 37ºC and 5% CO2. When 50% confluent 
growth was obtained, the medium must be changed with fresh one in order to eliminate any 
traces of DMSO because of its toxic effect on the cells. 
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2.9.6. Infection of eukaryotic cell lines with Listeria strains 
2.9.6.1. Invasion assay 
 
The ability of the wild type Listeria monocytogenes or its mutant derivatives to invade and/or 
proliferate in eukaryotic cells can be identified and quantitatively estimated by performing the 
invasion assay. Eukaryotic cells were seeded and grown in its corresponding tissue culture 
media in cell culture plates. The number of 24-wells cell culture plates used in the assay was 
equal to the number of time points at which the bacteria will be isolated and plated out after 
eukaryotic cell infection. In all assays performed during this work four plates, each 
corresponding to one time point, (ranging from 1 to 8 hours) were used. Each bacterial species 
were used to infect three wells containing eukaryotic cells in each plate, with an additional 
fourth well containing a slide cover for detecting the bacterial invasion through fluorescent 
microscopy. Carrying out the assay independently in triplicates is necessary to confirm the 
number of isolated bacteria from each well separately. One day before the screening assay, 
the cells were collected and counted by the aid of the counting cell chamber. 105 cells were 
seeded per well. At the same day, single colony from each bacterial species were picked with 
a sterile toothpick and used to inoculate 20 ml of BHI, with or without antibiotics, in a 250ml 
conical flask followed by overnight incubation. At the day of assay, the overnight bacterial 
culture was 1:50 diluted in BHI medium and incubated for further 3 hours at 180 rpm and 
37ºC till reaching OD600 of 0.8-1.0. 2 ml of the exponentially growing bacteria were 
centrifuged for 2 minutes at 8000 rpm and RT. The supernatants were flicked out and the 
bacterial pellets were washed twice by 2 ml of PBS by centrifugation at the same conditions 
to remove any traces of BHI. The number of bacteria in PBS will be quantitatively determined 
through measuring the optical density at OD600. The bacterial suspension will be diluted to be 
equivalent to OD600 of 0.1. By the aid of L. monocytogenes growth curve, it was estimated 
that OD600 of 0.1 for Listeria monocytogenes is equivalent to 1.6x108cfu/ml. Then bacterial 
suspensions were further 1:10 diluted in the eukaryotic cell culture medium and 300µl from 
this suspension (Approximately 5X106 cfu) were pipetted into its corresponding four wells 
containing the eukaryotic cell monolayer in each of the four assay plates to be equivalent to 
MOI of 10. The bacteria were spinned down for 1 minute at 2800 rpm to come in contact with 
the eukaryotic cells. The plates were incubated at 37ºC and 5% CO2 for a period depending 
on the invaded cell line; In case of J774 macrophages, 30 minutes will be enough for bacteria 
to be phagocytosed but in case of HeLa cells, the time will be elongated to one hour for 
bacteria to be internalised into the eukaryotic cells. The inoculating bacterial suspensions 
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were diluted to 1.6x103 cfu/ml by 1:10 serial dilutions in 1X PBS and 20 µl would be used for 
plating out BHI agar plates to confirm equal inoculating numbers of bacteria for all 
inoculating bacterial species. After incubation, plates were taken out and washed three times, 
each with 1ml of eukaryotic cell culture medium per well followed by addition of 1 ml of cell 
culture medium containing gentamicin (20µg/ml) in order to kill the extracellular bacteria. 
The plates were incubated for a period ranging from one hour to eight hours under the same 
conditions. At each determined time point after incubation, a single plate was taken out  from 
the incubator, washed 3 times with 1ml 1X PBS per well. The well containing the coverslip 
was fixed by treating with 0.5ml of cold 3.7% formaldehyde in 1X PBS for 10 minutes at RT 
followed by washing twice with 1X PBS and incubation in 1 ml 1X PBS at 4ºC for further 
processing for immunofluorescent microscopy preparation (see section 2.9.6.3).  
Permeablisation of eukaryotic cell membrane in the other 3 wells took place by addition of 
1.0ml of a cold sterile distilled water containing 0.2% (v/v) triton X-100 followed by 
incubation for 10 minutes at RT. The internalised bacteria diffused out of lysed eukaryotic 
cell line through strong pipetting in each well. The bacterial suspensions were 1:10, 1:100, 
and 1:1000 diluted in PBS and each dilution was plated out in dublicate on BHI agar plates 
followed by overnight incubation at 37ºC. Bacterial colonies were counted and the numbers of 
colony forming units per well were calculated by multiplying the colonies number by its 
corresponding dilution factors. The mean value of cfu/well and the standard error was 
estimated from the values of cfu in each of the 3 wells. Growth kinetics for each bacterial 
strain is represented through drawing a growth curve for each bacterial species by the aid of 
Sigma plot software. 
 
2.9.6.2. Plaque assay 
 
Performance of plaque assay (Sun et al., 1990) is similar to invasion assay in terms of 
bacterial or viral invasion and proliferation in eukaryotic cell lines but plaque assay can 
qualitatively determine these parameters. So, plaque assay gives indication for bacterial 
multiplication in eukaryotic cells as well as cell to cell spread by counting the number of clear 
plaques in a continuous sheet of cultured cell monolayer infected with bacteria. One day 
before performing the assay, L-929 cell line culture was diluted, and adjusted to 5 
x105cells/ml. 2 ml was seeded in each well of 6-well cell culture plates. Inoculating bacterial 
suspensions were prepared as described in invasion assay and 10µl from 1.6x108 cfu/ml 
bacterial cell suspension was used to inoculate each well of the 6-well plate. The plates were 
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incubated for 2 hours at 37ºC and 5% CO2 followed by washing twice with Hanks’ salt 
solution and addition of 2 ml of complete RPMI 1640 medium containing 20µg/ml 
gentamicin. The MEM-soft agar mixture (see section 2.9.2) must be prepared just before use. 
A sterile 2% agar was melted completely in a microwave.  Agar was allowed to cool slightly, 
to near 70°C and 20 ml was aliquoted to a 50 ml conical tube. 20 ml of pre-warmed 2X MEM 
containing 5% FCS, non-essential amino acids, glutamine, 10µg/ml gentamicin, as well as the 
recommended concentration of the selection antibiotic (when assay was performed for 
plasmid containing bacteria) was added to the 20 ml aliquot of 2% agar, and incubated in a 
37°C water bath. When ready, the plates were tipped up and let drain to one side. The entire 
medium was aspirated, the plates were turned to level and quickly the overlay agar was 
removed from the water bath and approximately 2 ml of molten overlay mixture was added to 
each well by allowing it to slide down the far wall of the well and onto the plate. The plates 
were incubated for 3 days at 37ºC and 5%CO2. This time period gave plaques the chance to be 
big enough to be detected. The plaques were stained by adding 1ml sterile neutral red (1:10 
diluted in 1X PBS, pH 7.4) to each well followed by further incubation for 3-4 hours at 37ºC. 
Destaining was performed with 1 ml of 1X PBS/well and subsequent 30 minutes incubation. 
Now plaques could be easily counted. The size and number of plaques can give information 
about the ability of bacteria to escape phagosomes, multiply and invade the neighbour cells. 
 
2.9.6.3. Immunofluorescence microscopy 
 
 The coverslips with attached infected eukaryotic cells (see section 2.9.6.1.) were prepared for   
immunofluorescence microscopy by flicking out the PBS followed by permeablization of 
eukaryotic cell membrane by only one minute incubation with 600µl 1X PBS containing 
0.2%(v/v) triton X-100 per well at RT with subsequent washing twice with 1X PBS. The 
coverslips were taken out of the 24-well plates and placed on a wet Whatman3MM paper 
(Biometra co. ,Göttingen). The intracellular infecting bacteria were stained by incubation with 
20µl of undiluted primary monoclonal antibody (a mixture of both specific α-ActA-antibody 
N4 and N81) for 30 minutes at RT. The coverslips were washed 3 times by immersing them 
in a beaker containing 1X PBS followed by removing the buffer by a careful attaching the 
coverslip to a Whatman3MM paper. 20 µl of 1:100 diluted Oregon Green 488 conjugated 
phalloidin (green) and anti-mouse antibody conjugated with Cy3 (red) mixture was added to 
each coverslip followed by incubation for 30 minutes at RT and 3 times washing with 1X 
PBS. Thereafter, 4 µl of 1:1 mowiol/antifade mixture (The antifade solution was purchased 
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from Biorad Lab., München) was pipetted as a drop on a preparation slide and the coverslip 
was carefully placed on the drop with the attached cells side coming in contact with the drop. 
The slides were kept away from light for 15 minutes allowing mowiol to dry. The coverslips 
were fixed to the slide by surrounding the coverslip with a layer of a nail polish, thus avoiding 
the movement of coverslips during microscopic examination and preventing air trapping 
between the coverslip and the slide. The coverslips were examined under a fluorescence 
microscope and images were captured and processed using KS 300 software (Carl Zeiss co., 
Berlin). Under the microscopic field, the green fluorescent eukaryotic cell actin skeleton and 
actin polymerisation processed by Listeria monocytogenes together with the red fluorescent 
bacterial cells could be detected. 
 
2.10. Immunological methods 
2.10.1. Experimental mice infection 
 
Mice used in all experiments were six to eight week-old female BALB/c mice, purchased 
from Harlan Winkelmann co., Borchen and were kept at breeding facilities in specific-
pathogen-free conditions. 
Primary infection with Listeria strains was performed by an intravenous or intraperitoneal 
injection of viable bacteria in a volume of 0.2 ml of PBS (for preparation of bacterial 
suspension, see section 2.5). In all experiments, the dose of primary infection with the wild 
type EGD-e was approximately 1000-2000 cfu/mouse while 50.000 cfu/mouse (equal to 10 
times the LD50 of the wild type L. monocytogenes) was the challenge dose. The primary 
infection dose of all L. monocytogenes mutants was approximately (106-107) cfu/mouse 
except for EGD-e∆frm (2000 cfu/mouse). 
 
2.10.2. Determination of bacterial load in infected organs 
 
At certain time points after infection, spleens and livers were aseptically removed from mice 
in a biohazard facility. Shortly, mouse was euthanised by CO2 inhalation and submerged in 
70% ethanol. The mouse was left to air dry on its back on a paper towel. Spleens and livers 
were removed using sterile instruments and carefully suspended in 3ml and 5ml 0.2% NP40 
in 1X PBS respectively. The organs were aseptically homogenized by means of polytron 
homogenizer (Kinematica AG, Littau-Lucerne; Switzerland.) at a speed of 7000 rpm. 
Bacterial growth in spleens and livers was determined by plating 10-fold serial dilutions in 1X 
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PBS (10-1-10-3) of the organ homogenates on BHI agar. The detection limit of this procedure 
was 102 colony forming units (cfu) per organ. Colonies were counted after 24 hours of 
incubation at 37°C. 
 
2.10.3. Production of protein-specific antibodies 
 
2.10.3.1. Polyclonal antibodies 
 
Specific polyclonal antisera against various listerial proteins were produced in rabbits. 6 week 
old rabbits (New Zealand White) were used for immunization. The purified protein is diluted 
to a final concentration of 200 µg in 1.0 ml PBS and combined with 1.0 ml of the appropriate 
adjuvant. The protein and adjuvant are mixed thoroughly to form a stable emulsion which is 
injected subcutaneously and provides enhanced immune response from the sustained presence 
of the immunogen. Blood is collected from the central ear artery with a 19-gauge needle and 
allowed to clot and retract at 37°C overnight. The clotted blood is then refrigerated for 24 
hours before the serum is decanted and clarified by centrifugation at 2500 rpm for 20 minutes. 
The schedule of immunization was carried out according to Richard et al. (2004) as follows: 
At the day of immunization (step A), 5.0 ml of blood is drawn from the rabbit’s ear to prepare 
about 2.0 ml of pre-immune serum utilizing as a negative control. For each rabbit, 200µg of 
antigen in PBS are emulsified with complete Freund’s adjuvant (CFA) and injected 
subcutaneously. At day 21 (step B), 200 µg of antigen in  PBS are emulsified with CFA and 
injected subcutaneously into each rabbit. At day 28 (step C), 200 µg of antigen in PBS are 
emulsified with incomplete Freund’s adjuvant (IFA) and injected subcutaneously into each 
rabbit. At day 35 (step D), 1.0 ml of blood is drawn from the rabbit’s ear to prepare about 0.5 
ml of serum. This sample is tested by ELISA or immunoblotting assay, against the protein 
used for immunization, for its positivity versus the pre-immune serum. A positive signal 
allows proceed to Step E, a negative signal results in the process returning to Step B. At day 
37 (step E), 100 µg of antigen in PBS are emulsified with CFA and injected subcutaneously 
into each rabbit. At day 44 (step F), 100 ml of blood are drawn from each rabbit. At least 40 
ml of serum is then obtained which can then be utilized at a dilution from 1:1000 to 1:10000.  
 
2.10.3.2. Monoclonal antibodies (mAb) 
 
Monoclonal antibodies utilized in this study were generated by hybridoma fusion (Berry et 
al., 2003). Mice were immunized i.p. with 5µg of purified protein in PBS emulsified with 
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complete Freund’s adjuvant. In general, mice were immunized every 2-3 weeks. When a 
sufficient antibody titer is reached in serum, the immunized mouse was euthanized by CO2 
inhallation, spleen was removed in a biohazard facility and kept in 10 ml of complete 
RPMI1640 medium for transport back to the lab. Additionally, peritoneal cells were removed 
from naive mouse by peritoneal lavage for use as feeder cells. Spleen was placed into sterile 
petri dish and cells were perfused out of the spleen by poking the spleen 8-10 times with an 
18 ga needle followed by injecting the complete RPMI medium slowly in the spleen by means 
of a 3ml-syringe with 21 gauge needle. The injection process was repeated many times until 
nearly all the spleen cells were washed out. The spleen was discarded into the biohazards bag. 
Spleen cells were carefully collected, transferred to a 50 ml conical tube and spinned down at 
900 rpm for 12 minutes at 4°C (Eppendorf centrifuge 5810 R, Eppendorf; Hamburg). The 
pellet was resuspended in 30 ml serum free complete RPMI 1640 medium and spinned down 
again as above. At the day of fusion, approximately 107 cells of P3-X63-Ag8–653 mouse 
myeloma cell line were spinned down at 850 rpm for 12 minutes at 4°C and washed with 30 
ml serum free complete RPMI 1640 medium. The cells were spinned down again, 
resuspended in the same medium and left at 37°C until spleens are retrieved. Both immune 
spleen cells and myeloma cells were counted using a microscope counting chamber and 
combined at a ratio of 5:1 (spleen cells: myeloma cells). In addition, peritoneal cells were 
washed twice as above in serum-free complete RPMI and counted. The cell combination was 
washed 2 times more with 30 ml serum-free complete RPMI 1640 medium and spinned down 
as above. The supernatant was aspirated and the pellet was broken by gentle tapping on the 
flow hood surface. The tube was placed in container of warm water (37°C). Gradually, over a 
period of 30 seconds, 1 ml of 37°C PEG 1500 (Roche diagnostics, Mannheim) was added 
while tapping the side of the tube to achieve thorough mixing. Mixing was continued over the 
next 90 seconds. After approximately 1 minute 40 seconds, mixing was stopped and a 5 ml 
pipet was filled with warm serum-free complete RPMI. When exactly 2 minutes had elasped, 
the PEG/cell mixture was slowly diluted by adding dropwise 1 ml of serum-free complete 
RPMI over a 1 minute time span. During the next 1 minute, 2 ml of the same medium was 
added dropwise. The remaining 2 ml in the pipet was added during the next 40 seconds. Next 
a 10 ml pipette was used to add 14 ml of 37°C pre-warmed serum-free complete RPMI during 
the last 1 minute period. The total volume was brought to 50 ml using a complete RPMI 
medium supplemented with 5% fetal calf serum, centrifuged at 4°C and resuspended in a 
selective HAT medium at the appropriate volume to bring the cells to a concentrations of 1.5 
x 106 cells per ml. HAT medium is a selection medium for hybrid cell lines; contains 
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hypoxanthine; aminopterin; thymidine. Only hybridoma cell lines (B-lymphocytes+myeloma 
cells), but not  unfused meyloma cells or B-lymphocytes, can  express both hypoxanthine 
phosphoribosyl transferase (HPRT+) and thymidine kinase (TK+) and subsequently survive in 
this medium. Peritoneal cells were added to the fused cells at 2.5 x 104 cells per ml and the 
cells are dispensed into 96 well plates in a volume of 150µl. 24-48 hours later, all wells are 
treated with 50µl of 4X HAT. Fusion plates were examined at 24-48 hours for any 
abnormalities (i.e. bacterial contamination). On day 7, wells were inspected under microscope 
and then fed. One half of the volume in each well was aspirated using a sterile Pasteur pipet. 
A new pipet was used for each plate. Wells were fed with 125 µl of complete RPMI1640 
supplemented with 1X HAT on days 7, 11 and thereafter as needed. Cultures were examined 
visually at each feeding. Once a majority of wells appear 50% confluent for growth, 
supernatants were harvested for screening by ELISA or by immunoblotting assay against the 
antigen used in immunization. Plates were fed at this time. Supernatants from Positive clones 
were isotyped using “hybridoma subisotyping kit” (Merck Biosciences co., Schwalbach), 
purified using standard methods on protein A-Sepharose (Sigma, St. Louis, MO). Antibody 
concentration was determined by the measurement of absorbance at OD 280. Supernatants 
were stored at –20°C. Positive hybridomas were expanded in 6-well plates till 50 % confluent 
growth, harvested and stored in liquid nitrogen. 
 
 2.10.4. Detection of Listeria-specific antibodies 
 
Type specific IgG anti-listeria antibodies were detected in mice antisera 7-9 days after 
Listeria infection. Listeria specific antibodies were either qualitatively detected using 
immunoblotting assay (see section 2.8.2.2) or quantitatively measured using ELISA assay.   
ELISA measures type specific IgG anti-Listeria specific antibodies present in mice serum. 
When dilutions of mice sera are added to type-specific Listeria antigen coated microtiter 
plates, antibodies specific for that antigen bind to the microtiter plates. The antibodies bound 
to the plates are detected using a goat anti-mouse IgG alkaline phosphatase-labeled antibody 
followed by a p-nitrophenyl phosphate substrate. The optical density of the coloured end 
product is proportional to the amount of anti-Listeria antigen antibody present in the serum. 
Blood was collected from mice by cardiac puncture. Cardiac puncture must be carried out on 
an anesthetized animal only. This is a terminal procedure used to acquire the maximum 
volume of blood from a mouse (approximately 1.5 ml). Mice were anesthetized with an 
inhalant diethyl ether and checking that the pedal response be absent before starting. The 
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mouse was laid flat on its back. An area on the left side of the mouse at the base of the elbow 
was landmarked where the heartbeat is the strongest. A 23ga needle was inserted, attached to 
a syringe, between 2 ribs into the heart. The needle was slowly advanced down and forwards. 
When the heart is pierced, blood would be visible in the hub of the needle which must be 
steady in this case with thumb and index fingers and the syringe was gently aspirated. Blood 
samples were transferred to a sterile 2.0 ml reaction tube and centrifuged at 14.000 rpm for 
10 minutes. Serum was carefully aspirated and stored at 20°C before analysis. 
For ELISA, 96-well NUNC Maxisorb plates (Nalge Nunc, Hamburg) were incubated at 4°C 
overnight with 100 µl of somatic soluble antigen from L. monocytogenes diluted 1:2 in 0.5 M 
sodium carbonate buffer, pH 9.6. Plates were sealed to prevent evaporation.  After two 
washes with TBS-0.2% Tween (TBS/T), non-specific binding was blocked by adding 150 µl 
of 2% bovine serum albumin. Plates were sealed and incubated at RT for 1-2 h. Individual 
sera were added to the samples starting at a dilution of 1:10 and serially diluted 1:2 in 0.5% 
BSA in TBS/T for determining the end point titers. Plates were sealed. After 1.5 h at 37°C, 
plates were washed three times with TBS/T, and 100 µl of alkaline phosphatase-coupled goat 
anti-mouse IgG (BD bioscience co., Heidelberg) diluted 1:1000 in TBS/T were added. Plates 
were sealed and incubated at RT for 30 minutes followed by 5 times washing with TBS/T. 
One tablet of alkaline phosphatase substrate (Sigma-Aldrrich co., Deiesenhofen) was 
dissolved in 10 ml diethanolamine buffer by vortexing. Immediately 50 µl of substrate 
solution was dispensed into each well. Plates were incubated at RT for 5-10 minutes for 
colour development. Optical densities were measured with a SpectraMax 250 ELISA reader 
(MWG Biotech, Ebersberg) at 405 nm. Each assay was performed in duplicates, and data 
represent means ±SD.  
 
2.10.5. DTH response to somatic listerial antigen 
 
For determination of DTH (Delayed Type Hypersensitivity) responsiveness, somatic soluble 
L. monocytogenes EGD-e antigen diluted in sterile PBS (final protein concentration: 60 
ng/ml) was injected into the left hind footpads of mice while the right one was injected with 
only PBS and acts as a control. Twenty-four hours later, thickness of the left and right 
footpads of individual mice were measured with dial-gauge calipers (Kröplin co., 
Schlüchtern). DTH-induced footpad swelling was calculated by subtracting the mean 
differences between left and right footpad thickness of injected naive control mice from those 
of immune mice (Mielke et al., 1998). Non-specific footpad swelling never exceeded 0.2 mm. 
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2.10.6. Stimulation of spleen cells in vitro for cytokine production 
 
Infection of mice with Listeria strains gives rise to T cell stimulation for proliferation and 
production of cytokines. For cytokines to be detected in cytokines immunoassayes, T cells 
have to be restimulated in vitro by synthetic Listeria derived antigens. 
Spleens of naïve (as a control) or previously infected mice were removed and used to prepare 
in vitro cell cultures. Single-cell suspensions were generated by cell perfusion out of spleen 
through injecting the spleens with PBS and dissociating the tissue mechanically (for details, 
see section 2.10.3.2). After spontaneous sedimentation of cell clusters, the single-cell 
suspension was filtered through a 100 W metal sieve and washed three times in culture 
medium RPMI 1640. Erythrocytes were lysed by osmotic shock in 3 ml erythrocyte lysis 
buffer. The cell population was stained with trypan blue solution and counted under 
microscope. At least 95% of the cells must be viable (for details, see section 2.9.3). Cells were 
incubated on the basis of spleen equivalents (1x108 cells/5 ml) in 25 cm2 cell culture flasks in 
complete RPMI 1640 medium. Lymphokine secretion was stimulated by either a synthetic 
peptide derived from L. monocytogenes EGD-e for CD8+ T lymphocytes stimulation or the 
released soluble antigens of L. monocytogenes EGD-e for CD4+ T lymphocytes stimulation 
(10 -100 ng). Peptides used in this work were derived from either listeriolysin O (LLO91-99) or 
P60 (P60217-225). At the end of 5 days incubation, cells were harvested and centrifuged in order 
to produce cell-free culture supernatant. The supernatant was passed through a 0.45 W filter, 
fractionated, and stored at -70°C until it was thawed only once before use in cytokine assays 
(Peters et al., 2003). Cells were resuspended in RPMI 1640 complete medium, counted and 
transferred directly to be analysed through ELISPOT assay. 
 
2.10.7. Cytokines ELISA 
 
Cytokine sandwich ELISA is a sensitive enzyme immunoassay that can specifically detect 
and quantitate the concentration of soluble cytokine and chemokine proteins. The basic 
cytokine sandwich ELISA method makes use of highly-purified anti-cytokine antibodies 
(capture antibodies) which are noncovalently adsorbed (coated) primarily onto plastic 
microwell plates as a result of hydrophobic interactions. After plate washings, the 
immobilized antibodies serve to specifically capture soluble cytokine proteins present in 
samples which were applied to the plate. After washing away unbound material, the captured 
cytokine proteins are detected by biotin-conjugated anti-cytokine antibodies (detection 
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antibodies) followed by an enzyme-labeled avidin or streptavidin stage. Following the 
addition of a chromogenic substrate-containing solution, the level of coloured product 
generated by the bound, enzyme-linked detection reagents can be conveniently measured 
spectrophotometrically using an ELISA plate reader at an appropriate optical density.  
In details, the purified anti-cytokine capture antibody (BD bioscience co., Heidelberg) was 
diluted to 10 µg/ml in binding solution (0.1M NaHCO3, pH 9.6). 50 µl/well diluted antibody 
was added to the wells of an enhanced protein Nunc Maxisorb binding ELISA plate (Nalge 
Nunc, Hamburg). Plates were sealed to prevent evaporation and incubated overnight at 4°C. 
Plates were brought to room temperature; the capture antibody solution was removed. The 
non-specific binding was blocked by adding 150 µl of 2% BSA or 10% of FCS. Plates were 
sealed and incubated at RT for 1-2 h. Plates were washed 3 times with TBS containing 0.2% 
Tween20 (TBS/T). 50µl/well of standards and samples were added. Plates were sealed and 
incubated for 2-4 h at RT or overnight at 4°C. Plates were washed 3 times with TBS/T. The 
biotinylated anti-cytokine detection antibody (BD bioscience co., Heidelberg) was diluted to 
10µg/ml in TBS/T and 50 µl of diluted antibody was added to each well. Plates were sealed 
and incubated for 1 h at RT followed by 5 times washing with TBS/T. 50µl/well of 1:1000 
diluted Streptavidin-Alkaline phosphatase conjugate (Sigma-Aldrrich co., Deiesenhofen) in 
TBS/T was added. Plates were sealed and incubated at RT for 30 minutes followed by 5 times 
washing with TBS/T. One tablet of Alkaline phosphatase substrate (Sigma-Aldrrich co., 
Deiesenhofen) was dissolved in 10 ml diethanolamine buffer by vortexing. The wells were 
emptied and immediately 50 µl of substrate solution was dispensed into each well, incubate at 
RT for 5-10 minutes for colour development. The optical density for each well was read with 
a microplate ELISA-reader set to 405 nm. 
 
2.10.8. Cytokines ELISPOT 
 
The ELISPOT assay is designed to enumerate cytokine producing cells in a single cell 
suspension. This method has the advantage of requiring a minimum of in vitro manipulations 
allowing cytokine production analysis as close as possible to in vivo conditions. This 
technique is designed to determine the frequency of cytokine producing cells under a given 
stimulation, and the follow-up of such frequency during a treatment and/or a pathological 
state. After cell stimulation, locally produced cytokines are captured by a specific monoclonal 
antibody. After cell lysis, trapped cytokine molecules are revealed by a secondary biotinylated 
detection antibody, which is in turn recognised by streptavidin conjugated to alkaline 
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phosphatase. PVDF-bottomed-well plates are then incubated with BCIP/NBT substrate. 
Coloured "purple" spots indicate cytokine production by individual cells.  
In details, PVDF-bottomed-96-well plates (Millipore co. Eschborn) were incubated with 
100µl of 70% ethanol for 10 minutes at RT. Wells were emptied and washed three times with 
100µl of PBS. 100µl of 10µg/ml of the capture antibody in 1X PBS was dispensed in each 
well. The plate was covered and incubated overnight at 4°C. The wells were emptied and 
washed 3 times with 100 µl of PBS. The wells were blocked by dispensing 100 µl of 2% BSA 
in PBS into wells. The plate was covered and incubated for 2 hours at RT. The wells were 
emptied by flicking the plate over a sink and tapping it on absorbent paper. The plate was 
washed once with PBS. 100 µl of complete RPMI 1640 medium containing in vitro 
stimulated spleen cells (104-106 cells) (see section 2.10.6.) and appropriate concentration of  
the stimulator peptide (10 ng) was dispensed into triplicate wells. As a positive control, when 
analysing CD8+ T cells producing IFN-γ, 100 µl of complete RPMI medium containing 
standard IFN-γ-X63.Ag8–653 producing cells (50-100 cells) was included. The plate was 
covered and incubated at 37°C in a 5% CO2 for 48 hours. During this period the plate could 
not be agitated or moved. The wells were emptied by flicking the plate over a sink and gently 
tapping it on absorbent paper. The wells were washed three times with PBS followed by 
addition of 100µl distilled water and 5 minutes incubation at RT to allow cell lysis. The wells 
were further washed twice with PBS. The biotinylated anti-cytokine detection antibody (BD 
bioscience co., Heidelberg) was diluted to 10.0 µg/ml in PBS and 50 µl of diluted antibody 
was added to each well. The plate was covered and incubated 90 minutes at 37°C. The wells 
were emptied and washed three times with PBS. 50µl/well of 1:1000 diluted Streptavidin-
Alkaline phosphatase conjugate (Sigma-Aldrich co., Deisenhofen) in PBS was added. The 
plate was covered and incubated at RT for 30 minutes followed by 5 times washing with PBS. 
100µl of ready-to-use Alkaline phosphatase conjugate substrate kit (Biorad lab., München) 
were distributed in wells and the reaction was let to go for about 5-20 minutes at RT. Spots 
formation was monitored by eyes. The wells were rinsed three times with distilled water and 
left to dry for 2 hours at RT or overnight at 4ºC away from direct light. The spots were 
counted with the aid of a magnifying lens or under microscope. 
 
2.10.9. Flow Cytometry Analysis 
 
Flow cytometry employs instrumentation that scans single cells flowing past excitation 
sources in a liquid medium. This technology can provide rapid, quantitative, multiparameter 
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analysis on living or dead cells based on the measurement of visible and fluorescent light 
emission. Flow cytometry is a widely used method for characterizing and separating 
individual cells. This basic protocol focuses on a measurement of fluorescence intensity 
produced by fluorescent-labelled antibodies and ligands that bind specific cell-associated 
molecules. Spleens of naïve (as a control) or previously infected mice were removed and used 
to prepare in vitro cell cultures. Single-cell suspensions were generated by injecting the 
spleens with PBS and dissociating the tissue mechanically. After spontaneous sedimentation 
of cell clusters, the single-cell suspension was filtered through a 100 W metal sieve and 
washed three times in culture medium RPMI 1640. Erythrocytes were lysed by osmotic shock 
by suspending them in 3 ml of erythrocytes lysis buffer followed by 5 minutes incubation at 4 
ºC and 5 minutes centrifugation at 1000 rpm and 20ºC.  The cell population was stained with 
trypan blue solution and counted under microscope. At least 95% of the cells must be viable. 
Spleen cells were suspended on the basis of spleen equivalents (1x108 cells/5 ml) in a 5 ml 
FACS buffer. 50 µl from the single cell suspension was added to a 96 well V-bottom plate 
(Nalge Nunc, Hamburg).  
100 µl of appropriately diluted labeled antibody was added to the cells, mixed gently and 
incubated at 4oC in dark for 30 minutes. The cells were washed three times by adding 100µl 
of FACS buffer to each well followed by centrifugation at 900 rpm and 4ºC for 5 minutes. 
The stained cell pellets were resuspended in 300 µl FACS buffer for flow cytometry. As a 
control, unstained cells must be included. Flow cytometry was performed using a FACS 
Calibur flow cytometer and further analysed with CELL Quest software (BD bioscience co., 
Heidelberg).  
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3.  Results 
 
3.1.  Purification and characterization of thiol-activated cytolysins hyper-expressed in      
         the non-pathogenic species Listeria innocua 
 
     The thiol-activated (oxygen-labile) cytolysin listeriolysin O (LLO) produced by 
pathogenic Listeria monocytogenes as well as pneumolysin (PLY) produced by  
Streptococcus pneumonia  belong to a family of related toxins that are expressed by diverse 
species of gram-positive bacteria including streptolysin, alveolysin, cereolysin, perfringolysin, 
produced by Streptococcus pyogenes, Bacillus alvei, Bacillus cereus, and Clostridium 
perfringens respectively (Smyth and Duncan, 1978). Molecular cloning and sequencing of 
these various toxins has shown that apart from the commonly shared properties such as being 
inactivated by free cholesterol and their presumed receptors on cell surface, they all contain a 
conserved undecapeptide sequence that includes a single conserved cystein located at the C-
terminal end of the respective molecules (Nato et al., 1991). 
 
3.1.1.  Listeriolysin O 
  
Several isolation procedures have been previously reported for purification of listeriolysin. 
The majority of these protocols suffer from the disadvantage that the protein is isolated from 
the bulk quantities of culture supernatants expressing various other virulence factors 
indigenous to pathogenic L. monocytogenes strains (Darji et al., 1995). Although expression 
and secretion of listeriolysin in the non-pathogenic species of B. subtilis has been reported 
(Bielecki et al,. 1990), the secretion of proteases by this species restricts its use as a source for 
efficient purification of this protein. Expression of this protein in E. coli has been hampered 
by lack of haemolytic activity levels, poor secretion of the polypeptide to the external medium 
and the probable contamination of the purified listeriolysin with the lipopolysaccharide (LPS) 
from E. coli (Mengaud et al,. 1988). Moreover, in the previous procedures,  listeriolysin  was  
purified from bacteria that were grown in enriched media containing high levels of proteins 
thus decreasing the efficiency of purification process. Therefore, listeriolysin was purified in 
this study from the closely related non-pathogenic species Listeria innocua engineered to 
hyperexpress listeriolysin and grown in a minimal medium that contains the lowest amounts 
of amino acids, and essential elements required for growth of Listeria giving the advantage of 
avoiding contamination of listeriolysin with other external proteins. In addition, expression of 
L. monocytogenes hly, plcB, actA, and plcA and production of their respective proteins is 
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upregulated by incubation under stress conditions, such as a shift from rich to minimal 
medium, heat shock, or growth within mammalian cells (Sokolovic et al., 1993; Bohne et al., 
1994; Klarsfeld et al., 1994) giving the advantages of higher yield production of listeriolysin 
O. Moreover, it was previously established that co-expression of the positive regulatory factor 
prfA in the plasmid vector in conjunction with the structural gene hly increased the expression 
over 500-fold (Darji et al., 1995). In addition, strains of the species L. innocua are devoid of 
extracellular proteases and permitted the development of a simple and rapid procedure for the 
purification of large quantities of listeriolysin. 
 
3.1.1.1.  Bacterial strain and growth conditions  
 
Listeriolysin O was purified from Listeria innocua serotype 6a strain NCTC 11288 
electroporatically transformed with pERL3-503 gram-positive/gram-negative schuttle vector 
containing the intact gene of listeriolysin O under the regulatory control of  prfA gene (Darji 
et al., 1995). This strain was grown on brain heart infusion agar, broth, or in minimal medium 
supplemented with 5 µg/ml erythromycin. 10 ml of BHI overnight culture of the recombinant 
L. innocua strain was used to inoculate one liter of minimal medium.  
 
Table 3.1. Expression of listeriolysin O and pneumolysin in BHI and minimal medium culture    
                 supernatants of the recombinant L. innocua strain       
                   
Hemolytic activity a 
Medium 
Listeriolysin O Pneumolysin 
BHI 1024 64 
Minimal medium 2048 128 
 
a Hemolytic activity are estimated from supernatants of overnight cultures starting with an equal 
inocula and calculated as the reciprocal of the highest dilution required to lyse sheep erythrocytes.  
 
 
To determine the effect of growth in minimal medium on activity of listeriolysin O, 200µl of 
BHI overnight culture of L. innocua expressing LLO was used to inoculate 10 ml of either 
BHI or minimal medium. After further overnight incubation at 37°C, hemolytic activity of 
both culture supernatants, isolated from equal number of bacteria, was measured. In 
accordance with previous reports (Bohne et al., 1994; Klarsfeld et al., 1994), the shift of this 
strain  from  enriched  BHI  medium  to minimal  medium  resulted  in  a  2 fold  increase  of  
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haemolytic activity in culture supernatant of minimal medium over that of BHI medium 
(Table 3.1.).  
 
3.1.1.2.  Purification and characterization of listeriolysin O 
 
Listeriolysin was purified to homogeneity from the supernatant of the L. innocua strain 
harbouring plasmid pERL3-503 by two consecutive steps of ion exchange chromatography 
separated by a desalting step. As can be seen in Table. 3.2., already the concentration step 
resulted in a 15.9-fold enrichment of specific activity probably due to the loss of low 
molecular weight materials during the procedure.  
Listeriolysin O has an isoelectric point of 6.7 (Nomura et al., 2002) and shows an optimum 
activity at acidic pH. So, it was purified using cation exchange chromatography. Efficient 
elution of the toxin from the column was achieved with a buffer combining high salt (1M 
NaCl) with acidic pH (5.6). Listeriolysin eluted as a sharp peak between 0.18-0.23 M NaCl.  
 
Table 3.2. Purification of listeriolysin O from recombinant Listeria innocua cultures 
Purification steps 
Volume 
(ml) 
Total protein 
(mg) 
Total activity 
(HUa x 107   ) 
Specific activity 
(HU/mg) 
Enrichment 
(fold) 
Recovery
(%) 
Crude sup. 1000 2412 2.21 9.2x103 _ 100 
Conc. Sup. 25 145 2.11 1.46x105 15.9 95.5 
Q-sepharose Na-Frb 25 95 2.05 2.16x105 23.5 92.8 
Resource-S purified Fr. 4 5.4 1.66 3.07x106 333.7 75.1 
 
a One haemolytic unit is defined as the reciprocal dilution of the toxin that is required for 50% lysis of       
  erythrocytes compared to the lysis obtained by distilled water . 
b Na-Fr = Non-absorbed fraction         
 
 
The eluate containing the peak of haemolytic activity exhibited a specific activity of 3.07x106 
HU per mg protein (Table 3.2). The homogeneity and purity of the protein was confirmed by 
SDS-PAGE electrophoresis. A protein of 58 kDa was visualised as a single band after 
coomassie brilliant blue (Fig.3.1.A). The monoclonal antibody (M275) that neutralised the 
haemolytic activity (Darji et al,. 1995) also recognized this polypeptide in an immunoblot 
(Fig.3.1.B) confirming the identity of the protein as listeriolysin O. 
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Fig. 3.1. A) Analysis of the purification steps of listeriolysin by SDS-PAGE. Crude unconcentrated 
supernatant of L. innocua transformed with PERL3-503 (1), concentrated supernatant (2), fraction 
unabsorbed on Q-sepharose (3), fraction eluted from the Resource-S column (4). B) Immunoblot 
developed with a monoclonal mouse anti-listeriolysin antibody (M275) using 1 µg of the fraction 
eluted from Resource-S column. Lane (M) corresponds to the running marker protein while the 
numbers to the left of the both figures correspond to apparent molecular weights (in kDa). 
 
 
3.1.2.  Pneumolysin 
 
All cholesterol-binding cytolysins are produced in the extracellular medium except 
pneumolysin which  is an intracytoplasmic toxin that lacks a leader peptide and thus released 
due to the action of surface pneumococcal autolysin (Jedrzejas, 2001). All previous 
procedures that reported  pneumolysin purification have used the wild type Streptococcus 
pneumonia as a source of pneumolysin which is released in a low amount as a consequence of 
cell lysis along with other virulence factors including both proteins and proteases. 
Furthermore, Not all strains of S. pneumonia were found to produce pneumolysin (Kanclerski 
and Mollby, 1987). To further investigate the properties of the pneumolysin and to use it as an 
antigen in a serological assay of pneumococcal disease, it was necessary to improve the 
methods of production and purification of this protein. Here, the structural gene of 
pneumolysin was over-expressed in the non-pathogenic L. innocua species under the control 
of listeriolysin O promoter and prfA regulator and was efficiently exported to the extracellular 
medium by the aid of Listeriolysin O signal peptide and purified using a single step of anion 
exchange chromatography. 
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3.1.2.1.  Bacterial strain and growth conditions 
 
Bacterial strain used in this study is the wild type Listeria innocua 6a strain NCTC 11288    
electroporatically transformed with pSOG306 gram-positive/gram-negative schuttle vector 
which contains the intact promoter of listeriolysin O followed by its signal peptide coding 
sequence under the regulatory control of prfA gene (Otten et al., unpublished) and harbours 
the structural gene of pneumolysin which was cloned downstream from listeriolysin O signal 
peptide (Fig. 3.25.A). Bacteria were grown in brain-heart infusion (BHI) broth as well as in 
minimal medium in presence of  5 µg/ml erythromycin. As described above for listeriolysin 
O, shift of L. innocua expressing pneumolysin from BHI to minimal medium also resulted in 
a 2 fold increase in haemolytic activity of pneumolysin in culture supernatants (Table 3.1.). 
 
3.1.2.2.  Purification and characterization of pneumolysin 
 
A simple one step anion exchange chromatography procedure was performed for purifying 
pneumolysin. The concentrated crude supernatant underwent desalting and buffer exchange in 
HiPrep™ 26/10 Desalting column. The  desalted  product  was  subjected  to  anion  exchange  
 
Table 3.3.  Purification of pneumolysin from recombinant Listeria innocua culture 
Purification steps 
Volume 
(ml) 
Total protein 
(mg) 
Total activity 
(HUa x 106   ) 
Specific activity 
(HU/mg) 
Enrichment 
(fold) 
Recovery
(%) 
Crude sup. 1000 1920.0 4.67 2.43x103  100 
Conc. Sup. 25 162.25 3.96 2.44x104 10 84.8 
Resource-Q purified Fr. 4 2.0 3.27 1.6x106 673.9  70.0 
 
a One haemolytic unit is defined as the reciprocal dilution of the toxin that is required for 50% lysis of    
  erythrocytes compared to the lysis obtained by distilled water . 
 
chromatography using resourse-Q column. Chromatography of the concentrated supernatant 
fluid on the resource Q-anion-exchange column produced two major peaks of absorbance. 
Pneumolysin eluted reproducibly from the column at 0.21 to 0.28 M NaCl, pH 7.5, as the 
second major peak and was collected in fraction 16. This fraction retained a hemolytic activity 
of approximately 1.6x106  hemolytic  units  per  mg  and contained  approximately  500  µg of 
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Fig. 3.2.A) Analysis of the purification steps of pneumolysin by SDS-PAGE. Crude unconcentrated 
supernatant of L. innocua transformed with pSOG306 harbouring pneumolysin gene (1), concentrated 
supernatant (2), fraction eluted from the Resource-Q column (3). B) Immunoblot developed with a 
monoclonal mouse anti-pneumolysin antibody using 5 µg of the fraction eluted from Resource-Q 
column. Lane (M) corresponds to the running marker protein while the numbers to the left of both 
figures correspond to apparent molecular weights (in kDa). 
 
 
protein per ml, representing approximately 70.0 % recovery of lytic activity and a 674.0-fold 
purification (Table 3.3.). In SDS-PAGE, fraction 16 was shown by coomassie blue staining to 
contain a single homogeneous protein with a molecular mass of 53 kDa (Fig. 3.2.A). The 
protein was recognized in immunoblots by a specific monoclonal antibody (Fig. 3.2.B).  
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3.2. The  ferritin  protein Frm, a novel listerial antigen, mediates hydrogen peroxide       
       resistance and is required for efficient intracellular growth of L. monocytogenes 
 
Iron is an essential element for mammalian cell growth. It is a required constituent of 
numerous enzymes, including iron sulphur and haem proteins of the respiratory chain, as well 
as ribonucleotide reductase, which catalyses the rate-limiting step in DNA synthesis 
(Cammack et al., 1990). However, free iron has the capacity to participate in oxygen free 
radical formation via Fenton chemistry (Linn, 1998). Balancing the deleterious and beneficial 
effects of iron thus emerges as an essential aspect of cell survival. Therefore, bacteria have 
evolved complex iron acquisition systems that allow them to maintain this delicate 
intracellular iron balance (Theil, 1990; Harrison and Arosio, 1996; Chasteen, 1998). Bacteria 
possess three different kinds of iron storage proteins that belong to distinct, albeit distantly 
related families. Ferritins and heme-containing bacterioferritins which share the molecular 
architecture of mammalian ferritins (Harrison and Arosio, 1996; Andrews, 1998) in addition 
to the recently discovered prototype of ferritin from the gram-positive bacterium L. innocua 
(Bozzi et al., 1997). These ferritins have the ability to sequester iron atoms which is not 
required for immediate metabolic needs. Iron is taken up by ferritins in the ferrous form, 
oxidised in its ferroxidase center and  stored in the central cavity of the molecule in the ferric 
form (Harrison and Arosio, 1996). 
In an attempt to identify the role of humoral immunity in response to Listeria infection, the 
respective target antigens recognized by antisera of mice previously infected with the wild 
type L. monocytogenes were examined. A cross-reactivity with a 110 kDa polypeptide species 
present in the soluble antigen fraction of L. monocytogenes were detected in the antisera of 
mice infected with pathogenic L. monocytogenes. N-terminal amino acid sequencing of this 
species revealed identity to the previously described ferritin Fri from L. innocua as well as the 
ferritin-like protein, Flp of L. monocytogenes. Here the role of the listerial ferritin in response 
to oxidative stress as well as during systemic Listeria infection was assessed.  
 
3.2.1.  Bacterial strains and culture 
 
Wild type Listeria monocytogenes strain EGD-e (Glaser et al., 2001) and its isogenic  
derivatives EGD-e∆frm, EGD-e∆frm: :pPL2-frm and EGD-e∆hly were used in this study. 
Bacteria were grown either in brain-heart infusion (BHI) broth or in minimal medium at 
indicated temperatures in presence or absence of antibiotics. 
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3.2.1.1.  Generation of the ∆frm mutant and its complementation 
  
The isogenic deletion mutant L. monocytogenes EGD-e∆frm was generated following a 
published procedure (Schäferkordt and Chakraborty, 1995). For the generation of the isogenic 
deletion mutant, a 1000 bp long PCR fragment comprising  frm upstream sequences was  
 
Fig. 3.3. Generation of the ∆frm mutant and its complementation. A) Construction of the pAUL-A 
integration vector carrying approximately 1000 and 500 pbs upstream and  downstream fragments 
from the frm gene, respectively. Both fragments are ligated at the NotI restriction site and cloned into 
the mcs of the lacZa` gene (empty arrow) in pAUL-A using BamHI and HindIII restriction sites. B) 
Plasmid map of the pPL2 integration vector harbouring the structural gene of ferritin-like protein 
(Frm) of L. monocytogenes. The structural gene encoding ferritin-like protein (Frm) of L. 
monocytogenes with SacI and SalI restricted ends was cloned in the multiple cloning site of pPL2.  
 
 
amplified with oligonucleotides (Lmo-fri for. 1, BamHI) (-105) and  (Lmo-fri rev. 1, NotI) (-
1036). A second PCR fragment harbouring frm downstream regions was amplified with 
oligonucleotides (Lmo-fri for 2, NotI) (1419)  and (Lmo-fri rev 2, HindIII) (1965) (see section 
2.7.11). Both fragments were restricted with endonuclease NotI and used in a ligation 
reaction. The entire PCR fragment of 1423 bp, lacking  frm gene, was amplified with –105 
and 1965 oligonucleotides, restricted with BamHI and HindIII and was cloned into the BamHI 
and HindIII restriction sites of the pAUL-A plasmid (Fig. 3.3.A). Transformation of this 
pAUL-A::∆frm plasmid into E. coli and subsequently into L. monocytogenes EGD-e followed 
by generation of chromosomal in-frame deletion of the frm gene was performed as described 
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in section 2.7.8. The desired deletion of the frm gene was confirmed by nucleotide sequencing 
and immunoblotting. 
For the construction of EGD-e∆frm strains complemented with  frm gene (EGD-e∆frm: :frm), 
pPL2 plasmid was used (Lauer et al., 2002). A 935 bp long fragment containing entire frm 
gene was cloned on to the multiple cloning site of pPL2 plasmid (Fig. 3.3.B) using (fri for. 
SacI) and (fri rev. SalI) oligonucleotides primers (see section 2.7.11). Transformation of 
EGD-e∆frm strains with pPL2 plasmid containing frm gene was performed by electroporation 
(Schäferkordt and Chakraborty, 1995). The desired recombinants were selected using 
chloramphenicol  (8µg/ml) on  BHI  agar  plates and subsequently verified by sequencing. 
 
3.2.2.  Detection of Frm during infection 
 
Antisera obtained from mice 9 days after infection with the wild type L. monocytogenes 
EGD-e (2000 cfu) were detected using immunoblotting assay against a soluble antigen 
fraction of L. monocytogenes. Antisera reacted with a 110 kDa polypeptide species derived 
from the soluble  antigen fraction. This crossreactivity was not observed with antisera from 
mice infected with a non-pathogenic L. innocua strain (Fig. 3.4.A). To identify the novel 110 
kDa polypeptide species that was specifically recognized by the antisera, the soluble antigen 
fraction was subjected to separation by SDS-PAGE and transferred by blotting to a PVDF 
filter. The filter was stained with Coomassie Blue and the band corresponding to the 110 kDa 
species excised, and subjected to N-terminal sequencing.    
The sequence obtained MKTINSVDTKEFLN was identical to the N-termini of two 
previously described 18 kDa polypeptides described as L. innocua ferritin (Fri) and the 
ferritin-like protein (Flp) of L. monocytogenes respectively (Bozzi et al, 1997; Hebraud and 
Guzzo, 2000).  In  keeping  with the nomenclature describing the ferritin gene from L. 
innocua as fri, the designation frm for ferritin from L. monocytogenes was proposed.  Rabbit 
polyclonal antibodies were produced against the purifed Fri protein from L. innocua and 
immunoblotting experiments revealed the presence of a 18 kDa polypeptide in both L. 
monocytogenes  EGD-e and  L. innocua  soluble antigen  fractions  (Fig.3.4.B).  Additional, 
distinct multimeric forms of the protein were also recognised by the antibody in soluble 
antigen preparations of either strains.  
The Fri-specific antibodies were also used to monitor expression of the Frm-protein under 
various growth conditions. Expression of Frm at different growth temperatures was complex; 
Frm was observed  in bacteria  grown at 37 °C  but  was not  detectable in  cultures  grown  at 
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Fig. 3.4. Immunoblot analysis and physical characterization of Frm. Soluble antigen fractions (15 µg) 
either from L. monocytogenes (Lane 1) or L.innocua (Lane 2) were transferred onto a PVDF filter and 
incubated with antisera obtained from mice infected with the wild type L. monocytogenes EGD-e 
(Lane 1), L.innocua (Lane 2) (A) or with a polyclonal rabbit antibody raised against purified ferritin 
(B) of L. innocua followed by AP-conjugated secondary antibody. Blots were visualised using BCIP 
as a substrate. The arrow refers to the position of the 110 kDa polypeptide. Equal amounts of soluble 
fractions obtained from L. monocytogenes EGD-e cultures grown at 37°C at different  time intervals 
over a period of 5.5 hours and purified ferritin as a positive control (+) were transferred  onto a PVDF 
filter (D). Equal amounts of soluble fractions obtained from L. monocytogenes EGD-e grown at 37°C 
(Lane 1) , 20 °C (Lane 2) and 5 °C (Lane 3)  were blotted onto PVDF filter (C). Blots (C and D) were 
developed with the Fri polyclonal rabbit antibody using the ECL chemiluminescence kit. The numbers 
to the left of the figures correspond to apparent molecular weights (in kDa). 
 
 
20°C (Fig. 3.4.C). Nevertheless, expression of Frm was regained in cultures grown at 5°C. As 
can be seen in data presented in Fig. 3.4.D, expression of Frm also increased with the age of 
the cultures indicating growth-phase dependent regulation.  
 
3.2.3.  Properties of the ∆frm L. monocytogenes mutant 
 
Further evidence that the protein recognized by antisera of L. monocytogenes EGD-e is indeed 
Frm was sought by generating a ∆frm mutant lacking the entire gene.  Fri-specific  antibodies  
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Fig. 3.5. Immunological characterization of the ∆frm mutant. Equal amounts of soluble antigen 
fractions from L. monocytogenes EGD-e (Lanes 1), the isogenic deletion mutant L. monocytogenes 
EGD-e∆frm (Lane 2), and 1µg purified bacterial ferritin from L. innocua (Lane 3) were loaded onto 12 
% SDS-polyacrylamide gel. Gels were stained with Coomassie Blue (A) or electrophoretically blotted 
and developed with rabbit anti-ferritin polyclonal antibody followed by AP-conjugated anti-rabbit IgG 
(B). The arrow indicates the position of the monomeric Fri polypeptide (18kDa). Proteins  in Fig. A 
were transfered electrophoretically onto  a PVDF filter and incubated with antisera obtained from mice 
infected with the wild type Listeria monocytogenes followed by AP-conjugated anti-mouse IgG. Blots 
were visualized using BCIP as a substrate (C). The arrow refers to the absence of the 110.0 kDa 
polypeptide in EGD-e∆frm. 
 
 
were used to confirm its absence in the resulting mutant strain. As can be seen from the 
results depicted in Fig. 3.5.A and B, the 18 kDa protein observed in the wild type strain was 
lacking in the mutant. In addition, antisera obtained from mice following infection with L. 
monocytogenes EGD-e also do not react with the soluble fraction preparations from the 
mutant strain indicating that the 110 kDa species observed is indeed a multimeric form of the 
Frm monomer (Fig. 3.5.C).  
 
 
 
 
 
 
 
 
Fig. 3.6. Plaque formation of EGD-e∆frm mutant strain in mouse fibroblasts. L-929 mouse fibroblast 
monolayer was infected with the wild type L. monocytogenes EGD-e (1) and mutant L. monocytogenes 
EGD-e∆frm (2) for 2 hours followed by further 30 minutes incubation with 20µg/ml gentamicin. The 
overlay agar was added to the infected cells followed by 3 days incubation at 37ºC and 5%CO2. 
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Fig. 3.7. Impaired intracellular growth of EGD-e∆frm mutant strain in eucaryotic cells. A) Human 
HeLa cell line  was infected with the wild type L. monocytogenes EGD-e, mutant L. monocytogenes 
EGD-e∆frm, L. monocytogenes EGD-e∆frm complemented with the ferritin gene (∆frm: :frm) and 
mutant L. monocytogenes EGD-e ∆hly strains. Cells were lysed at certain time intervals and plated on 
BHI plates. The viable bacteria were enumerated. B) The mouse macrophage like cell line J774 was 
infected  with the wild type L. monocytogenes EGD-e and the mutant L. monocytogenes EGD-e∆frm 
strains. Bacteria were labelled with Cy3 conjugated anti-Listeria antibody (red). The kinetics of 
infection were monitored by immunofluoresence microscopy at 1 and 4 hours post infection.  
 
 
When grown in laboratory media, growth of the ∆frm mutant was indistinguishable from that 
obtained with the wild type strain (Fig. 3.8.A). Further properties of the mutant were 
examined using tissue culture infection assays. Both the wild type L. monocytogenes and its 
mutant strain ∆frm showed the same efficiency to form plaques upon infection of mouse 
fibroblasts L-929 (Fig. 3.6) reflecting the same ability to spread from cell to cell. Also, the 
invasion rate of the ∆frm mutant was not significantly different from that obtained with its 
parental wild type strain for HeLa cells. When examined for its ability to replicate 
intracellularly it was observed that although the overall generation time of the mutant was 
similar to the wild type strain, a significant lag phase was observed before intracellular 
growth was  initiated (Fig. 3.7.A)  indicating  that  Frm  may  be  involved in  initiating  
efficacious  intracellular growth. To obtain information on the nature of the defect we 
compared the intracellular growth properties of  the ∆frm  mutant  to that of the ∆hly strain. It 
has been previously shown that ∆hly is unable to escape from the phagolysosome of J774 
macrophages and therefore does not replicate in this cell line (Lety et al., 2001). For the HeLa 
cell line, intracellular  growth of ∆hly occurs, but  is delayed  primarily because the bacterium  
escapes only slowly into the cytoplasmic milieu  (O´Riordan et al., 2002). In HeLa cells 
growth  of  the  ∆hly  strain  is  initiated  following   an   extended   lag  phase   and  is   more   
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pronounced  than  that observed with the ∆frm strain. Extrapolating from this information, it 
appears that the ∆frm mutant may have a defect in exiting from the host vacuole to the 
cytoplasm. Indeed, immunofluoresence staining of bacterial growth in J774 macrophages 
using both strains showed that growth of the mutant is retarded at early times of infection 
(Fig. 3.7.B). 
Also a single copy chromosomally located frm-complementing mutant was constructed by 
inserting the frm gene into the PSA bacteriophage attachment site at tRNAArg- attBB´ using 
the integration vector pPL2. From the growth properties of these mutants in HeLa cells, it is  
 
Fig. 3.8. The EGD-e∆frm mutant is sensitive to hydrogen peroxide–mediated killing. Overnight 
cultures in BHI of the wild type L. monocytogenes EGD-e and the mutant L. monocytogenes EGD-
e∆frm strains were diluted 1:50 in normal BHI medium (A) and in BHI medium containing 0.03% 
hydrogen peroxide (B) and the bacterial growth was followed over a period of time by measuring the 
optical density of bacterial culture at 600nm.Sensitivity to hydrogen peroxide was also monitored by 
plating both the wild type L. monocytogenes EGD-e and the mutant L. monocytogenes EGD-e∆frm 
strains after 3 hrs of 0.03% hydrogen peroxide treatment (C). *P<0.05 (EGD-e vs EGD-e∆frm both 
treated with 0.03% H2O2) 
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clear that single-copy complementation restored the growth capabilities of these strains to 
essentially wild type levels (Fig. 3.7.A).  
 
3.2.4. Frm mediates resistance to the effects of hydrogen peroxide  
 
The growth properties of the wild type and mutant strains were examined under a variety of 
abiotic stress conditions. Strains were grown at high and low temperatures, in acidic media, in  
the presence of sub-lethal concentrations of SDS, under high osmolarity conditions involving 
salt and in the presence of hydrogen peroxide. In all of the conditions tested, no differences 
were observed excepting for cultures grown in the presence of low concentrations (0.03%) of 
hydroxide peroxide in the growth medium (Fig. 3.8.B). Indeed, using plating assays it was 
found that the percentage of viable bacteria of the ∆frm mutant to be about 50% of the 
parental EGD-e strain when exposed to 0.03% hydrogen peroxide  (Fig.3.8.C). 
 
3.2.5. Frm promotes bioaccessibility of mineralized iron 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.9. Ferric citrate restores growth of EGD-e∆frm mutant strain in chemically defined minimal 
medium. Parallel cultures (controlled by equal optical densities) of both the wild type L. 
monocytogenes EGD-e and the mutant L. monocytogenes EGD-e∆frm strains were grown in a minimal 
medium at 37°C. At 8h of growth (indicated by an arrow), equal volumes of cultures of both the L. 
monocytogenes EGD-e and the mutant L. monocytogenes EGD-e∆frm strains were supplemented with 
different divalent cations (citrate salts 260 µM) or left untreated. The bacterial growth was followed 
over a period of 22 hours by measuring the optical density of the cultures at 600nm. Addition of 
different salts has no significant effect on the growth of the wild type L. monocytogenes EGD-e 
strains. For clarity only the supplemented cultures of the mutant L. monocytogenes EGD-e∆frm strains 
are plotted. 
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When the strains were grown in a minimal medium containing iron citrate virtually no growth 
was observed for the ∆frm mutant (Fig. 3.9.) while the parental strain grew on to reach  
stationary phase. The addition of further iron citrate to the culture of non-growing ∆frm 
bacteria after 8 hours promoted bacterial growth. To further determine the ∆frm strain’s  
selectivity for iron, a number of divalent cations such as Cu2+, Mn2+, Mg2+ were added to the 
non-growing ∆frm cultures. As indicated in Fig. 3.9. none of them was able to additionally 
support the growth of non-growing ∆frm suggesting that the bio-availability of iron is limiting 
to the ∆frm strain. Increase in the amount of other components of the minimal medium i.e. 
essential amino acids did not affect growth of the ∆frm mutant.  
 
3.2.6.  The ∆frm mutant exhibits defects at early stages of infection 
 
Studies were performed comparing the virulence properties of the mutant and the 
∆frm::pPL2-frm complemented strain to that of the wild type strain EGD-e in the mouse 
model of infection. At all time points studied the number of bacteria isolated from an EGD-e 
infected  mouse  was  set  arbitrarily  at 100%. Although  a similar  inoculum  was used for all  
 
 
Fig. 3.10. Frm is required for efficient growth at early stages of listerial infections. The kinetics of 
bacterial growth was followed in organs of mice infected with the wild type L. monocytogenes EGD-e, 
L. monocytogenes EGD-e∆frm  and L. monocytogenes EGD-e∆frm complemented with the ferritin 
gene (EGD-e∆frm::frm). Mice were injected (i.v.) with 2000 viable bacteria for all strains. Bacterial 
survival was followed in both spleens (A) and livers (B) of infected mice over 5 days. The number of 
surviving EGD-e∆frm and EGD-e∆frm::frm are calculated as a percent of survival number of the wild 
type L. monocytogenes at each time point examined. *P<0.05 (EGD-e∆frm vs EGD-e∆frm::frm). 
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three bacteria we found that the ∆frm mutant had consistently lower numbers of bacteria 
present in both spleens and livers of the infected mice as compared to the complemented and 
wild type strain at all of the experimental time points examined (Fig. 3.10.). This effect was 
most visible at 4 hours and 8 hours as well as one day post infection, where although roughly 
equivalent initial doses of either bacteria were used, significantly lower numbers of bacteria 
were recovered from the spleens (Fig. 3.10.A) and livers (Fig. 3.10.B) of mice infected with 
the ∆frm mutant as compared to the complemented mutant or the wild type strain. 
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3.3. Induction of immune responses by attenuated isogenic mutant strains of Listeria  
        monocytogenes 
 
Listeria monocytogenes has been used for decades for the induction and analysis of T cell-
mediated immunity ( Mackaness, 1962; Hahn and Kaufmann, 1981; Kaufmann, 1993; Mielke 
et al., 1997; 1998;). These studies have led to extensive and detailed information on the host 
response to infection, and have triggered strong interest in bacterial virulence factors that 
allow entry into the host, support intracellular survival and facilitate dissemination of these 
bacteria during infection (Portnoy et al., 1992; Chakraborty and Wehland, 1997). Studies of 
cell biology revealed that invading bacteria use active mechanisms to escape from the 
encapsulating phagosome, and that they can replicate in the cytoplasm of both professional 
phagocytes and parenchymal cells, such as hepatocytes. These studies have also explained the 
cellular basis of Listeria potent intrinsic capacity to induce major histocompatibility complex 
(MHC) class I-restricted protective CD8+ T cells (Mielke et al., 1989; Kaufmann, 1993; 
Pamer et al., 1997). This in turn resulted in the current interest in developing L. 
monocytogenes as a viable bacterial T cell vaccine vector as an alternative to Salmonella, 
which mainly induces CD4+ T cell responses (Hess et al., 1996). Indeed, recombinant L. 
monocytogenes expressing foreign antigens has already been shown to be a highly effective 
vector for the induction of specific T cells active in the prevention of tumor growth and for 
protection against viral infections (Schafer et al., 1992; Ikonomidis et al., 1994; Frankel et al., 
1995; Goossens et al., 1995; Pan et al., 1995; 1996; Shen et al., 1995; Jensen et al., 1997). 
However, one drawback to the use of virulent L. monocytogenes as a vector is that Listeria 
infection induces a strong T cell responses mediating DTH and granulomatous inflammation 
that may result in extensive tissue destruction which make their use as vaccine vectors 
undesirable (Darji et al., 2003). For increased safety, however, a more appropriate vaccine 
vector would be a well-characterised mutant that is reliably attenuated in virulence but that 
still retains the favourable immunological CD8+ T cell-inducing properties of the parental 
strain. In addition, the accompanying CD4+ T cell response mediating delayed type 
hypersensitivity (DTH) and granulomatous inflammation (Mielke et al., 1989; 1992) should 
be downmodulated in order to prevent inflammatory tissue destruction. Here, the 
immunological properties of isogenic Listeria monocytogenes mutants carrying a specific 
deletion within the actin nucleator (actA) or multiple deletions within actA and phospholipase 
B (plcB) were systemically examined for their suitability for use as delivery vehicles. 
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3.3.1. Survival   and   persistence  of   wild   type  L.  monocytogenes   and   isogenic    L.    
          monocytogenes mutant strains in vivo 
 
The presence of viable microorganisms during the early phase of infection is critical in the 
induction and the establishment of cell-mediated immunity. L. monocytogenes EGD-e mutant 
strains (L. monocytogenes ∆actA2 and L. monocytogenes ∆actA∆plcB) were examined 
whether they display similar virulence attenuation in vivo compared to their parental wild type 
L. monocytogenes EGD-e strain. A group of BALB/c mice (20 mice) were infected i.v. with 
sub-lethal doses of either wild type L. monocytogenes EGD-e (103), or the isogenic L. 
monocytogenes mutant strains (107). In vivo survival and growth kinetics of bacteria were 
followed by determining the number of bacteria in the spleen and liver of infected mice at 
various time points for several days. As indicated in Fig. 3.11., bacterial count of the mutant 
Listeria strains dropped rapidly from day 2 after the infection onwards and levelled off at a 
low number, persisting up to day 8 post-infection. On the other hand, the bacterial number of 
the wild type L monocytogenes, both in spleen and liver, increased between day 2 and day 4 
of the infection and declined rapidly from day 5 post-infection onwards. Since higher dose of 
the wild type Listeria strain is lethal, growth kinetics was performed with a lower infection 
dose (103). In all cases, both in the wild type EGD-e and in the isogenic EGD-e mutant 
strains, bacteria were cleared from the spleen and liver by days 8 -10 after the infection. 
 
 
 
Fig. 3.11. Kinetics of primary infection in mice with the wild type L. monocytogenes and isogenic L. 
monocytogenes mutant strains. Mice were infected i.v. with either 103 wild type L. monocytogenes or 
107 isogenic L. monocytogenes mutant strains ∆actA2 and ∆actA∆plcB. Different time intervals after 
the infection, 3 mice per group were sacrified and the number of viable bacteria in the organs 
enumerated. Data presented are representative of three independent expirements. 
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3.3.2. Spleen morphology on day 4 post-infection 
 
L. monocytogenes infection often elicits host inflammatory reaction accompanied by a 
cascade of tissue alterations, such as splenomegaly and granulomatous inflammation that 
finally result in the eradication of bacteria. These responses are cell-mediated and 
predominantly involve activation of non-specifically invading CD4+ T cells at the site of 
infection. Since the bacterial number of isogenic EGD-e mutant strains in vivo declined faster 
(Fig. 3.11.) than the parental wild type EGD-e strain, the morphological alterations in the 
spleens, following i.v. infection of mice with either the wild type EGD-e strain or isogenic  
EGD-e mutant strains were examined. As shown in Fig. 3.12., marked differences were 
observed in the morphological structure of spleens obtained from mice infected with these 
strains. Spleens obtained from mice infected with the wild type EGD-e strain displayed a 
pronounced strong granuloma formation from day four post-infection onwards. These 
granulomas probably resulted from intense and vigorous monocytes infiltration. In contrast, 
granuloma formation was hardly visible in spleens of mice infected with both L. 
monocytogenes ∆actA and ∆actA ∆plcB mutant strains.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.12. Morphological alterations in the spleens of mice infected i.v. with the wild type L. 
monocytogenes and isogenic L. monocytogenes mutant strains. Spleens of mice (infected i.v. as 
mentioned in Fig. 3.11.) were removed on day 4 after infection. Shown is the scanned picture of 
spleens from the wild type L. monocytogenes and its isogenic mutant strains. Infiltration of monocytic 
cells and granulomatous lesions are only detectable in the spleens isolated from mice infected with the 
wild type L. monocytogenes. 
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3.3.3.  Listeria-induced  IFN-γ  production  of  spleen  cells  in vitro  and  DTH-response  
           in vivo 
 
Antigen-induced CD4+ T cell-derived IFN-γ production of spleen cells was measured as an in 
vitro correlate of DTH to determine whether immunization with the various mutants may lead 
to quantitative differences in the proinflammatory T cell response. Day 9 after infection was 
chosen for the analysis of the primary immune effector phase. Spleen cells were isolated and 
stimulated in vitro with the released soluble antigen of L. monocytogenes EGD-e (100 ng). 
Spleen cells from mice immunized with L. monocytogenes ∆actA2 and L. monocytogenes 
∆actA∆plcB mutant produced significantly lower levels of IFN-γ in comparison to 
splenocytes of mice pre-immunized with the wild type strain (Fig. 3.13.A). Furthermore, the 
observations obtained in vitro were confirmed in vivo by antigen-elicited skin responses 
showing corresponding results (Fig. 3.13.B). Six mice per group were injected into the left 
hind footpads with 50 µl of somatic soluble L. monocytogenes EGD-e antigen (60 ng/ml) at 
day 9 post-infection. Twenty-four hours later, thickness of the left and right footpads of 
individual mice were measured. Footpads of mice pre-immunized with both L. 
monocytogenes ∆actA2 and L. monocytogenes ∆actA∆plcB mutant strains showed a 
markedly lower thickness than those of mice pre-immunized with the wild type EGD-e strain.  
 
 
Fig. 3.13. A) Listeria-induced IFN-γ production by spleen cells 9 days after infection (i.v.). Mice were 
infected with 103 CFU of L. monocytogenes EGD-e or with 107 CFU of its isogenic mutants. On day 9 
after infection, mice were killed and spleens were removed. Single cell suspensions were stimulated in 
vitro with secreted soluble Listeria antigen (100 ng) to produce IFN-γ. After 48 h, culture supernatants 
were tested for presence of IFN-γ by ELISA.*P<0.05 (EGD-e vs ∆actA2 and ∆actA∆plcB). B) DTH 
response to listerial antigen 9 days after primary infection. Mice were infected as in Fig. 3.13.A. 9 
days after infection, DTH was triggered through injection of soluble somatic listerial antigen. Twenty-
four hours later, specific skin response was determined. Experiments were repeated twice. The mean 
value ± S.D. of five animals of a representative experiment is shown.*P<0.05 (EGD-e vs ∆actA2 and 
∆actA∆plcB). 
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3.3.4. Acquired protection conferred by isogenic attenuated mutants 
 
Sub-lethal infecting doses of wild type L. monocytogenes strains are generally controlled by 
mice  in  the  initial  infection  and  result  in  the  induction of   protective immunity to further  
 
  
Fig. 3.14. A) Induction of protective immunity conferred after infection with the wild type L. 
monocytogenes and its isogenic mutant strains. Groups of mice were infected i.v. as described in 
Fig.3.11. Two months later all mice were challenged with a lethal dose (10X LD50) of the wild type L. 
monocytogenes. As a control, a group of uninfected normal mice was included. Survival of mice after 
the challenge was monitored up to 8 days. B) Bacterial titers in spleens and livers of 3 mice per group 
of mice challenged in Fig. A were monitored at day 2 after challenge. 
 
 
infections. Such an acquired protective immunity is exclusively T cell-mediated and requires 
specific cytotoxic CD8+ T cells. So, most noteworthy is to investigate whether infection of 
mice with the highly attenuated isogenic EGD-e mutant strains L. monocytogenes ∆actA2 and 
∆actA∆plcB confers a protective immunity to re-infection. Groups of BALB/c mice were 
infected with the wild type L. monocytogenes EGD-e strain (103) or with the isogenic L. 
monocytogenes mutant strains (107). Two months later, all mice were challenged with a lethal 
i.v. dose (5x104), corresponding to 10X LD50, of the wild type L. monocytogenes EGD-e 
strain, and the survival of mice in all groups was monitored. As a control, a group of untreated 
normal BALB/c mice that have received a similar lethal dose (5x104) of the wild type L. 
monocytogenes EGD-e strain were included. As shown in Fig. 3.14.A, immunization with 
isogenic EGD-e mutant strains protects mice against a lethal infection with the wild type 
EGD-e strain. The protective response was significant as all mice, pre-immunized with the 
isogenic EGD-e mutant strains, survived. Not surprisingly, all mice that were pre-immunized 
with sub-lethal doses of the wild type EGD-e strain were also protected against a lethal 
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listerial infection and survived. All control mice that were not pre-immunized succumbed to 
the infection and died within 3 days after re-infection. In addition, the bacterial titres were 
determined in spleens and livers at day 2 post-challenge in each mice group. Naïve unprimed 
mice were not able to control challenge infection as indicated by the high bacterial load in 
spleen and liver. In contrast, mice primed with the wild type as well as the isogenic mutant 
strains L. monocytogenes ∆actA2 and L. monocytogenes ∆actA∆plcB managed to restrict 
listerial growth in the first 2 days after infection (Fig. 3.14.B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.15. Number of antigen-specific IFN-γ producing CD8+ T cells in the spleens of mice infected 
i.v. with the wild type L. monocytogenes and isogenic L. monocytogenes mutant ∆actA and 
∆actA∆plcB strains, determined by ELISPOT. Spleen cells from infected mice were isolated either 9 
days after the primary infection or 5 days after the recall challenge infection and stimulated with 
immunodominant MHC class I peptide LLO91-99 in triplicates in nitrocellulose based 96-well culture 
plates. Number of specific IFN-γ producing cells against the dominant H-2Kd restricted LLO91-99 
epitope were determined by counting the number of spots under microscope. 
 
 
The ability of L. monocytogenes to gain access to the cytoplasm of infected cells allows 
processing and presentation of bacterial antigens through the MHC class I pathway. Infection 
of mice with L. monocytogenes leads therefore to the generation of MHC class I restricted 
CD8+ T cells, specific for listerial antigens, which transfer protective immunity and are also a 
major component of the adaptive immune response of the host to re-infection by this 
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intracellular pathogen. Mice, pre-immunized with isogenic EGD-e mutant strains were 
protected against a lethal challenge of the wild type EGD-e strain. The impact of previous 
immunization with attenuated isogenic EGD-e mutant strains on the generation of antigen-
specific MHC class I restricted CD8+ T cells were quantitatively determined. The numbers of 
IFN-γ producing CD8+ cells, after immunization with either the wild type or mutant EGD-e 
strains, against the dominant H-2Kd restricted LLO91-99 epitope (Wipke et al., 1993) in in vitro 
ELISPOT assay were evaluated. The number of LLO91-99-specific CD8+ T cells in spleens of 
mice infected with the two isogenic mutant strains (L. monocytogenes ∆actA2, L. 
monocytogenes ∆actA∆plcB) was very similar. It was however approximately 1.5-fold lower 
than that observed in spleens of mice primarily infected with the wild type EGD-e strain (Fig. 
3.15.). The number of LLO91-99-specific CD8+ T cells however, was significantly raised 
during the recall challenge infection in spleens of mice primarily infected with the two 
isogenic mutant strains (L. monocytogenes ∆actA2, L. monocytogenes ∆actA∆plcB). It was 
almost as high as that observed in spleens of mice infected with the wild type L. 
monocytogenes EGD-e strain (Fig. 3.15.). 
Sub-lethal infections of L. monocytogenes in mice are generally cleared by innate and specific 
immune responses, providing the animals with long-term immunity to re-infection. Such 
infections usually resulted in a rapid activation and an expansion of cytotoxic T lymphocytes 
(CD8+), specific for multiple peptides derived from L. monocytogenes (Mercado et al., 2000). 
The number of cells in the spleen, particularly CD8+ T cells, increases during the recall 
response to L. monocytogenes. Antigen specific T cells were monitored in mice 9 days after 
immunization (primary infection) with the wild type EGD-e and the isogenic mutant strains 
(L. monocytogenes ∆actA2, L. monocytogenes ∆actA∆plcB). They were found to be 
predominantly CD8+ effector T cells, as determined by the rapid induction of IFN-γ 
(ELISPOT) following antigen exposure (Fig. 3.15.). It was previously shown that pathogen 
specific T cells are programmed during the first days of infection and subsequently undergo 
proliferation and differentiation into effector T cells (Mercado et al., 2000). All mice, pre-
immunized either with the wild type EGD-e, or with the mutant L. monocytogenes ∆actA2 
and L. monocytogenes ∆actA∆plcB strains survived a lethal challenge with the wild type 
EGD-e strain (Fig. 3.14.A).The contribution of CD8+ T cells to the conferred protection was 
therefore further investigated through quantifying the expression of CD62L (as a memory T 
cell marker) on CD8+ T cells before and after the recall infection with L. monocytogenes (Fig. 
3.16.). CD62L (L-selectin) is expressed at high levels on the surface of naïve T lymphocytes, 
but rapidly down-regulated upon T cell activation. As indicated in Fig. 3.16., a striking 
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increase in the number of CD8+CD62Llo T cells was observed in the spleens of mice, pre-
immunized with the wild type EGD-e and the isogenic mutant (L. monocytogenes ∆actA2, L. 
monocytogenes   ∆actA∆plcB)  strains  after  the   recall  infection,   as   determined   by  flow 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.16. Expression levels of CD62L on CD8+ splenocytes following primary and recall infection 
with L. monocytogenes and its isogenic mutant strains. Flow cytometry was performed with spleen 
cells, isolated from mice at day 9 after the primary infection or day 5 after the challenge. Cells were 
stained with FITC-labeled anti-Lyt-2 and biotinylated anti-CD62L, and the binding of anti-CD62L on 
the cell surface was detected with PE-conjugated streptavidin. Numbers shown are gated CD8+CD62lo 
T cells (lower panel) and analysed with CELLQuest software.   
 
 
cytometric analysis. Two months after the primary infection, all groups of mice showed 
approximately 19-23% of CD8+CD62Llo expressing T cell population which is relatively 
similar to that expressed in naïve uninfected mice (Mercado et al., 2000). During the recall 
infection however the population of CD8+CD62Llo expressing T cells increased from about 
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20% to over 50%. The increase in the percentage of CD8+CD62Llo  T cell population, 
attributed to the isogenic mutant (L. monocytogenes ∆actA2, L. monocytogenes ∆actA∆plcB) 
strains, was similar or higher than that observed in animals primarily infected with the wild 
type L. monocytogenes EGD-e strain and positively correlated with the increase in the number 
of LLO91-99-specific CD8+ T cells (Fig. 3.15.). 
 
3.3.5. Induction of listeriolysin O-specific antibodies against isogenic L. monocytogenes  
          deletion mutant strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.17. Induction of specific antibody response against isogenic Listeria mutants. Listeriolysin O-
specific antibodies in sera of mice 9 days post infection with the wild type L. monocytogenes or its 
isogenic deletion mutants (∆actA2 and ∆actA∆plcB) were measured with ELISA at 405 nm. Results 
from 3 mice per group are given. 
 
 
It was previously established that listeriolysin O is a main protein target of the human 
humoral response against L. monocytogenes (Grenningloh et al., 1997). Moreover, the 
monoclonal antibody against listeriolysin O was found to be protective from a lethal dose of 
the wild type L. monocytogenes (Edelson et al., 1999; Edelson and Unanue, 2001). The ability 
of mice infected with the L. monocytogenes isogenic deletion mutants (∆actA2 and 
∆actA ∆plcB) to produce listeriolysin O-specific antibody was examined. Groups of 3 mice 
were injected i.v. with the wild type L. monocytogenes (103) cfu, its isogenic mutants (∆actA2 
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and ∆actA ∆plcB) (107) cfu, or left uninfected.  9 days later, blood was collected from all 
groups by heart puncture, sera were isolated and incubated in ELISA plates with 100 ng of 
purified listeriolysin O. The amount of antibody in mice sera was measured by means of 
ELISA reader at 405 nm. As shown in Fig. 3.17., the isogenic Listeria monocytogenes mutant 
strains managed to induce listeriolysin O-specific antibodies in an amount comparable to the 
wild type strain while no significant antibody production was demonstrated in naïve unprimed 
mice.   
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3.4.  Immunological  characterization  of  a  L. innocua  recombinant  strain  carrying       
        the virulence gene cluster (vgc) of L. monocytogenes 
 
As previously discussed, the virulence of pathogenic L. monocytogenes wild type strain is 
attributed to the presence of the virulence gene cluster (vgc) comprises genes (hly, plcA, plcB, 
mpl, actA , inlA , inlB ) required for survival in host vacuoles following uptake as well as 
replication and intracellular motility in the host cell cytoplasm  (Chakraborty et al., 2000). 
The virulence gene cluster is, however, totally absent from the non-pathogenic L. innocua 
strain (Gouin et al., 1994; Kreft et al., 1999; Chakraborty et al., 2000) explaining its non-
invasivness. However, It was interesting to examine the immunological properties of a 
recombinant strain of L. innocua transformed with a gram-positive/gram-negative schuttle 
BAC-based vector (pUvBBAC) harbouring a 96.9 kb fragment encoding the prfA virulence 
gene cluster ( prfA-plcA-hly-mpl-actA-plcB ) of L. monocytogenes (Hain et al., unpublished). 
The suitability of this recombinant strain to be an appropriate vaccine vector was systemically 
examined through testing its ability to induce sufficient CD8+ T cell response as well as 
lower levels of the unfavourable accompanying CD4+ T cell response mediating delayed type 
hypersensitivity (DTH) and granulomatous inflammation. 
 
3.4.1.  Growth kinetics of the recombinant L. innocua strain in vivo 
 
It is well-known that the ability of listeria to survive in vivo at the early stage of infection is 
crucial for induction of cell-mediated immunity. The in vivo survival of the recombinant L. 
innocua strain harbouring the complete virulence gene cluster of L. monocytogenes was 
compared to that of the wild type L. monocytogenes EGD-e in both spleen and liver. A group 
of BALB/c mice (16 mice) were infected i.v. with sub-lethal doses of wild type L. 
monocytogenes EGD-e (103), the recombinant L. innocua mutant strain, (designated L. 
innocua: :vgc) (107), or the wild type L. innocua strain (107). In vivo survival and growth 
kinetics of bacteria were followed by daily determining the number of bacteria in the spleen 
and liver of infected mice beginning at day 1 till day 4 after infection. As expected, regardless 
of the dose of infection, the wild type L. innocua strain was rapidly cleared from both organs 
from the outset (Fig. 3.18.) whereas L. innocua: :vgc strain successfully survived in both 
spleen and liver during the first two days after infection as indicated by the bacterial number 
that increased in both spleen and liver till day 2 and falled gradually over days 3 and 4 post-  
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Fig. 3.18. Course of primary infection in mice with the wild type L. monocytogenes and the 
recombinant L. innocua strain. Mice were infected i.v. with 103 wild type L. monocytogenes, 107 wild 
type L. innocua, or 107 recombinant L.innocua strain (L.innocua: :vgc). Different time intervals after 
the infection, 3 mice per group were sacrified and the number of viable bacteria in the organs was 
enumerated. Data presented are representative of three independent experiments. 
 
infection  onwards. On  the  other  hand,  the  bacterial  number  of  the  wild  type  L. 
monocytogenes,  both in spleen and liver, increased from day 1 till day 4 of the infection 
onwards. Since higher dose of the wild type listeria strain is lethal, growth kinetics was 
performed with a lower infection dose (103).  
 
 
3.4.2.  Downmodulation of CD4+-mediated inflammatory responses by the recombinant  
           L. innocua derivative 
 
To determine the degree of CD4+-mediated inflammatory response induced by the 
recombinant L. innocua strain (L. innocua: :vgc), morphological changes were examined in 
the spleens on day 3 after i.v. infection with the wild type EGD-e(103), the wild type L. 
innocua strain and its recombinant derivative (L. innocua: :vgc) (107). Although the number 
of  bacteria  survived  from  spleens  at  day 3 post-infection for both the wild type EGD-e and  
L. innocua: :vgc were approximately the same, marked difference in the morphological 
appearance between spleens isolated from mice primarily infected with the wild type EGD-e 
and those isolated from mice primarily infected with L. innocua: :vgc (Fig. 3.19.). 
Splenomegaly associated with extensive granuloma formation was characteristic to spleens of 
EGD-e infected mice, as a result of intensive leukocyte infiltration, whereas only 
splenomegaly (without granuloma) was the case in spleens of L. innocua: :vgc infected mice. 
Infection with the wild type L. innocua strain did not result in any morphological changes in 
spleens on day 3 post infection. 
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Fig. 3.19. Morphological appearance of the spleens of mice infected i.v. with the wild type L. 
monocytogenes and the recombinant L.innocua strain. Spleens of mice (infected i.v. as mentioned in 
Fig.3.18.) were removed on day 3 after infection. Shown is the scanned picture of spleens from the 
wild type L. monocytogenes, the wild type L.innocua and its recombinant mutant strain L.innocua: 
:vgc. Infiltration of monocytic cells and granulomatous lesions are only detectable in the spleens 
isolated from mice infected with the wild type L. monocytogenes. 
 
 
Moreover, antigen-induced CD4+ T cell-derived IFN-γ production of spleen cells was 
measured as an indication for DTH and proinflammatory T cell response induced against 
EGD-e, L. innocua, or its recombinant derivative. Spleen cells were isolated at day 9 post-
infection and stimulated in vitro with the released soluble antigen of L. monocytogenes EGD-
e (100 ng). Spleen cells from mice immunized with the L. innocua: :vgc mutant produced 
significantly lower levels of IFN-γ when compared with that produced after immunization 
with the wild type EGD-e strain. The wild type L. innocua strain failed to prime T cells for 
the production of IFN-γ (Fig. 3.20.A.). Most notably, the observations obtained in vitro were 
confirmed in vivo by antigen-elicited skin responses showing corresponding results (Fig. 
3.20.B). 6 mice per group were injected into the left hind footpads with 50 µl of somatic 
soluble L. monocytogenes EGD-e antigen (60 ng/ml) at day 9 post-infection. Twenty-four 
hours later, thickness of the left and right footpads of individual mice were measured. 
Footpads of mice pre-immunized with L. innocua: :vgc mutant strain showed a markedly 
lower thickness than those of mice  pre-immunized with the wild type EGD-e strain. The wild 
type L. innocua strain could not able to induce DTH response in footpads. 
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Fig. 3.20. A) Listeria-induced IFN-γ production by spleen cells 9 days after infection (i.v.). Mice were 
infected with 103 CFU of L. monocytogenes EGD-e, 107 CFU wild type L. innocua, or with 107 CFU 
its recombinant mutant strain L.innocua: :vgc. On day 9 after infection, mice were killed and spleens 
were removed. Single cell suspensions were stimulated in vitro with secreted soluble Listeria antigen 
to produce IFN-γ. After 48 hours, culture supernatants were tested for presence of IFN-γ by 
ELISA.*P<0.05 (EGD-e vs L.innocua: :vgc). B) DTH response to listerial antigen 9 days after primary 
infection. Mice were infected with 103 CFU of L. monocytogenes EGD-e , 107 CFU wild type 
L.innocua,  or 107 CFU its recombinant mutant strain L.innocua: :vgc. 9 days after infection, DTH was 
triggered through injection of soluble somatic listerial antigen. Twenty-four hours later, specific skin 
response was determined. Experiments were repeated twice. The mean value ± S.D. of five animals of 
a representative experiment is shown.*P<0.05 (EGD-e vs L.innocua: :vgc). 
 
 
 
3.4.3.  Expression of T cell-mediated immune response to the recombinant L. innocua  
           strain  
 
A number of cell types are involved in host defenses to Listeria. Antigen-specific T 
lymphocytes mediate recovery from primary listerial infections and protective immunity to 
subsequent infections (Lane and Unanue, 1972; North, 1973). Both CD4+ (helper, MHC class 
II restricted) and CD8+ (cytotoxic, MHC class I restricted) T cell subpopulations have been 
implicated (Kaufmann et al., 1985; Ladel et al., 1994). Recent experimental evidence 
indicates, however, that CD8+ T cells play the predominant role (Mielke et al., 1988; Berche 
et al., 1989 ;  Baldridge  et al., 1990; Goossens  et al., 1992; Roberts et al., 1993; Ladel et al., 
1994). The ability of the recombinant L. innocua strain to induce T cell mediated immunity 
was examined. Groups of BALB/c mice were infected with the wild type EGD-e (103), the 
wild type L. innocua strain (107) and its recombinant derivative (L. innocua: :vgc) (107). Two 
months later, all mice were challenged with  a  lethal  i.v. dose (5x104), corresponding to 10X 
LD50, of the wild type L. monocytogenes EGD-e strain and the survival of mice in all groups 
was monitored. As a control, a group of untreated  normal BALB/c mice that  have received  a 
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Fig. 3.21. Induction of protective immunity conferred after infection with the L.innocua recombinant 
mutant strain L.innocua: :vgc. Groups of mice were infected i.v. as described in Fig. 3.20. Two 
months later all mice were challenged with a lethal dose (10X LD50) of the wild type L. 
monocytogenes. As a control, a group of uninfected normal mice was included. Survival of mice after 
the challenge was monitored up to 8 days.  
 
 
similar lethal dose (5x104) of the wild type L. monocytogenes EGD-e strain were included. 
Primary infection with L. innocua: :vgc strain protected mice against a lethal infection with 
the wild type EGD-e strain. The protective response was significant as all mice, pre-
immunized with the recombinant L. innocua strain, survived. As expected, all mice that were 
pre-immunized with sub-lethal doses of the wild type EGD-e strain were also protected 
against a lethal listerial infection and survived whereas all the non-immunized mice as well as 
those pre-immunized with wild type L. innocua strain died within 4 days after challenge (Fig. 
3.21.).  
Entry of Listeria into the cytosol is a critical event for CD8+ T-cell recognition and the 
induction of immunity (Brunt et al., 1990). In order to establish the correlation between the 
protection of mice previously infected with the wild type EGD-e strain or the L. innocua 
recombinant  strain  upon  lethal  challenge  with   the  wild  type   L. monocytogenes   EGD-e   
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Fig. 3.22. Number of antigen-specific IFN-γ producing CD8+ T cells in spleens of mice infected i.v. 
with the wild type L. monocytogenes, L.innocua and L.innocua recombinant mutant strain (L.innocua: 
:vgc), determined by ELISPOT. Spleen cells from infected mice were isolated either after the primary 
infection or after recall challenge infection and stimulated with the immunodominant MHC class I 
peptide LLO91-99 in triplicates in nitrocellulose based 96-well culture plates. Number of specific IFN-γ 
producing cells against the dominant H-2Kd restricted LLO91-99 epitope was determined by counting 
the number of spots under microscope. 
 
 
strain and the induction of CD8+ cells in response to infection, the generation of antigen-
specific MHC class I restricted CD8+ T cells were quantitatively examined. The amount of 
antigen specific MHC class I restricted effector CD8+ T cells induced in spleens of mice 9 
days after the primary infection and 5 days after the challenge with the wild type L. 
monocytogenes (2x103) was determined through evaluation of the number of IFN-γ producing 
CD8+ T cells induced against the dominant H-2Kd restricted LLO91-99 epitope (Wipke et al., 
1993) in in vitro ELISPOT assay. As shown in Fig. 3.22., infection with wild type L. 
monocytogenes as well as the recombinant L. innocua derivative (L. innocua: :vgc) managed 
to induce a highly detectable population of LLO91-99 specific CD8+ T-cells. This number 
raised significantly during the recall infection. On the other hand, Infection with the wild type 
L. innocua strain failed to induce a significant level of CD8+ T-cells population either 
primarily or after challenge. 
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It was recently established that activated CD8+ T cells seem to be programmed to develop 
into memory T cells, because CD8+ T cells that were stimulated briefly (~24 hours), 
proliferated and differentiated into CTLs without further antigenic stimulation and continued 
to develop into long-lived, protective memory CD8+ T cells (Mercado et al., 2000; Kaech and 
Ahmed, 2001). Memory T cells can be subdivided into two categories on the basis of 
activation markers, homing receptor expression, and effector function (Lanzavecchia and 
Sallusto , 2000). Central memory T cells, which express high levels of the chemokine 
receptor CCR7 and the adhesion molecule CD62L and do not express effector functions, may 
differentiate into effector memory T cells, which express low levels of CCR7 and CD62L 
(also known as L-selectin or Mel-14) but produce cytokines ( Sallusto  et al., 1999). Whether 
these memory T cell subsets differ in their capacity to mediate protective immunity is 
unknown. Furthermore, the stimuli that generate central versus effector memory T cells 
remain undefined (Lauvau et al., 2001). In order to address the contribution of effector 
memory CD8+ T cells in mediating long last immunity after re-infection with the wild type 
Listeria monocytogenes, the expression level of CD62L, an effector memory  CD8+ T cell 
surface marker, was quantified. Two months after the primary infection, the number of 
CD8+CD62Llo lymphocytes was approximately identical in all groups of primarily infected 
mice. This number increased dramatically upon re-infection with the wild type L. 
monocytogenes (2x103) in mice pre-immunized with EGD-e as well as L. innocua: :vgc 
mutant strain while pre-immunization with the wild type L. innocua strain was not able to  
induce a significant CD62L down-regulation  (Fig. 3.23.). 
  
3.4.4.  Induction  of  listeriolysin O  specific  antibody in  response to  the recombinant L.  
           innocua: :vgc strain 
 
As previously discussed (section 3.3.5.), listeriolysin O (LLO) was efficiently recognized 
with antisera of mice primarily infected with the wild type L. monocytogenes as well as its 
isogenic deletion mutants, ∆actA2  and  ∆actA∆plcB, while  antisera  from  unprimed  mice  
failed  to recognize the purified listeriolysin O. In an attempt to examine if primary infection 
with L. innocua: :vgc recombinant strain can induce a humoral immune response against 
listeriolysin O, groups of 3 mice were injected i.v. with the wild type L. monocytogenes (103), 
L. innocua: :vgc (107), the wild type L. innocua (107), or left uninfected. 9 days later, blood 
were collected from all groups, sera were isolated and used to detect purified listeriolysin O 
(100 ng)  in  an immunoblotting  assay. As  expected  antisera   from mice  primarily  infected  
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Fig. 3.23. Expression levels of CD62L on CD8+ splenocytes following primary and recall infection 
with L. monocytogenes, L.innocua and L.innocua: :vgc. Flow cytometry was performed with spleen 
cells, isolated from mice at day 9 after the primary infection or day 5 after the challenge. Cells were 
stained with FITC-labeled anti-Lyt-2 and biotinylated anti-CD62L. The binding of anti-CD62L on the 
cell surface was detected with PE-conjugated streptavidin. Numbers shown are gated CD8+CD62lo T 
cells and analysed with CELLQuest software. 
 
 
with the wild type L. monocytogenes can recognize listeriolysin O. Antisera from mice 
primarily infected with L.inn: :vgc recombinant strain can also efficiently recognize LLO 
while antisera from  unprimed mice as well as mice primarily infected with the wild type L. 
innocua failed to recognize LLO (Fig. 3.24.). 
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Fig. 3.24. Induction of listeriolysin O-specific antibodies against the recombinant L. innocua: :vgc 
strain. 100 ng of purified LLO were loaded onto 10 % SDS-polyacrylamide gel, transferred 
electrophoretically onto  a PVDF filter and incubated with antisera obtained from mice 9 days after 
infection with the wild type Listeria monocytogenes (1), L. innocua: :vgc (2), wild type L.innocua (3), 
unprimed mice (4), and M275 antibody (as a control) (5), followed by AP-conjugated anti-mouse IgG. 
Blots were visualized using BCIP as a substrate. The numbers to the left of the figure correspond to 
apparent molecular weights (in kDa). 
 
 
Based on its ability to induce effector CD8+ T lymphocytes as well as humoral immunity in 
addition to the downmodulation of unfavourable CD4+ inflammatory response, L. innocua 
complemented with the virulence gene cluster of L. monocytogenes is shown to be a 
promising vaccine or delivery vector.   
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3.5.  Molecular and immunological characterization of a Listeria monocytogenes strain    
        harbouring a gene of pneumolysin in instead of listeriolysin O 
 
Lysis of the host cell vacuole is mediated in large part by the thiol-activated cytolysin 
listeriolysin O (LLO) (Gaillard et al., 1987; Tilney and Portnoy, 1989; Bielecki et al., 1990). 
Transposon insertions in hly, the structural gene encoding LLO, result in a non-hemolytic 
phenotype, complete avirulence and inability to lyse the host vacuole (Gaillard et al., 1986; 
Kathariou et al., 1987; Kuhn et al., 1988; Portnoy et al., 1988). Introduction of hly on a 
plasmid restores both haemolytic capacity and virulence (Cossart et al., 1989). Thiol-activated 
hemolysins, so named for the the unique cysteine highly conserved undecapeptide, or in other 
wards, cholesterol-binding cytolysins (CBCs), due to their ability to bind cholesterol, have 
been identified in 23 taxonomically different species of gram-positive bacteria (Alouf, 2000) 
including for example streptolysin O (SLO) produced by Streptococcus pyogenes, 
pneumolysin (PLY) produced by Streptococcus pneumonia, suilysin (SLY) produced by 
streptococcus suis and perfringolysin O produced by Clostridium perfringens (Smyth and 
Duncan, 1978; Alouf and Geoffroy, 1991). LLO, however, is the only one that is produced by 
intracellular bacterium (Jones and Portnoy,1994). Apart from pneumolysin, which is an 
intracytoplasmic toxin, all other toxins are produced in the extracellular medium (Alouf, 
2000). It was previously shown that L. monocytogenes expressing perfringolysin O in place of 
listeriolysin O was able to lyse the host cell vacuole, grow in the cytoplasm, and spread from 
cell to cell to a limited extent in vitro followed by damage of the cells, preventing the 
intracellular proliferation of bacteria (Jones and Portnoy,1994). 
Subclinical infection of BALB/c mice with virulent Listeria monocytogenes leads to the 
induction of Listeria-immune T-cell populations and protective immunity. LLO production 
appears to be required for induction of protective immunity, since preparations of killed L. 
monocytogenes or mutants of L. monocytogenes which lack LLO expression remain within 
the phagocytic vacuole of the host cell, do not replicate intracellularly, and do not trigger a 
protective antilisterial immune response (Barry et al., 1992; Cossart , 1988; Mengaud et al., 
1989). Here, a related cytolysin, pneumolysin (PLY) was chosen to be tested if it is able to 
complement LLO for intracellular survival, virulence, and induction of protective immunity. 
 
3.5.1.  Bacterial strains and growth conditions 
 
Bacterial strains used in this study are the wild type Listeria monocytogenes EGD-e serotype 
1/2a (Glaser et al., 2000), its isogenic deletion mutant EGD-e∆hly (Leimeister-Wächter et al.,  
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Fig. 3.25. A) The structural gene encoding pneumolysin with NdeI and XhoI restricted ends was 
cloned in the multiple cloning site (mcs) of pSOG306, containing the same restriction ends, 
downstream from the promoter and signal peptide sequence of listeriolysin O (hly P+SP). B) The 
intact gene encoding listeriolysin O with XhoI and SpeI restricted ends was cloned in the multiple 
cloning site of pSOG304 restricted with the same enzymes.   
 
 
1990; Guzman et al., 1995), both were electroporatically transformed with pSOG306 gram-
positive/gram-negative schuttle vector, containing the intact promoter of listeriolysin O 
followed by its signal peptide coding sequence under the regulatory control of  prfA gene 
(Otten et al., unpublished) and its isogenic derivatives EGD-e∆hly::pSOG304-hly (designated 
EGD-e∆hly: :LLO), and EGD-e∆hly::pSOG306-ply (designated EGD-e∆hly: :PLY). Bacteria 
were grown in brain-heart infusion (BHI) broth in presence of 5µg/ml erythromycin.  
 
3.5.2.  Construction of plasmid-based strains   
 
For the construction of EGD-e∆hly strains complemented with either intact ply or hly gene, 
pSOG306 or pSOG304 plasmid, respectively, was used. 
 
3.5.2.1. EGD-e∆hly::pSOG306-ply 
 
The structural gene for PLY were amplified from the S. pneumonia (Genbank accession no. 
X52474) chromosomal DNA by means of  (ply-gene for., NdeI) and   (ply-gene rev., XhoI)  
oligonucleotides primers (see section 2.7.11) which contained restriction sites for the enzymes 
NdeI and XhoI, respectively. The 1397 bp fragment was cloned into pSOG306 that was 
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restricted with the same enzymes, downstream from the signal peptide sequence of hly (Fig. 
3.25.A). 
 
3.5.2.2. EGD-e∆hly::pSOG304-hly 
  
By means of (hly-gene for., XhoI) and   (hly-gene rev., SpeI)  oligonucleotides primers (see 
section 2.7.11), a 2086 bp long fragment containing entire hly gene including its promoter 
was amplified from the Listeria monocytogenes chromosomal DNA using high fidelity PCR 
procedure followed by cloning on to pSOG304 plasmid, harbouring the prfA regulator (Otten, 
et al., unpublished) using XhoI and SpeI restriction sites (Fig. 3.25.B). Both constructions 
were checked by DNA sequence analysis. Transformation of EGD-e∆hly strains with 
pSOG306 or pSOG304 plasmid containing ply or hly genes respectively was performed by 
electroporation (Schäferkordt and Chakraborty, 1995). The desired recombinants were 
selected using erythromycin (5µg/ml) on BHI agar plates and subsequently verified by 
sequencing and western blot analysis. 
  
3.5.3. Expression and hemolytic activity of pneumolysin  
 
Pneumolysin was expressed and efficiently secreted into the culture supernatent of EGD- 
e∆hly, as shown by Western blot using monoclonal anti-PLY antibody (Fig. 3.26.).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.26. Immunoblot analysis. Equal amounts of proteins precipitated by 10% trichloroacetic acid 
from BHI culture supernatants of L. monocytogenes EGD-e∆hly  (Lanes 1) and the isogenic deletion 
mutant L.monocytogenes EGD-e∆hly expressing either LLO (Lanes 2) or PLY (Lanes 3) were loaded 
onto 10 % SDS-polyacrylamide gel. Proteins were electrophoretically blotted and developed with 
either mouse anti-LLO monoclonal antibody (M275) or mouse anti-PLY monoclonal antibody 
followed by AP-conjugated anti-mouse IgG. Lane (M) corresponds to the running marker protein 
while the numbers to the left of the figure correspond to apparent molecular weights (in kDa). 
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Fig. 3.27. Hemolytic activity of recombinant pneumolysin. Serial twofold dilutions of each culture 
supernatant (isolated from bacterial cultures at OD600 of 1.0) from L. monocytogenes EGD-e (Lane 1), 
the isogenic deletion mutant L. monocytogenes EGD-e∆hly (Lane 2), and EGD-e∆hly expressing 
either LLO (Lane 3) or  PLY (Lane 4) (starting from 50 µl of non-diluted sample) were incubated with 
defibrinated sheep erythrocytes at pH 5.6 and 37°C for 2 hours. Cytolysis of erythrocytes is visualized 
by a uniform grey colour of the well (corresponding to haemoglobin release). A dark spot at the 
bottom of the well corresponds to sedimented intact erythrocytes.  
 
 
Interestingly, pneumolysin was recognized with anti-LLO monoclonal antibody  (M275) 
while  LLO  was  also  recognized  with  anti-PLY  monoclonal antibody. The  cross reactions 
of   LLO  and  PLY  against  both  antibodies  are  more  likely  due  to  the  close  structure 
homology between the two proteins. The regulated expression of the cloned gene products 
was  examined by  assaying the  hemolytic activity  of bacterial  culture supernatants on sheep 
erythrocytes at pH 5.6. As expected, EGD-e∆hly had no detectable hemolytic activity. 
Pneumolysin showed a comparable hemolytic activity to that of LLO (Fig. 3.27.).  
 
3.5.4.  Listeria  expressing  pneumolysin  shows  a  limited  intracellular  growth in  J774  
           macrophages 
 
The ability of this strain to grow inside the mouse macrophage like cell line J774 was 
examined. During the first 8 hours of intracellular growth, wild type EGD-e as well as the 
mutant strain EGD-e∆hly complemented with LLO doubled approximately 5 times, whereas 
the pneumolysin expressing  EGD-e∆hly mutant strain doubled only once during the first 4 
hours  followed by a decrease in  the  growth  rate   suggesting   the  induction  of  host  cell 
cytotoxicity by pneumolysin, resulting in entry of extracellular gentamicin and bacterial death 
(Fig. 3.28.). 
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Fig. 3.28. A)  Intracellular growth kinetics in macrophages. A) macrophage-like J774 cell line was 
infected with the wild type L monocytogenes EGD-e, mutant Lmonocytogenes EGD-e∆hly expressing 
either LLO  or PLY, and mutant L. monocytogenes EGD-e∆hly strains at MOI of 10. Viable bacteria 
were enumerated at indicated time intervals following incubation at 37°C. B) macrophage-like J774 
cell line was infected with the wild type L.monocytogenes EGD-e (1), mutant L.monocytogenes EGD-
e∆hly expressing either LLO (2) or PLY (3), and mutant L. monocytogenes EGD-e∆hly strains (4). 4 
hours after gentamicin treatment, cells were fixed with 4% formaldehyde and visualised by staining F-
actin using Oregon Green 488 conjugated phalloidin under a fluorescence microscope. 
 
 
In order to confirm this suggestion, the infected macrophages were examined 4 hours post-
infection by flourescent microscopy after staining with beta-phalloidin to visualize the F-
actin. The wild type L. monocytogenes as well as mutant bacteria expressing wild type LLO 
had multiplied and were found associated with tails of polymerized actin, propelling bacteria 
to adjacent cells, whereas  bacterial escape  as  well  as actin polymerisation for the EGD-
e∆hly mutant strain expressing pneumolysin was significantly lower (Fig. 3.28.). As expected, 
the EGD-e∆hly strain was unable to multiply or to polymerize actin.  
 
3.5.5.  L. monocytogenes expressing pneumolysin shows a reduced in vivo survival  
 
In order to correlate the in vitro intracellular growth of the L. monocytogenes expressing 
pneumolysin strain to its in vivo survival, the virulence of this strain in comparison to the 
wild-type was assessed by using the i.v. mouse model. The number of bacteria in both spleens 
and livers of infected mice was determined over 9 days after infection. A group of BALB/c 
mice were intravenously (i.v) injected with sublethal doses of either wild type EGD-e strain 
(103), or the isogenic L. monocytogenes derivatives EGD-e∆hly, EGD-e∆hly: :LLO, and 
EGD-e∆hly: :PLY (8x106). As shown previously, regardless of the dose of infection, the 
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mutant EGD-e∆hly is rapidly cleared from both organs from the outset (Lety et al., 2001; 
Peters et al., 2003).  On day 3 post-infection, bacterial load had already fallen to a level of 
approximately 40 cfu/mg of spleen and 10 cfu/mg of the liver even after infection with 8x106 
viable bacteria per mouse (Fig. 3.29.). Although the survived numbers of EGD-e∆hly: :PLY 
mutant strain increased from day one to day three post infection in both spleen and liver, it 
remained 10–60 as well as 10 folds lower than the number of wild type survived from spleen 
or liver respectively over the first 3 days after the infection. Then, the number of survived 
mutant strain EGD-e∆hly: :PLY decreased rapidly from day 4 post-infection onwards. 
Survival was fully restored in EGD-e∆hly complemented with plasmid-encoded LLO to an 
extent seems to be identical to that of the wild type L. monocytogenes where the number 
increased between day 1 and day 3. On day 3, the number of wild type and EGD-e∆hly +LLO 
peaked at the same level and declined rapidly from day 4 post-infection onwards. In all cases, 
both in the wild type EGD-e and in its mutant derivatives, bacteria were cleared from the 
spleen and liver by day 8 -10 post-infection. 
 
3.5.6.  Induction of a protective antilisterial immune response by Listeria monocytogenes  
           expressing pneumolysin in place of listeriolysin O 
 
Analysis of the specificity of antilisterial cytotoxic cells from Listeria immune BALB/c mice 
donors has shown a dominant response to an epitope corresponding to amino acids 91 to 99 of  
LLO (Pamer et al., 1991; Harty and Bevan, 1992). Pamer and co-workers have identified four 
major Listeria-derived epitopes of CD8+ T cells presented by H2-kd (Busch et al., 1998; 
1999). Two of the peptides derive from p60, a constitutively secreted protein of Listeria:  
p60449–457 is presented at a high density by infected cells but is subdominant based on the size 
of the T cell population specific for this peptide; in contrast a stronger T cell response is 
specific for p60217–225, even though this epitope is presented at a lower level. A third epitope 
derives from LLO (residues 91–99);  although  presented  in  smaller  amounts  than  the  p60 
epitopes, it dominates the T cell response. The fourth epitope is from a secreted 
metalloprotease, mpl84–92. A major contribution in understanding the response to Listeria has 
been made by following the development of the CD8+ T cell  response to  these four  peptides 
(Busch et al., 1998; 1999) using the MHC tetramer approach developed by Davis and Altman 
(Altman et al., 1996). Demonstration of antilisterial T cells with specificity to non-LLO-
derived  epitopes  had  been  difficult  to  achieve  because  of  the  requirement  of  LLO  in  
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Fig. 3.29. In vivo kinetics of primary infection. The kinetics of bacterial growth was followed in 
organs of mice infected i.v. with either 103 wild type L. monocytogenes EGD-e or 8x106 isogenic L. 
monocytogenes mutant strains EGD-e∆hly expressing either LLO or PLY, and mutant L. 
monocytogenes EGD-e∆hly strains. On days 1, 2, 3, 4, 5, 8, and 9 after infection, the numbers of 
viable bacteria in the spleens and the livers of three animals per group were determined. Data 
presented are representative of three independent experiments. 
 
 
facilitating escape of the bacteria to the cytoplasm of the host cell and the apparent dominance 
of an anti-LLO response in antilisterial immunity. In this study, it was examined if the ability 
of pneumloysin expressing EGD-e∆hly mutant  strain to  escape  phagolysosome  and  gain  
access  to  the  cytoplasm  can induce a protective immunity against a lethal infection with the 
wild type L. monocytogenes by facilitating endogenous antigen processing and presentation of 
non LLO-determinant epitopes for association with MHC class I molecules for surface 
display to CD8+ T cells. Groups of BALB/C mice were infected i.v. with the wild type strain 
(103) or its isogenic derivatives (8x106). 2 months later, all mice were challenged with a lethal 
i.v. dose (5x104), corresponding to 10X LD50 of the wild type L. monocytogenes, and survival 
was monitored. As a control, a group of non-immunized normal BALB/C mice that have 
received a similar lethal dose of the wild type L. monocytogenes were included. As expected, 
all the non-immunized mice died in 3 days as well as those pre-immunized with the isogenic 
mutant strain EGD-e∆hly were dead in 4 days after the challenge infection with L. 
monocytogenes whereas those pre-immunized with the wild type as well as EGD-e∆hly 
complemented with  LLO  were  protected  against  a  lethal  Listeria  infection  and  survived 
(Fig. 3.30.A). Surprisingly, all the mice pre-immunized with EGD-e∆hly mutant strain 
expressing PLY can also survive the lethal infection of the wild type EGD-e strain. 
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Fig. 3.30. Induction of protective immunity by Listeria monocytogenes expressing pneumolysin. A) 
Mice were infected i.v. with either 103 wild type L. monocytogenes EGD-e or 8x106 isogenic  L. 
monocytogenes mutant strains EGD-e∆hly expressing either LLO or PLY, and mutant L. 
monocytogenes EGD-e∆hly strains. Two months later all mice were challenged with a lethal dose 
(10X LD50) of the wild type L. monocytogenes. As a control, a group of uninfected normal mice was 
included. Survival of mice after the challenge was monitored up to 8 days. Data were pooled from two 
independent experiments with a total of 15 mice per group. B) Bacterial titres in spleens and livers of 
3 mice per group of mice challenged in Fig. A were monitored at day 2 after challenge. 
 
 
 In addition, the bacterial titres were determined in spleens and livers at day 2 post-challenge 
in each mice group. Mice primed with the isogenic mutant strain EGD-e∆hly as well as naïve 
unprimed mice were not able to control challenge infection as indicated by the high bacterial 
load in spleen and liver. In contrast, mice primed with the wild type EGD-e or the mutant 
strain EGD-e∆hly complemented with either LLO or PLY managed to restrict listerial growth 
in the first 2 days after infection (Fig. 3.30.B). Hence, to this point, pneumolysin seems to 
manage to induce a protective immunity in absence of listeriolysin O. 
In order to determine whether T cells with specificity for non-LLO-derived epitopes of L. 
monocytogenes are a component of a protective antilisterial immune response, the amount of 
antigen specific MHC class I restricted effector CD8+ T cells induced against a P60 derived 
peptide, P60217-225, in mice spleens 9 days after the primary infection as well as  5 days after 
the challenge with a sub-lethal dose (2x103) of L. monocytogenes was quantitatively 
determined  through evaluation of the number of IFN-γ producing CD8+ T cells induced 
against the dominant H-2Kd restricted P60217-225 subdominant epitope (Vijh and Pamer, 1997) 
in in vitro ELISPOT assay. As shown in Fig. 3.31., infection with the PLY expressing mutant 
strain managed to induce a highly detectable population of P60217-225 specific CD8+ T-cells 
comparable to those induced in response to infection with the wild type L. monocytogenes as 
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well as the mutant complemented with LLO. This number raised significantly during the 
recall infection. On the other hand, Infection with the isogenic mutant strain EGD-e∆hly failed   
to   induce  a  significant  level  of  CD8+   T-cells   population   either   primarily   or   after 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.31. Number of antigen-specific IFN-γ producing CD8+ T cells in the spleen of mice infected 
i.v. with L.monocytogenes or its mutants, determined by ELISPOT assay. Spleen cells from infected 
mice were isolated either at day 9 after the primary infection or day 5 after recall challenge infection 
and stimulated with the immunosubdominant MHC class I peptide  P60217-225 in triplicates in 
nitrocellulose based 96-well culture plates. Number of specific IFN-γ producing cells was determined 
by counting the number of spots under microscope. 
 
 
challenge. These data reveal that pneumolysin can replace listeriolysin for induction of 
protective anti-listerial immunity developed against non-listeriolysin derived epitopes. 
The induction of antilisterial protective immunity with PLY expressing Listeria was 
addressed by identifying the production of memory T cells in response to challenge infection.  
The magnitude of down regulation of CD62L T cell surface marker was quantitatively 
determined 2 months after the primary infection and 5 days after the recall infection. The 
expression of CD62L on the T cells was shown to be downregulated in response to primary 
Listeria infection and is upregulated after bacterial clearance (Busch and Pamer, 1999). 
However, during the recall infection with L. monocytogenes, CD62L was significantly down 
regulated.  Day  5  post  challenge  was chosen because maximum spleen cellularity as well as 
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Fig. 3.32. Expression levels of CD62L on CD8+ splenocytes following primary and recall infection 
with L. monocytogenes strains. Flow cytometry was performed with spleen cells, isolated from mice 2 
months after the primary infection or 5 days after the challenge. Cells were stained with FITC-labeled 
anti-Lyt-2 and biotinylated anti-CD62L, and the binding of anti-CD62L on the cell surface was 
detected with PE-conjugated streptavidin. Numbers shown are gated CD8+CD62Llo T cells (lower 
panel) and analysed with CELL Quest software.    
 
 
maximum number of CD8+ T cells was established on this day (Busch and Pamer, 1999). As 
shown in Fig. 3.32., challenge with the wild type L. monocytogenes managed to induce a 
significant  down  regulation of  CD62L  on  CD8+  splenocytes in mice pre-immunized  with 
PLY expressing EGD-e∆hly strain similar to that induced in mice pre-immunized with the 
wild type L. monocytogenes as well as with EGD-e∆hly: :LLO suggesting that CD8+ T 
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lymphocytes induced against non-listeriolysin determinants are able to confer anti-Listeria 
protective immunity.  
 
3.5.7.  Humoral response is induced against both listeriolysin O and pneumolysin 
 
It was previously shown that Listeriolysin O and irpA are major protein targets of the human 
humoral response against L. monocytogenes (Grenningloh et al., 1997). So, it was important 
to examine if mice pre-immunized with either the wild type  L. monocytogenes or  its  
isogenic derivatives can produce antibodies against either listeriolysin O or pneumolysin.  
Blood was obtained from mice by heart puncture at day 8 post-infection, corresponding to the 
plateau phase of antibody response to antigen. Sera were separated from blood cells by 
ultracentrifugation  at  15.000  rpm  for  15  minutes.  Purified listeriolysin O  or  pneumolysin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.33. Induction of humoral immunity against thiol-activated cytolysins. Equal amounts (1µg) of 
purified listeriolysin O (LLO) or pneumolysin (PLY) were loaded onto 10 % SDS-polyacrylamide gel. 
Gels were electrophoretically blotted and incubated with antisera obtained from mice 9 days after 
infection with 103 wild type L. monocytogenes EGD-e (Lane 1), 8x106 isogenic L. monocytogenes 
mutant strains EGD-e∆hly expressing either LLO (Lane 2) or PLY (Lane 3), and 8x106 mutant L. 
monocytogenes EGD-e∆hly strains (Lane 4) followed by AP-conjugated anti-mouse IgG. Blots were 
visualized using BCIP as a substrate. The numbers to the left of the figure correspond to apparent 
molecular weights (in kDa). 
 
(1µg/serum tested) were used as antigens in immunoblots and incubated with mice sera. 
Surprisingly, Sera from mice pre-immunized with the wild type EGD-e as well as the isogenic 
mutant strain complemented with either listeriolysin O or pneumolysin have strongly 
recognized the two cytolysins while those isolated from mice pre-immunized with the 
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isogenic EGD-e∆hly mutant strain failed to detect the two toxins as shown in Fig. 3.33. The 
cross reactivity of monoclonal antibodies as well as natural antibodies against both 
listeriolysin O and pneumolysin was suggested to be due to the structural similarities between 
the two toxins. So, pneumolysin expressing EGD-e∆hly mutant strain acts as a target for both 
antilisterial cellular and humoral immune responses.  
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3.6.  The PEST-like region in Listeriolysin O is critical for induction of effective long- 
         term immunity 
 
Listeriolysin O (LLO), a major virulence factor secreted by the bacterial pathogen Listeria 
monocytogenes, contains near to its N-terminus a putative PEST-like sequence (P, Pro; E, 
Glu; S, Ser; T, Thr)  which was recently identified to be essential  for the virulence and 
intracellular compartmentalization. The first study concerning the role of  PEST like motif in 
the pathogenicity of Listeria monocytogenes was conducted with Decatur et al, and concluded 
that the PEST like motif may target eukaryotic proteins for phosphorylation and/or 
degradation by the proteasome, and may generally represent sites of protein-protein 
interactions (Decatur and Portnoy, 2000) although the actual mechanism by which the PEST-
like sequence acts to negate LLO toxicity was not clear.  The critical role of this sequense in 
mediating escape from the host cell phagolysosome was recently established (Lety et al., 
2001; 2002). 
Listeria monocytogenes has been used for decades for the induction and analysis of T cell-
mediated immunity (Mackaness, 1962; Mielke et al., 1998). Among the listerial virulence 
factors, Listeriolysin O is critical for  generating a protective anti-listerial T lymphocyte 
response (Dunn and North, 1991). In an attempt to analyze if the PEST like sequence lacking 
listeriolysin O can induce a T cell-mediated immunity, 28 amino acid residues at the N-
terminus of listeriolysin O harbouring the PEST like sequence was deleted and the growth 
kinetics of the isogenic Listeria mutant lacking the PEST-like sequence as well as its 
immunological properties were systemically examined. 
 
3.6.1.  Generation of the  LLO mutant protein 
3.6.1.1.  Bacteria  
 
Bacterial strains used in this study are wild type Listeria monocytogenes EGD-e serotype 1/2a 
(Glaser et al., 2001), its  isogenic deletion mutant EGD-e∆hly (Leimeister-Wächter et al., 
1990; Guzman et al., 1995), both were electroporatically transformed with pSOG304 gram-
positive/gram-negative schuttle vector (Otten et al., unpublished), and its isogenic derivatives 
EGD-e∆hly: :pSOG304-hly (designated EGD-e∆hly: :LLOwt), and EGD-e∆hly: :pSOG304-
hly∆PEST(designated EGD-e∆hly: :LLO∆PEST). Bacteria were grown in brain-heart infusion 
(BHI) broth in presence of 5µg/ml erythromycin. In all in vitro and in vivo experiments, fresh 
cultures of bacteria, prepared from an overnight culture, were used.  
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3.6.1.2. Construction of the mutants 
 
For the construction of EGD-e∆hly strains complemented with either intact hly gene or hly 
gene lacking the PEST-like sequence, pSOG304 plasmid was used.  
 
 
3.6.1.2.1.  EGDe∆hly::pSOG304-hly∆PEST  
 
A 28 amino acids region (a`a` 26 - a`a` 53) harbouring the PEST-like sequence at the N-
terminus of Listeriolysin O was removed using a method  of site-directed mutagenesis called 
gene splicing by overlap extension (Ho et al., 1989). A 309 bp long PCR fragment comprising 
PEST-like region upstream sequences was amplified with (hly-P for., KpnI) and  (PEST rev., 
NdeI) oligonucleotides primers. A second 1595 bp PCR fragment harboring PEST-like region 
downstream sequences was amplified with (PEST for., NdeI)  and (hly∆PEST rev., XhoI) (see 
section 2.7.11). Both fragments were restricted with endonuclease NdeI and used in a ligation 
reaction. So, the deleted sequence was substituted with a NdeI restriction site encoding a (h) 
and (m) residues (Fig. 3.34.B). The entire PCR fragment, lacking the PEST-like region , was 
amplified with oligonucleotides containing KpnI and XhoI restriction sites, restricted with 
KpnI and XhoI restriction enzymes and was cloned into the KpnI and XhoI restriction sites of 
the pSOG304 plasmid vector (Fig. 3.34.A). Both constructions were checked by DNA 
sequence analysis. 
 
 
3.6.1.2.2.  EGD-e∆hly: :pSOG304-hly 
 
EGD-e∆hly expressing the intact wild type listeriolysin O was used in all experiments as a 
positive control. By means of (hly-gene for., XhoI) and   (hly-gene rev., SpeI) oligonucleotides 
primers (see section 2.7.11),  a  2086  bp  long      fragment  containing entire hly gene and its 
promoter was amplified from Listeria monocytogenes chromosomal DNA using high fidelity 
PCR procedure followed by cloning on to pSOG304 plasmid using XhoI and SpeI restriction 
sites (Fig. 3.25.B).  
Transformation of EGD-e∆hly strains with pSOG304 plasmid containing intact hly gene or 
hly lacking PEST-like sequence was performed by electroporation (Schäferkordt and 
Chakraborty, 1995). The desired recombinants were selected using erythromycin (5µg/ml) on 
BHI agar plates and subsequently verified by sequencing and western blot analysis. 
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Fig. 3.34. A) Cloning of the PEST-knock out listeriolysin O in pSOG304. The structural gene 
encoding listeriolysin O lacking the PEST-like sequence with KpnI and XhoI restricted ends was 
cloned in the multiple cloning site (mcs) of pSOG304 restricted with the same enzymes. B) Sequence 
of the mutated protein. DNA and amino acid sequences of the LLO∆PEST mutant. The created NdeI 
site is underlined, and the corresponding residues are in bold. The numbers above the sequences refer 
to the amino acid position. 
 
 
3.6.2.  Expression and hemolytic  activity of the LLO mutant protein 
 
The LLO mutant protein  was expressed and efficiently secreted into the culture supernatant  
of EGD-e∆hly, as shown by western blot using monoclonal anti-LLO antibody (M275) (Fig.  
3.35.A). The PEST-like sequence lacking LLO was normally recognized by the monoclonal 
antibody which appeared to react more strongly with LLOwt than with the mutant protein. 
Moreover, several additional bands of lower molecular weight were clearly detected with  
LLOwt but poorly recognized with the mutant protein suggesting more instability of LLOwt 
than of the mutant protein.  
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Fig. 3.35. A) Immunoblot analysis. Equal amounts of precipitated proteins from culture supernatants 
of  L. monocytogenes EGD-e (Lane 1), the isogenic deletion mutant L. monocytogenes EGD-e∆hly 
expressing either LLOwt (Lane 2) or LLO∆PEST (Lane 3), and EGD-e∆hly (Lane 4) were loaded onto 
10 % SDS-polyacrylamide gel. Proteins were electrophoretically blotted and developed with mouse 
anti-LLO monoclonal antibody (M275) followed by AP-conjugated anti-mouse IgG. The numbers to 
the left of the figure correspond to apparent molecular weights (in kDa). B) Hemolytic activity of the 
truncated protein. Serial two-fold dilutions of each culture supernatant from L. monocytogenes EGD-e 
(Lane 1), the isogenic deletion mutant L.monocytogenes EGD-e∆hly (Lane 2), and  EGD-e∆hly 
expressing either LLOwt  (Lane 3) or  LLO∆PEST (Lane 4) (starting from 50 µl of non-diluted 
sample) were incubated with defibrinated sheep erythrocytes at pH 5.6 and 37°C for 2 hours. Cytolysis 
of erythrocytes is visualized by a uniform grey colour of the well (corresponding to haemoglobin 
release). A dark spot at the bottom of the well corresponds to sedimented intact erythrocytes.  
 
 
 
The regulated expression of the cloned gene products was examined by assaying the 
hemolytic activity of bacterial culture supernatants on sheep erythrocytes at pH 5.6. As 
expected, EGD-e∆hly had no detectable hemolytic activity. The mutant protein show a 
hemolytic activity  appears to be identical to that of  LLOwt (Fig. 3.35.B).  
 
 
3.6.3.  Deletion of the PEST-like sequence of LLO inhibits bacterial phagosomal escape 
 
 
To understand the role of PEST-like sequence in mediating survival of L. monocytogenes in 
vivo, the interaction of mutant L. monocytogenes lacking the PEST-like sequence with J774 
macrophages was examined in vitro. It has been previously shown that EGD-e∆hly is unable 
to escape from the phagolysosome of J774 macrophages and therefore does not replicate in 
this cell line (Decatur and Portnoy, 2000, Lety et al., 2001; 2002). During the first 6 hours of  
intracellular growth, the wild type EGD-e as well as the mutant strain EGD-e∆hly 
complemented with LLOwt doubled approximately 5 times (Fig. 3.36.A), whereas the number 
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Fig. 3.36. Intracellular growth kinetics in eukaryotic cells. A) macrophage-like J774 cell line was 
infected with the wild type L. monocytogenes EGD-e (filled circles), mutant L. monocytogenes EGD-
e∆hly expressing either LLOwt (open circles) or LLO∆PEST (closed triangles), and mutant L. 
monocytogenes EGD-e∆hly strains (open triangles) at MOI of 10. Viable bacteria were enumerated at 
indicated time intervals following incubation at 37°C. B) macrophage-like J774 cell line was infected 
with the wild type L. monocytogenes EGD-e (1), mutant L. monocytogenes EGD-e∆hly expressing 
either LLOwt (2) or LLO∆PEST (3), and mutant L. monocytogenes EGD-e∆hly strains (4). 4 hours 
after gentamicin treatment, cells were fixed with 4% formaldehyde and visualised by staining F-actin 
using Oregon Green 488 conjugated phalloidin under a fluorescence microscope. 
 
 
of  both mutant strain lacking the PEST-like sequence  and EGD-e∆hly neither increased nor  
severely decreased during the 8 hours infection path although the number of colony forming 
units of the former remained slightly higher than that of the latter  suggesting that both strains 
remained trapped, but viable, in phagosomes of the J774 macrophages. The infected 
macrophages were examined 4 hours post-infection by flourescent microscopy after staining 
with beta-phalloidin to visualize the F-actin. The wild type L. monocytogenes as well as 
mutant bacteria expressing wild type LLO had multiplied and were found associated with tails 
of polymerized actin, propelling bacteria to adjacent cells (Fig. 3.36.B), whereas bacteria 
expressing LLO∆PEST showed a severely reduced replication with very low capacity to 
polymerize actin in most of the infected cells. As expected, the EGD-e∆hly strain was unable 
to multiply or to polymerize actin. These data reflects the importance of PEST-like sequence 
in mediating disruption of the phagosomal membrane and bacterial intracellular 
multiplication. 
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3.6.4.  PEST-like sequence mediates survival of L. monocytogenes in vivo   
 
The first and crucial step in the in vivo characterization of mutants was the determination of 
their growth kinetics in spleen and liver. The presence of viable microorganisms during the 
early phase of infection is critical in the induction and establishment of cell-mediated 
immunity   (Darji et al., 2003).  Therefore,    the    virulence    of   EGD-e∆hly    transformants  
 
 
Fig. 3.37. In vivo kinetics of primary infection in mice with the wild type L. monocytogenes and its 
isogenic mutants. Mice were infected i.v. with either 103 wild type L. monocytogenes EGD-e (filled 
circles) or 106 isogenic L. monocytogenes mutant strains EGD-e∆hly expressing either LLOwt  (open 
circles) or LLO∆PEST (closed triangles), and mutant L. monocytogenes EGD-e∆hly strains (open 
triangles). On days 1,2,3,4,5,8,and 9 after infection, the numbers of viable bacteria in spleens and 
livers of three animals per group were determined. Data presented are representative of three 
independent experiments. 
 
 
expressing LLOwt and LLO∆PEST was compared with that of wild type L. monocytogenes 
and EGD-e∆hly. A group  of BALB/c  mice  were  intravenously  (i.v)  injected with sublethal 
doses of either wild type EGD-e strain(103), or the isogenic L. monocytogenes derivatives 
EGD-e∆hly , EGD-e∆hly: :LLOwt, and EGD-e∆hly: :LLO∆PEST (106). In vivo survival and 
growth kinetics of bacteria were followed by determining the number of bacteria in spleens 
and livers of infected mice at various time points for several days. As shown previously, 
regardless of the dose of infection, the mutant EGD-e∆hly is rapidly cleared from both organs 
from the outset  (Lety et al., 2001; Peters et al., 2003). On  day  3  post-infection,  bacterial 
load had already fallen to a level of approximately 40 cfu/mg of spleen and 10 cfu/mg of the 
liver even after infection with 106 viable bacteria per mouse (Fig. 3.37). Although the PEST-
like sequence lacking strain showed a slightly more survival than EGD-e∆hly in spleen and 
3. Results                                                                                                                                 132                       
liver of infected mice, bacterial counts remains very low up the first day after infection and 
dropped more after day 2 onwards. Survival was fully restored in EGD-e∆hly complemented 
with plasmid-encoded LLOwt to an extent identical  to that  of  the  wild  type L. 
monocytogenes  where the  number  increased between day 1 and day3. On day 3, the number 
of the wild type EGD-e and EGD-e∆hly+LLOwt peaked at the same level and declined 
rapidly from day 5 post-infection onwards. In all cases, both in the wild type EGD-e and in its 
isogenic mutant strains, bacteria were cleared from spleens and livers by day 8-10 post-
infection. 
 
3.6.5. Spleen morphology on day 3 after infection 
 
Because  the  spleen  is  the lymphatic organ where the immune response is initiated 
following an i.v. inoculum, morphological alteration in the spleens on day 3 after i.v. 
infection with the wild type EGD-e and its isogenic derivatives was monitored. As shown in 
Fig. 3.38., marked differences were observed in the morphological structure of spleens 
obtained from mice infected with these strains. Spleens obtained from mice infected with the 
wild type EGD-e strain showed a pronounced strong granuloma formation on day 3 post-
infection resulted  from intense and vigorous leukocyte infiltration  of the white pulp, whereas   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.38. Morphological changes in spleens of mice infected with Listeria strains. Spleens of mice 
(infected i.v. as mentioned in Fig. 3.37) were removed on day 3 after primary infection. Shown is the 
scanned picture of spleens from the wild type L. monocytogenes EGD-e (A), mutant L. monocytogenes 
EGD-e∆hly expressing either LLOwt (B) or LLO∆PEST (C), and mutant L. monocytogenes EGD-
e∆hly strains (D).Vigourous monocytic infiltration and intense granulomatous lesions are detectable 
only in the spleens isolated from mice infected with the wild type L.monocytogenes(A) while 
splenomegaly was detected in the spleens isolated from mice infected with mutant L. monocytogenes 
EGD-e∆hly expressing LLOwt (B). No morphological alterations were detected in spleens of mice 
infected with  mutant L. monocytogenes EGD-e∆hly expressing LLO∆PEST (C) or those infected with 
the isogenic mutant L. monocytogenes EGD-e∆hly (D). 
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EGD-e∆hly: :LLOwt displayed a splenomegaly without granuloma. Infection with both EGD-
e∆hly and EGD-e∆hly: :LLO∆PEST did not result in morphological changes on day 3 post 
infection.   
 
3.6.6.   PEST-like   sequence truncated Listeriolysin O fails to induce IFN-γ  either in    
            serum or by splenocytes during primary infection 
 
It was previously reported that IFN-γ produced at the first stage of infection with L. 
monocytogenes is critical for the generation of host resistance (Xiong et al., 1994). The 
induction of IFN-γ was, therefore, measured after infection with wild type and its isogenic 
derivatives. Mice  were i.v. injected with (103)  cfu of  L. monocytogenes  or (106) cfu   of   its  
 
 
Fig. 3.39. A) IFN-γ concentration in the serum of mice infected with Listeria strains. Mice were 
infected with 103 CFU of L. monocytogenes EGD-e or 106 CFU of the various Listeria mutants. On 
day 2, animals were killed and blood was obtained by heart puncture. Serum concentration of IFN-γ 
was determined by ELISA. B) Listeria-induced IFN-γ production by spleen cells 9 days after 
infection. Mice were infected with 103 CFU of L. monocytogenes EGD-e or with 106 CFU of various 
Listeria mutants. On day 9 after infection, mice were killed and spleens removed. Single cell 
suspensions were stimulated in vitro with secreted soluble Listeria antigens to produce IFN-γ. After 48 
hours, culture supernatants were tested for presence of IFN-γ by ELISA. 
 
 
isogenic derivatives, and  IFN-γ concentration was measured in serum samples on day 2 post- 
infection. As shown in Fig. 3.39.A, infection with the wild type and EGD-e∆hly: :LLOwt 
resulted in  high serum levels of IFN-γ while a significantly low amount of IFN-γ was 
detected in sera of mice infected with either EGD-e∆hly or the ∆PEST strain. In addition, the 
IFN-γ level in vitro in culture supernatants of spleen cells isolated from the same groups mice 
on day 9 post-infection was measured. Only the wild type strain and the mutant EGD-e∆hly 
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complemented with LLOwt induced detectable levels of IFN-γ whereas EGD-e∆hly and 
∆PEST strains failed to induce production of IFN-γ (Fig. 3.39.B). 
 
3.6.7.  Expression  of  acquired  immunity  by  the  wild  type  L. monocytogenes  and its    
            isogenic derivatives 
 
It was established that sub-lethal primary infection with the wild type L. monocytogenes was 
controlled by mice and resulted in the induction of protective immunity to further infections 
(Darji et al., 2003). Such an acquired protective immunity is absolutely mediated by  
cytotoxic CD8+ T lymphocytes. It was therefore noteworthy to investigate whether the 
induction  of protective  immunity is  affected  with  absence of  the PEST-like sequence from  
Fig. 3.40.  Primary infection with ∆PEST mutant Listeria strain fails to induce a protective immunity 
against a lethal wild type L. monocytogenes infection. (A) Mice were infected i.v. with either 103 wild 
type L. monocytogenes EGD-e or 106 isogenic L. monocytogenes mutant strains EGD-e∆hly 
expressing either LLOwt or LLO∆PEST, and mutant L. monocytogenes EGD-e∆hly strain. Two 
months later all mice were challenged with a lethal dose (10X LD50) of the wild type L. 
monocytogenes. As a control, a group of uninfected normal mice was included. Survival of mice after 
the challenge was monitored up to 8 days. Data were pooled from two independent experiments with a 
total of 15 mice per group. (B) Bacterial titer in spleens and livers of 3 mice per group of mice  
challenged in Fig. A were monitored at day 2 after challenge. 
 
 
Listeriolysin O. Groups of BALB/C mice were infected i.v. with the wild type strain(103) or 
its isogenic derivatives (106). 2 months later, all mice were challenged with a lethal i.v. dose 
(5x104), corresponding to 10X LD50 of the wild type L. monocytogenes, and survival was 
monitored. As a control, a group of non-immunized normal BALB/C mice that have received 
a similar lethal dose of the wild type L. monocytogenes were included. As shown in Fig. 
3.40.A, all the non-immunized mice died in 3 days as well as those pre-immunized with 
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mutant strains EGD-e∆hly and EGD-e∆hly: :LLO∆PEST were dead in 4 days after the 
challenge infection with L. monocytogenes whereas those pre-immunized with either  the wild 
type or EGD-e∆hly complemented with LLOwt were protected against a lethal Listeria 
infection and survived. In addition, the bacterial titer was determined in spleens and livers at 
day 2 post-challenge in each mice group. Mice primed with mutant strains EGD-e∆hly and 
EGD-e∆hly: :LLO∆PEST as well as naïve unprimed mice were not able to control challenge 
infection as indicated by the high bacterial load in spleens and livers. In contrast, mice primed  
with either the wild type or the mutant strain EGD-e∆hly complemented with LLOwt 
managed to restrict listerial growth in the first 2 days after challenge infection (Fig. 3.40.B). 
Hence, absence PEST-like sequence abrogates the induction of a protective Listeria-specific 
T cell response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  3.41. Number of antigen-specific IFN-γ producing CD8+ T cells in the spleen of mice infected 
i.v. with the wild type L.monocytogenes and its mutant strains, determined by ELISPOT assay. Spleen 
cells from infected mice were isolated either at day 9 after the primary infection or day 5 after recall 
challenge infection and stimulated with immunodominant MHC class I peptide  LLO91-99 in triplicates 
in nitrocellulose based 96-well culture plates. Number of specific IFN-γ producing cells were 
determined by counting the number of spots under microscope. 
 
 
To obtain information on the nature of the inability of mutant strain lacking PEST-like 
sequence  to  confer a protective immunity  upon re-infection, the amount of antigen specific 
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MHC class I restricted effector CD8+ T cells induced in mice spleens 9 days after the primary 
infection and 5 days after the challenge with a sublethal dose (2x103) of L. monocytogenes 
was quantitatively determined through evaluating the number of IFN-γ producing CD8+ T 
cells induced against the dominant H-2Kd restricted LLO91-99 epitope (Wipke et al., 1993) in 
an in vitro ELISPOT assay. As shown in Fig. 3.41., infection with the wild type Listeria 
monocytogenes as well as the mutant complemented with LLOwt managed to induce a highly 
detectable population of LLO91-99 specific CD8+ T-cells. This number raised significantly 
during the recall infection. On the other hand, Infection with both mutant strains EGD-e∆hly 
and EGD-e∆hly: :LLO∆PEST failed to induce a significant level of CD8+ T-cells population 
either primarily or after challenge. So, the lack of PEST-like sequence seems to influence the  
antigen presentation efficiency through the MHC class I pathway due to the inability of 
PEST-like sequence lacking strain to gain access to the cytosole of the infected cell and to 
undergo further processing and antigen presentation.  
It was recently established that  the pathogen specific T lymphocytes are programmed during 
the  first  day of  infection  and  subsequently undergo  proliferation  and  differentiation  into  
effector  T cells without further calibration by the progressing inflammatory response but the 
magnitude of the LLO91-99-specific response correlates with the duration of in vivo bacterial 
growth during the first 24 hours after infection (Mercado et al., 2000). 
To correlate the in vivo growth kinetics of bacteria in spleens of infected mice with the 
magnitude  of memory  T cell response, the expression of CD62L (L-selectin) on CD8+ T 
cells, as an effector memory T cell marker, 2 months after the primary infection and 5 days 
after the recall infection has been quantified. CD62L is expressed at high levels on the surface 
of naïve T lymphocytes, but its expression is rapidly downregulated upon T cell activation 
(Bush and Pamer, 1999). 2 months after the primary infection, all groups of mice showed 
approximately 19-22 % of CD8+CD62Llo expressing T cell population which is relatively 
similar to that expressed in naïve uninfected mice (Mercado et al., 2000). During the recall 
infection however the CD8+CD62lo T cell population showed more than three folds increment  
in  mice  pre-immunized  either  with  the  wild  type  or  with    EGD-e∆hly: :LLOwt whereas 
pre-immunization with EGD-e∆hly or EGD-e∆hly: :LLO∆PEST fails to induce CD62L 
downregulation on the surface of T-lymphocytes (Fig. 3.42.) as indicated by the slight 
increase in the percent of  CD8+CD62lo  T cells during recall infection suggesting that the 
restricted in vivo growth and intracellular replication of EGD-e∆hly: :LLO∆PEST as well as  
EGD-e∆hly inhibits the capability of naïve T cells to come into contact with APCs in order to 
elicit a full T cell response.  
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Fig. 3.42. Quantification of CD62L expression on CD8+ splenocytes following primary and recall 
infection with L. monocytogenes and its mutant strains. Flow cytometry was performed with spleen 
cells, isolated from mice two months  after the primary infection or day 5 after the challenge. Cells 
were stained with FITC-labeled anti-Lyt-2 and biotinylated anti-CD62L, and the binding of anti-
CD62L on the cell surface was detected with PE-conjugated streptavidin. Numbers shown are gated 
CD8+ CD62lo T cells analysed with CELLQuest software.    
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4.  Discussion 
 
4.1. Antibody responses are important in defense during  infection with intracellular    
       bacteria 
 
The view that antibody-mediated immunity against many prokaryotic and eukaryotic 
intracellular pathogens is not important was popular until recently. The concept of a division 
whereby antibody-mediated immunity protected against extracellular pathogens and cell-
mediated immunity protected against intracellular pathogens may have had its intellectual 
origins in the great debate between the advocates of humoral and cellular immunity at the turn 
of the 20th century. The humoralists viewed immunity as being conferred by soluble 
substances in the blood and the generation of an effective antibody response, with phagocytic 
cells functioning primarily to clean up microbial debris while the cellularists viewed 
immunity as being conferred by macrophages and other phagocytic cells, with the role of 
humoral factors being to provide opsonins (Silverstein, 1979; Casadevall,  1998). This debate 
was fuelled by the success and difficulties associated with demonstrating antibody-mediated 
protection against certain pathogens in passive immunization studies. Administration of 
immune serum protected against toxin-mediated diseases such as tetanus and diphtheria and a 
certain subset of extracellular bacterial pathogens like Streptococcus pneumoniae, Neisseria 
meningitidis, and Haemophilus influenzae (Casadevall and Scharff, 1994). A recent study 
showed that monoclonal antibody raised against PLY protected mice against pneumococcal 
pneumonia (Garcia-Suarez et al., 2004). However, passive immunization provided little or no 
protection against intracellular microbes such as Mycobacterium tuberculosis (Glatman-
Freedman and Casadevall, 1998) and Listeria monocytogenes (Osebold and Sawyer, 1957; 
Mackaness, 1962; Miki and Mackaness, 1964).  
The fact that a microbe inside a cell is separated from serum antibody has contributed to the 
belief that serum antibody cannot be effective against an intracellular pathogen. However, a 
recent  surprising finding concluded that a neutralizing mAb to LLO provided resistance to 
Listeria infection (Edelson et al., 1999). Antibody-mediated protection was evident very early 
(within 6 hr) after infection and occurred in SCID mice, indicating that the effects of antibody 
were independent of the adaptive immune response. The authors reasoned that anti-LLO 
antibody-mediated protection was occurring through intracellular neutralization of LLO 
within phagocytic cells  which would block Listeria escape to the host cell cytosol and 
thereby block the rapid bacterial replication which takes place at this site (Edelson and 
Unanue, 2001). 
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Indeed, both LLO (Low et al., 1992)  and PLY (Cima-Cabal et al., 1999) were found as major 
targets of serum antibodies in  listeriosis or  pneumococcal pneumonia patients. In addition, 
due to their  potential role in bacterial virulence as well as in immunoregulation against their 
corresponding pathogens, it was noteworthy to purify these toxins to facilitate understanding 
their role in bacterial pathogenicity and immune responses elicited against them. 
In this study an improved production and a conventional column method for the bulk 
purification of pure cytolysins was reported. Listeriolysin O as well as pneumolysin were 
currently isolated from the supernatant of pathogenic L. monocytogenes and S. pneumonia 
strains respectively. There are 2 basic problems associated with this; large quantities of the 
pathogen have to be cultivated, restricting large scale purification of the toxin to designated 
facilities (Walton et al., 1999). Previous attempts to purify pneumolysin depended on its 
passive release in culture supernatants as a result of autolysis phenomena, since pneumolysin 
is an intracytoplasmic protein lacking a leader peptide to be exported to the extracellular 
medium, giving rise to a poor yield (Kanclerski and Mollby, 1987). Furthermore, the 
pathogenic L. monocytogenes and S. pneumonia strains secret a large number of additional 
proteins into its supernatant fluids including proteases (Courtney, 1991, Domann et al., 1993). 
To circumvents these problems, either listeriolysin O or pneumolysin gene was expressed in a 
non-pathogenic strain, Listeria innocua, a species found to lack all known virulence factors 
present in pathogenic L. monocytogenes (Leimeister-Wächter and Chakraborty, 1989). By 
including the positive regulator of listeriolysin production, the prfA gene, on the same 
plasmid it was possible to express large quantities of listeriolysin O in the culture supernatants 
of recombinant Listeria innocua strains. This 27 kDa cytoplasmic protein is a positively 
acting transcriptional activator required for all known listerial virulence genes (Leimeister-
Wächter et al., 1990). In addition, by introducing both promoter and signal peptide of 
listeriolysin O gene under the regulatory control of prfA, expression of pneumolysin as well 
as its active export to the extracellular medium was facilitated. 
  In all previous reports concerning of LLO purification, Listeria was grown in an enriched 
Brain Heart Infusion (BHI) medium for production of LLO. In addition to containing a high 
amounts of proteins that may interfere with efficiency of purification process, expression of 
virulence genes of L. monocytogenes, including LLO, are not induced in BHI but highly up 
regulated upon shift of L. monocytogenes from enriched medium to minimal medium 
(Sokolovic et al., 1993; Bohne et al., 1994; Klarsfeld et al., 1994) which has also the 
advantage of containing the minimum amount of amino acids required for bacterial growth, 
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thus enhancing both quantity and quality of purified LLO. Indeed, hemolytic activity of both 
toxins showed a 2-fold increment upon shift from BHI to minimal medium (Table 3.1).  
Listeriolysin O has been previously purified by thiol-disulphide exchange chromatography on 
thiopropyl/sepharose-6B, by immunoaffinity chromatography or by conventional methods 
using several column chromatographic steps (Geoffroy et al., 1987, Low et al., 1992, Matar et 
al., 1992, Schoel et al., 1994). The method described here used batch absorption of 
concentrated bacterial supernatants to Q-sepharose, followed by column chromatography of 
the non-absorbed fraction on a Resource-S column. The use of a buffer with an acidic pH was 
instrumental in improving the yields of pure listeriolysin. Using this procedure, approximately 
5.4 mg of purified protein per liter of original culture supernatant was obtained (Table 3.2). 
This is a substantial improvement to the methods with the highest  yields reported previously 
(Nato et al., 1991 , Schoel et al., 1994, Darji et al., 1995). 
On the other hand, earlier purification methods for pneumolysin have used preparative 
electrophoresis as a last step (Shumwory and Klebanoff, 1971; Johnson, 1972 ; Paton et al., 
1983) resulted in a poor yield. Other methods such as gel filtration and sucrose density 
gradient centrifugation have resulted in findings of different molecular weights (Kreger and 
Bernheimer, 1969). The method developed by  Kanclerski and Mollby resulted in a  highly 
purified pneumolysin but several column chromatographic steps were required (Kanclerski  
and Mollby, 1987). In the present study, pneumolysin underwent a simple one purification 
step resembles that used for LLO but due to the difference in pH activity and isoelectric 
points (LLO=6.7; PLY=5.2), pneumolysin was subjected to anion exchange chromatography 
on Resource-Q column. This procedure gave a pure protein yield of 2.0 mg per liter of 
original culture supernatant with a specific activity of 1.6x106 Hu/mg (Table 3.3). 
The relative ease with which listeriolysin O and pneumolysin can be purified from 
recombinant L. innocua strains will simplify the isolation and characterization of novel 
mutants of both toxins that are defective for hemolysis or for binding to its putative receptor 
on the eukaryotic cells. In addition, it will facilitate studies in pathogenicity of their parent 
strains as well as serological diagnosis of both listeriosis and pneumococcal infections.  
 
To date, studies on specific antilisterial antibodies following infection with L. monocytogenes 
have revealed cross-reactivity to only a few proteins, including listeriolysin, IrpA, InlB, actA, 
and P60 as targets of the humoral immune response (Gentschev et al., 1992; Low et al., 1992; 
Gholizadeh et al., 1996; Grenningloh et al., 1997). A pivotal study by Edelson and Unanue 
showed that prior treatment of mice with neutralizing monoclonal antibody to listeriolysin 
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prevents subsequent infection with this bacterium suggesting that listerial antigens targeted by 
the humoral response are required for successful host infection and thus warrant investigation 
(Edelson et al., 1999). Here it was shown that specific antibodies are directed against Frm, a 
newly discovered ferritin-like protein in L. monocytogenes, during infection by this 
bacterium. Physiological studies suggest that ferritin is required for making environmental 
iron available to these bacteria and in mediating protection against hydrogen peroxide and the 
reactive oxygen intermediates derived thereof. The properties exhibited by an isogenic ∆frm 
strain provide evidence that the listerial ferritin is involved in efficacious bacterial growth at 
early times in the infectious process.  
The identity of a 110 kDa species seen by the immune antisera from L. monocytogenes 
infected mice as the frm gene product was revealed in several ways. First, antisera from L. 
monocytogenes-immunized mice recognised the 110 kDa polypeptide species derived from 
the L. monocytogenes (Fig. 3.4.A). This cross-reactivity was not observed with antisera from 
mice infected with a non-pathogenic L. innocua strain indicating that antibodies are directed 
to this protein during infection. Second, antisera from L. monocytogenes-infected mice 
showed cross-reactivity to the 110 kDa polypeptide species in soluble antigen extracts derived 
from the wild type, but not from the ∆frm mutant strain (Fig.3.5.C). Third, specific rabbit 
antisera raised against L. innocua ferritin also cross-reacted with the L. monocytogenes 
counterpart but was absent in a mutant lacking  frm (Fig.3.5.B).  
Immunoblotting experiments revealed distinct differences in the multimeric molecular species 
detected in L. innocua and L. monocytogenes (Fig.3.4.B). One explanation for these 
differences could possibly be the two amino acid substitutions in L. monocytogenes Frm 
relative to the L. innocua Fri protein, namely Lys114→Gln and Asp126→Asn both of which 
are located at the entrance of the three-fold channels pores and are hydrogen-bonded to each 
other. Similarly, changes in the subunit arrangement and spatial structures could account for 
differences in multimeric species of Frm observed in the L. innocua and L. monocytogenes. In 
a study on proteins induced by cold shock in L. monocytogenes, a ferritin-like protein (Flp) 
has been described and purified to homogeneity (Hebraud and Guzzo, 2000). Flp is identical 
in its N-terminal sequence and molecular weight to Frm described in this study. Based on its 
elution properties, these authors suggested a native molecular mass for Flp of about 110 kDa, 
composed of six identical 18 kDa subunits (Hebraud and Guzzo, 2000).  
Inoculation of mice with a sub-lethal dose of the virulent L. monocytogenes EGD-e strain 
invariably led to the production of Frm-specific antisera in the infected mice. Although the 
non-pathogenic L. innocua strain also produces a related ferritin no antibody is directed to this 
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protein during infection with this strain (Fig.3.4.A), suggesting that some level of 
extracellular bacterial growth early in systemic infection is required for adequate amounts of 
Frm to be recognized by cells regulating the humoral response. Indeed the rapid elimination 
of non-pathogenic bacteria from the host could explain the absence of Frm-specific antisera in 
the infected host. 
Listerial ferritin levels were strongly dependent on growth phase (Fig.3.4.D). A complex 
pattern of Frm expression was observed in cultures growing at 5, 20 and 37°C.  Thus, in 
bacteria grown at 20°C Frm could not be detected, but was readily detectable in cultures 
grown at either 5° or 37°C (Fig.3.4.C) suggesting that Frm is subjected to multiple forms of 
regulation. This phenomenon was also described in the study of Hebraud and Guzzo who 
found that transcription of the ferritin gene was barely detectable at 30°C but was induced in 
cells that were either heat- or cold- shocked at 49° and 5°C respectively (Hebraud and Guzzo, 
2000). Similarly, in a study on adaptive changes to high and low temperatures in Listeria, 
Phan-Thanh and Gormon described a 17.6kDa polypeptide that was induced under conditions 
of both cold and heat shock (Phan-Thanh and Gormon, 1995).  
In previous studies, transcription of the L. innocua fri gene was shown to be dependent on 
iron in growth medium (Polidoro et al., 2002). In brain heart infusion cultures depleted for 
iron by chelation, induction of RNA corresponding to the fri gene was detected. In contrast, 
fri was poorly transcribed in cultures growing in brain heart infusion showing that the 
availability of iron regulates Fri expression. Promoter mapping studies indicate the presence 
of two sites at which transcription is initiated, one of which is probably a sigB-dependent 
transcript (Polidoro et al., 2002). In that study, similar results were detected using the L. 
innocua fri gene as a probe to monitor expression of the corresponding gene in L. 
monocytogenes. Since sigB-dependent genes are expressed as bacteria enter a nutrient 
limiting stage it is indeed likely that both Fri and Frm expression is also dependent on this 
alternative sigma factor (Ferreira et al., 2003; Fraser et al., 2003; Moorhead and Dykes, 
2003).  
Unlike the parental wild type strain, a ∆frm strain is capable of very limited growth in 
minimal media containing 260µM ferric citrate. Reconstruction experiments revealed that the 
arrested growth of ∆frm strain in minimal medium can only be restored upon addition of 
further ferric citrate (260µM) to the cultures (Fig.3.9). Addition of other divalent citrate salts 
like, Cu2+,Mg2+,or Mn2+ (260µM) to growth-arrested cultures of the ∆frm strain in minimal 
medium failed to promote further growth. These data strongly emphasize reduced 
bioavailability of iron in the ∆frm mutant strain grown in minimal medium and exclude the 
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possibility of induction of a citrate-inducible iron acquisition system as previously described 
(Adams et al., 1990).  
Evidence that Frm is required for early survival in the infected host was suggested by the 
observation that although the ∆frm mutant strain was as proficient as the wild type strain for 
invasion and cell to cell spread as indicated by the plaque assay (Fig.3.6), it exhibited an early 
defect in intracellular growth in both the HeLa and J774 macrophage cell lines (Fig.3.7). 
Complementation of the ∆frm strain restored the intracellular proliferative ability of these 
bacteria to wild type strain levels (Fig.3.7.A). This deficiency in growth at early times was 
also manifested in the mouse model of infection (Fig.3.10) indicating that expression of the 
listerial ferritin is required for efficient systemic growth and spread. 
It has been suggested that the reaction of ferrous ions with metabolically generated reactive 
oxygen intermediates leads to killing of the bacterial cell (Harrison and Arosio, 1996). Based 
on the most recent in vitro (Zhao et al., 2002) and in vivo evidence (Ishikawa et al., 2003; 
Ueshima et al., 2003) that the ferritin-like activity of Dps proteins leads to protection against 
the toxic combination of Fe(II) and hydrogen peroxide, it was reasoned that the early defect 
observed following cellular infection was related to the inability of the ∆frm mutant to remove 
excess ferrous ions thereby inducing cell damage, in particular during transit through the host 
cell vacuole. Indeed, hydrogen peroxide is a constituent of the host vacuole and, among the 
various bacterial stresses examined; it was the only deleterious one for growth of the ∆frm 
mutant bacteria during bacterial growth (Fig.3.8). Reintroduction of a single copy of the frm 
gene to mutant ∆frm bacteria restored the growth ability to wild type levels in the presence of 
this agent. 
In conclusion, the present data indicate that listerial ferritin appears to be a general survival 
factor required for overcoming changes in cellular redox state in the diverse habitats that 
Listeria spp. occupy. Thus, regulated expression of the frm gene is probably of great 
consequence for the lifestyle of this bacterium. A large number of iron and other metal 
transporters are present in the genome of L. monocytogenes to ensure uptake of iron from both 
the extracellular and intracytoplasmic environment of the infected host (Glaser et al., 2001). 
Clearly other mechanisms for iron homeostasis must exist in the absence of the listerial 
ferritin because mutant bacteria lacking frm are still capable of intracytoplasmic growth. 
Further analysis of the role of iron in listerial growth and physiology would provide valuable 
information on the ability of L. monocytogenes to adapt to different ecological niches. 
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4.2. Tailored bacterial vehicles as vaccine strains 
 
In this study, it was shown that selective manipulation of virulence genes in L. monocytogenes 
can generate mutant bacteria that retain the marked protective immunogenic potential of the 
wild type strain but are attenuated in virulence as well as their capacity to induce CD4+-
mediated inflammation. Two approaches were conducted to generate these mutants; the first 
was the deletion of certain virulence genes from the wild type L. monocytogenes. The second 
was the complementation of the non-pathogenic L. innocua strain with the virulence gene 
cluster isolated from the wild type L. monocytogenes.   
Here, the induction of a protective cell-mediated immunity elicited by attenuated isogenic 
Listeria mutant strains was reported. Two highly attenuated isogenic L. monocytogenes 
mutant strains, L.monocytogenes EGD-e∆actA and ∆actA∆plcB that have retained the desired 
immunological characters of a wild type L. monocytogenes strain were characterized. The 
mutant EGD-e∆actA2 strain is identical to the wild type L. monocytogenes strain, except for 
lacking the entire actA gene, crucial for actin polymerisation, and thus it devoids of the 
Listeria’s intracellular actin-based motility (Chakraborty et al., 1995). The EGD-
e∆actA∆plcB lacks both the actA gene and the gene encoding the phosphatidyl choline-
specific phospholipase (plcB), located in the lecithinase operon. The plcB protein modulates 
host signalling pathway and its absence impairs the mechanisms by which Listeria escapes 
from being translocated in the host vacuoles (Bannam and Goldfine, 1999; Wadsworth and 
Goldfine, 1999). Although both mutant strains lack genes responsible for intracellular motility 
and cell to cell spread, they persist long enough in the host to induce a potent CD8+ T cell-
mediated immunity, accompanied by a reduced capacity to induce helper T cell-mediated 
inflammatory response. 
As revealed by the in vivo growth kinetics, both mutants were slowly and continuously 
eliminated from the host, although could still be detected at a lower number in the spleen and 
liver up to day 8 after infection. This is in contrast to the non-pathogenic Listeria innocua 
strain (Fig.3.18) or a L. monocytogenes strain lacking the hly gene, encoding the toxin 
listeriolysin (Fig.3.29), where bacteria are completely eliminated 3 days after infection. The 
latter strains were unable to provide a protective immunity to re-infection (Fig.3.21 and 
3.30.A), in accordance with the findings that the persistence and the number of viable 
microorganisms are important factors for efficient T cell-mediated immunity (North et al., 
1981). Here, the data also show that even a few hundred bacteria, as in the case of 
4. Discussion                                                                                                                           145                        
∆actA∆plcB mutant, persisting in spleens or livers of infected mice are sufficient for the 
generation of sterile immunity (Fig. 3.11).  
Even at higher doses (107) of infection with the mutant strains, no obvious morphological 
alterations in spleens and livers were detected. Thus, pathologically these mutants behave 
similarly to the non-pathogenic L. innocua strain that is efficiently cleared by the host 
(Fig.3.19), without inducing any detectable morphological changes. On the other hand, strong 
monocytic infiltrations were observed in spleens of mice infected with the wild type EGD-e. 
The morphological difference observed between spleens of mice infected with the wild type 
EGD-e and its isogenic mutant strains were not due to the absence of bacteria, as comparable 
numbers of mutant EGD-e strains were present on day 3. The intensity of detectable changes 
in the spleen morphology (Fig.3.12) was associated with the level of the induced DTH 
response, a reaction mainly associated with helper CD4+ T cell activation, as indicated with 
the skin reactions (Fig.3.13.B) and the production of IFN-γ after in vitro stimulation of spleen 
cells (Fig.3.13.A). Significant reduction in DTH response and in production of IFN-γ was 
observed in mice infected with the mutant EGD-e strains in comparison to the wild type 
EGD-e strain. 
Dynamics and early programming of T cells, responding to antigen, during L. monocytogenes 
infection has recently been reported (Busch and Pamer, 1999). It has been shown that during 
the primary phase of infection, the cytotoxic T cells specific for listerial antigens express low 
levels of CD62L. This expression of CD62L on the cytotoxic T cells (CD8+) is up-regulated 
during the memory phase. The expansion of antigen-specific T cells and generation of the T 
cell memory were reported to be independent of the duration and severity of in vivo bacterial 
infection (Mercado et al., 2000). The in vivo growth kinetics of isogenic mutants (EGD-
e∆actA2 and ∆actA∆plcB) and the induction of memory cytotoxic cells (CD8+CD62lo) 
presented here are in agreement with this report (Fig. 3.16). Both isogenic mutant strains have 
functional listeriolysin genes that enable the bacteria to escape from the phagosome to the 
cytosole. The data of this study therefore further suggest that transient infection with isogenic 
mutant strains is sufficient for the induction and expansion of protective CD8+ T cells (Fig. 
3.15). 
Significant levels of antiserum to the haemolytic toxin, listeriolysin, were observed in mice 
infected with the wild type EGD-e and both mutant strains (Fig.3.17). There were no 
significant differences between these strains even though there were differences in the 
numbers of viable bacteria at the later time points during infection. Thus generation of anti-
listeriolysin antibodies may be an early event during infection where larger number of 
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bacteria is present during hematogenous spread. Neutralizing antibodies to listeriolysin can 
also confer immunity (Edelson et al., 1999). 
In an attempt to increase immunogenicity, a number of approaches, taking advantage of the 
properties of a particular cytokine (for example, IL-12, IFN-γ) have recently been employed. 
Many of these approaches were unable to produce satisfactory results simply because they led 
to a strongly dominant CD4+ T cell response (Miller et al., 1995), or developed into a Th2 
recall as well as Th1 response (Wolf et al., 1995). Others considered approaches to in vivo 
modulation of Th1 response by using neutralising antibodies against cytokines (IFN-γ) 
resulting, beside exacerbated infection, in a dramatic increase of IL-4 and a switch from Th1 
to Th2 cells (Nakane et al., 1996). Genetically defined mutants, on the other hand, display 
differential capacities to induce IFN-γ levels and activation of CD4+ T cells and, in this study, 
led to a reduction in both granuloma formation and DTH. At the same time, these bacteria 
were able to produce sufficient immunomodulators that retain their ability to induce a potent, 
protective cell-mediated T cell response. Indeed, these two strains have advantages over 
strains lacking metabolic genes like L. monocytogenes auxotrophic mutant bearing deletions 
in alanin racemase (daI) and D-amino acid aminotransferase (dat), two genes required for the 
biosynthesis of bacterial cell walls (Thompson et al., 1998). This strain showed, in absence of 
D-alanine,  a defective growth in mice and a failure to induce a protective immunity against 
challenge infection. Another example is L. monocytogenes ∆pheA, a gene encoding the 
prephenate dehydratase (pheA), an enzyme acting late in the pathways for biosynthesis of 
phenylalanine. This strain was not efficiently attenuated and had elicited the same level of 
CD4+ inflammatory responses as the wild type (Alexander et al., 1993). In addition, 
Salmonella typhimurium ∆aroA, although attenuated, induced mainly CD4+ T cell responses 
(Hess et al., 1996). 
Isogenic mutants of wild type L. monocytogenes that are highly attenuated for virulence were 
identified. They showed a strong reduction in the undesirable localized inflammatory 
capacities, but are nevertheless capable of providing effective protective responses. The 
highly reduced virulence of the ∆actA∆plcB mutant, in particular, indicates that a very low 
number of persisting bacteria is required for immunity. Based on these studies, it will be 
interesting to determine, through the introduction of further mutants, whether there is a 
minimum number of persisting live replicating bacteria needed for mediating immunity. As 
shown above, the ∆actA∆plcB mutant is able to induce sufficient IFN-γ to prevent a Th1 to 
Th2 switch and retains its ability to induce a strong CD8+-mediated T cell response. Recently 
initial clinical studies in healthy human volunteers with similar mutants have been carried out 
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indicating no serious long-term health consequence (Angelakopoulos et al., 2002). These 
virulence-attenuated isogenic mutant strains can not only be used as live vaccines against the 
corresponding virulent pathogen, but also as carriers for introducing heterologous protective 
antigens of other pathogenic microorganisms into animals and humans.        
 
The gene products of the PrfA-dependent gene cluster, which are crucial for the release from 
the host cell phagosome, intracellular replication, intracellular movement, and the cell-to-cell 
spread of pathogenic Listeria monocytogenes strain (Portnoy et al., 1992), are lacking in the 
non-pathogenic L. innocua strain. The present study investigated that expression of the prfA-
dependent virulence gene cluster of the wild type Listeria monocytogenes strain in the non-
pathogenic L. innocua strain can generate a recombinant attenuated strain that can efficiently 
induce a protective immunogenic responses  with a capacity to downmodulate CD4+ T cell-
mediated inflammation. The recombinant L.innocua strain transformed with a gram-
positive/gram-negative schuttle BAC-based vector (pUvBBAC) harbouring the chromosomal 
region of Listeria monocytogenes that encodes the gene cluster prfA-plcA-hly-mpl-actA-plcB 
was assessed. 
Investigation parameters were selected to correspond to critical steps of the host response 
during the pre-immune phase, the primary immune effector phase, and the memory immune 
effector phase of the infection (Mielke et al., 1997). Day 3 of a Listeria infection marks the 
end of the pre-immune phase. It is the last day before the expansion of specific T cells in this 
model (Kaufmann, 1986; Ehlers et al., 1992). The presence of viable bacteria on this day has 
been shown to be critical for the successful induction of T cell-mediated immunity (North et 
al., 1981). On day 3, therefore, bacterial load as well as spleen morphology was investigated. 
Day 9 corresponds to the primary immune effector phase, that is, acquired resistance. On this 
day, DTH to soluble antigen was measured in vivo as well as T cell-derived IFN-γ production 
by spleen cells, known to be an in vitro correlate of DTH reaction and a measure of CD4+ T 
cell activity (Mielke et al., 1998). Moreover, the induction of antigen specific IFN-γ 
producing CD8+ cytotoxic T cells was estimated on this day. Day 60 as well as day 5 post-
challenge were chosen to refer to the memory immune effector  phase (Busch and Pamer, 
1999)  when the number of memory effector T- cells were quantitated. 
Bacterial growth kinetics in vivo indicate not only the virulence of a bacterium but are also 
associated with the induction of T cell-mediated host responses (Kaufmann, 1984). 
Experiments that temporally abrogated Listeria infection with antibiotics (North et al., 1981) 
have revealed that the persistence and number of viable microorganisms are important 
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parameters for efficient induction of T cell-mediated immunity. The recombinant L. innocua: 
:vgc strain showed a significant survival pattern in the first 3 days after infection in both 
spleens and livers (Fig.3.18.). It was present in a substantial number for at least 3 days which 
was comparable to that of the wild type L. monocytogenes. The wild type L. innocua, lacking 
the vgc, was rapidly eliminated from day 1 onwards even when high inocula were used for 
infection. Most noteworthy, although the recombinant L. innocua::vgc strain was injected in 
mice in a dose of 107 cfu, mice can efficiently control the infection. Morphological 
appearance of infected spleens have shown that the wild type L. monocytogenes induces 
granuloma as a result of monocytic infiltrations of the white pulb which is most intensive on 
day 3 post infection while only splenomegaly without any detectable granulomas was the case 
after  L. innocua: :vgc infection (Fig.3.19). The wild type Listeria innocua strain did not 
induce any detectable changes in spleen morphology. The intensity of the morphological 
alterations in spleens paralleled the level of Listeria-induced DTH responses. In accordance 
with data presented by Yang et al., IFN-γ turned out to be a most helpful in vivo and in vitro 
parameter predicting the strength of the proinflammatory CD4+ T cell-mediated immune 
response to the bacteria (Yang et al., 1997). A previous study showed that only vaccination 
with strains with the capacity to induce T cell-mediated immunity, i.e. the wild type L. 
monocytogenes strain resulted in appreciable levels of type I cytokines transcripts like IL-12 
and IFN-γ (Peters et al., 2003). In the present study, the wild-type L. monocytogenes strain 
could induce a significant level of IFN-γ in the supernatants of spleen cell cultures from 
immunized mice which was approximately 2 folds more than IFN-γ induced in response to L. 
inn: :vgc infection (Fig. 3.20.A). This finding was supported with the measurement of the in 
vivo induction of DTH after recombinant L. inn: :vgc strain infection which was also 
significantly lower than DTH induction after L. monocytogenes infection (Fig. 3.20.B). In 
both cases, the wild type L. innocua failed to induce any proinflammatoty CD4+ T cell-
mediated immune response. So, infection with the recombinant L. inn: :vgc strain seems to 
abrogate the induction of undesirable CD4+-mediated inflammatory responses. 
Recent advances in techniques to investigate the specific T cell response, in particular of the 
CD8+ subpopulation with peptide loaded tetrameric MHC, intracellular cytokine staining and 
the use of transgenic animals (Busch et al., 1999; Mercado et al., 2000; Huleatt et al., 2001; 
Lauvau et al., 2001; Badovinac et al., 2002; Yajima et al., 2002) have provided tremendous 
insight as to how the specific immune response is mounted. It is the elegant work by Pamer’s 
group that also revealed that priming of CD8+ T cells by heat-killed bacteria must be 
differentiated from differentiation into effector cells (Lauvau et al., 2001). Therefore, the 
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most reliable approach to assess the complex ability of T cells to protect animals against a 
lethal dose of microorganisms remains the demonstration of the in vivo function of T cells by 
the effect of T cell subset depletion (CD4+ and CD4+ plus CD8+) in previously immunized 
and subsequently challenged animals (Mielke et al., 1998). In contrast to animals immunized 
with the wild type L. innocua as well as unimmunized mice, all animals immunized with L. 
monocytogenes EGD-e or L. inn: :vgc were protected against 10X LD50 of virulent Listeria 
(Fig. 3.21), despite significant differences in their DTH responses. T cell subset depletion 
revealed that this protection was CD4+ T cell independent, but that it was severely impaired 
when both CD4+ and CD8+ T cells were depleted (Mielke et al., 1998). In accordance to this 
report, L. inn: :vgc strain was efficiently able to induce LLO91-99-specific CD8+ T cells 
producing IFN-γ after both primary and recall infection (Fig. 3.22). 
During an immune response, antigen-specific T cells proliferate enormously and develop into 
effector T cells capable of immediate effector functions, such as cytotoxicity and IFN-γ 
production (Butz and Bevan, 1998; Murali-Krishna et al., 1998). Following a successful 
immune response, activated effector T cells undergo large-scale apoptosis, presumably to 
maintain homeostasis in T cell numbers (Van Parijs and Abbas, 1998). However, the process 
leaves behind an enhanced pool of relatively quiescent antigen-experienced memory T cells 
that persist over long periods of time and mount a rapid and augmented response upon re-
challenge with antigen (Van Parijs and Abbas, 1998). The entry into memory stage, however, 
is accompanied by changes in gene expression profile of antigen-specific CD8+ T cells. This 
includes the ability to rapidly expand their population during recall responses and to 
downregulate expression of some cell surface markers such as CD62L (L-selectin) and CCR7 
which, therefore, have been widely used to define memory and naive phenotypes of T cells in 
humans and mice (Dutton et al., 1998; Kaech et al., 2002b; Gett et al., 2003; Wherry et al., 
2003). The expression of CD62L, an adhesion cell surface molecule, is used for identifying 
naive T cells, and the loss of CD62L expression correlates with T-cell priming. The presence 
of live bacteria over the first 48 hours after immunization was found to be critical for 
induction of effector CD8+ T cell mechanisms (Mercado et al., 2000). It was previously 
reported that primary infection with the wild type L. monocytogenes induces down regulation 
of CD62L on surface of effector CD8+ T cells which reaches its downregulation peak at day 8 
post infection (Kaech et al., 2002a; Wherry et al., 2003). However, over the next several 
weeks, expression of CD62L is up regulated. During recall infection, CD62L was massively 
and rapidly downregulated on the surface of memory CD8+ T cells (Mercado et al., 2000; 
Darji et al., 2003). Here, infection with the recombinant L. inn: :vgc strain managed to induce 
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a significant population of cytotoxic CD8+ T lymphocytes (Fig. 3.22) which, upon challenge 
with the wild type L. monocytogenes, showed a CD62L expression pattern similar to that 
shown upon infection with the wild type L. monocytogenes (Fig. 3.23) while primary 
infection with the wild type L. innocua failed to induce a significant down regulation of 
CD62L during recall infection. These data together with the successful in vivo survival pattern 
of the recombinant L. inn: :vgc strain support the previous findings. Moreover, a significant 
induction of humoral immunity against listeriolysin O was observed in mice primarily 
infected with L. inn: :vgc as well as the wild type L. monocytogenes but not with the wild type 
L. innocua (Fig.3.24) as indicated by the recognition of listeriolysin O by the immune mice 
antisera in immunoblotting assay proposing that the persistence of viable bacteria over the 
first three days after infection is critical for induction of humoral immunity. 
Most noteworthy, the inability of L. monocytogenes strain lacking only listeriolysin O 
(Tanabe et al., 1999) as well as L. innocua strain expressing only LLO (Peters et al., 2003) to 
induce a protective T cell response reflects the critical coordination role of virulence gene 
cluster elements in conferring a long lasting immunity. The delineation of its immunological 
properties shows that the recombinant L. inn: :vgc strain retains the favourable immunological 
properties of the wild type L. monocytogenes and fulfils appropriate criteria for a suitable live 
bacterial T cell vaccine vector.  
 
4.3. Listeriolysin O   is   not   absolutely   essential   for  induction  of  long  term  cellular    
       immunity against Listeria monocytogenes 
 
The role of the major virulence factor in L. monocytogenes, listeriolysin O, in mediating 
escape from host cell vacuole as well as in pathogenicity of L. monocytogenes was elucidated 
(Kathariou et al., 1987; Gaillard et al., 1986; Cossart et al., 1987; 1989; Portnoy et al., 1988; 
Tilney and Portnoy, 1989). Moreover, listeriolysin O production by infecting bacteria is 
essential for generating a protective T lymphocyte response against L. monocytogenes 
(Mengaud et al., 1988; Mielke et al., 1997). The results of the present study indicate that 
although the related hemolysin, pneumolysin, can not restore a full virulence to L. 
monocytogenes, it can functionally mediate lysis of the host cell vacuole and induce a 
protective immunity against a lethal dose of the wild type L. monocytogenes. Unlike other 
cytolysins, pneumolysin molecule is not surface exposed. It is a cytoplasmic enzyme that 
lacks a signal peptide and is, therefore, released due to the action of surface pneumococcal 
autolysin (Paton et al., 1983; 1986; 1993). So, the functional gene structure of pneumolysin 
was cloned downstream to the putative LLO signal peptide sequence in a plasmid-borne genes 
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under the control of LLO promoter and prfA regulator and expressed in EGD-e∆hly. In 
comparison to LLO, pneumloysin was efficiently secreted in culture medium (Fig.3.26) and 
showed a clear haemolytic phenotype comparable to that of the LLO expressing strain 
(Fig.3.27). 
In primary amino acid structure, thiol activated cytolysins  are defined by an almost invariant 
undecapeptide sequence ECTGLAWEWWR, which is important for cytolytic activity 
(Billington  et al., 2000) giving rise to a possibility that both LLO and PLY share some cross-
reacting epitopes. This structure homology can explain the cross-reactivity of both LLO and 
PLY proteins with either monoclonal antibodies produced against them (Fig.3.26). This cross 
reactivity was extended to include the immune sera from mice infected with either LLO or 
PLY-expressing strain which could recognize both purified LLO and PLY proteins (Fig.3.33). 
Definition of listeriolysin O as well as pneumolysin by sera of patients with listeriosis or 
pneumococcal diseases might be of great diagnostic value. 
L. monocytogenes has emerged as a model system for the molecular study of intracellular 
parasitism. It can enter into a wide variety of cells by phagocytosis. Subsequent to entry into a 
host cell, L. monocytogenes lyses its vacuole and escapes into the cytosol, where it can 
multiply and spread from cell to cell (Cossart and Lecuit, 1998). There is an overwhelming 
evidence that the primary L. monocytogenes determinant responsible for escape from a 
vacuole and thus entrance in the cytosol, two key events for virulence, is LLO, encoded by the 
hly gene. First, mutants lacking LLO fail to escape from a vacuole and are absolutely 
avirulent. Complementation with hly restores virulence (Cossart et al., 1989). Second, 
expression of LLO by Bacillus subtilis confers to these extracellular non-pathogenic bacteria 
the capacity to escape from a vacuole and grow in the cytosol (Bielecki et al., 1990). Third, 
purified LLO encapsulated into pH-sensitive liposomes can mediate dissolution of a vacuole 
(Lee et al., 1996).  
Several members of the pore-forming CBCs family such as perfringolysin O (PFO) of 
Clostridium perfringens have been characterized in detail (Rossjohn et al., 1997; Shatursky et 
al., 1999). The major known difference between LLO and other members of the family is that 
LLO has an optimum activity at acidic pH (Geoffroy et al., 1987). This raises the question of 
whether this unique trait has any physiological relevance in the infectious process. To start to 
address this question, PFO had been cloned and expressed in L. monocytogenes in place of 
LLO under the control of the endogenous hly promoter (Jones and Portnoy, 1994). PFO was 
able to mediate vacuolar escape at approximately 50% of the efficiency of LLO. However, 
after a small number of bacterial divisions in the cytosol, the host cell became permeabilized 
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and died. In accordance with these findings, results of this study showed that the PLY-
expressing strain is able to enter the host cell cytoplasm, grow, and spread from cell to cell to 
a limited extent over the first 4 hours post in vitro infection followed by inhibition of growth 
(Fig.3.28). These results indicate that LLO has evolved some specific properties to prevent 
cytotoxicity that are not shared by PLY, a protein from an extracellular pathogen that 
normally acts on cells from outside (Alouf and Geoffroy, 1991). It is unclear at this point 
what particular properties allow LLO but not PLY to mediate L. monocytogenes survival. 
Two striking different parameters between LLO and PLY were supposed to be responsible for 
L. monocytogenes survival pattern. The first parameter is their pH optima (Geoffroy et al., 
1987; Portnoy et al., 1988). LLO has a pH optimum in the acidic range, while PLY is equally 
active at both acidic and neutral pHs. Accordingly, one interpretation of these results is that 
released LLO is relatively inactive in the cytoplasm, while PLY is fully active. The low pH 
optimum of LLO may represent a protective mechanism to prevent host cell damage in the 
cytoplasm. Conceivably, L. monocytogenes has adopted a strategy used by eukaryotic cells to 
compartmentalize the potentially toxic activity of lysosomal acid hydrolases (Jones and 
Portnoy, 1994). The second parameter includes the protein instability in the cytosole. A recent 
study demonstrated that a PEST-like sequence is present at the NH2 terminus of LLO while 
absent in both PFO and PLY and is responsible for the rapid degradation of LLO in the host 
cell cytosole, thus decreasing the intracytoplasmic half life time of LLO (Decatur and 
Portnoy, 2000). PEST-like sequences are thought to target eukaryotic proteins for 
phosphorylation and degradation, and deletion or specific amino acid substitution of this 
sequence in LLO led to increased cytotoxicity and lower virulence in a mouse model. When 
the sequence was introduced in PFO and the chimeric toxin expressed in L. monocytogenes, 
bacteria were less toxic than those expressing wild-type PFO and were able to multiply 
intracellularly in J774 macrophages. Thus, introduction of a PEST motif in LLO is a strategy 
used by L. monocytogenes to restrict the activity of this powerful toxin to the host cell 
vacuole, thereby preserving the intracellular niche for bacterial multiplication. Based on these 
postulations, the limited survival of pneumolysin expressing strain in J774 macrophage-like 
cell line is supposed to be due to cytotoxicity of pneumolysin that induced permeability of cell 
membrane resulting in entry of extracellular gentamicin inside the macrophages and killing 
the bacteria. 
Determination of virulence in mice showed that, in contrast to the wild type, the isogenic 
mutant EGD-e∆hly strains expressing either LLO or PLY was avirulent. Mice can control a 
dose of 8x106 cfu suggesting that some levels of regulation were missing in plasmid based 
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strains. However, the strain expressing LLO followed the same in vivo survival pattern as the 
wild type strain in both spleens and livers (Fig.3.29) while in accordance to the in vitro 
survival, the pneumolysin expressing strain showed a slight increase in level of replication 
and survival in vivo over the first 3 days after infection followed by slow and continuous 
elimination from the host, although could still be detected at a lower number in the spleen and 
liver up to day 8 after infection. One speculation for slow in vivo replication of pneumolysin 
expressing strain is that cytotoxicity of pneumolysin causes the host cells to become 
permeable to the extracellular bactericidal factors in serum that enter the host cells and kill 
PLY-expressing strain. In contrast, the isogenic mutant EGD-e∆hly strain was rapidly cleared 
from both organs over the first 3 days after infection.   
Survival of mice primarily infected with pneumolysin-expressing strain upon recall infection 
with a lethal dose of the wild type L. monocytogenes supports previous reports showing that 
the persistence and the number of viable microorganisms over the first 48-72 hours after 
infection are important factors for efficient T cell-mediated immunity (North et al., 1981; 
Mercado et al., 2000) and that the presence of few hundreds of bacteria viable in spleens and 
livers of infected mice was sufficient for induction of protective immunity (Darji et al., 2003). 
Moreover, immunization of mice with a PFO-expressing strain led to a protective immunity 
(Bouwer et al., 1994) indicating that T cells with specificity for non-LLO-derived epitopes of 
L. monocytogenes are a component of a protective antilisterial immune response. Here, in 
agreement with these findings, the ability of pneumolysin-expressing strain to confer a 
protective immunity and to induce a significant number of CD8+ cytotoxic T cells specific to 
the subdominant Listeria epitope, P60217-225,  either primarily or after challenge (Fig.3.30 and 
3.31) confirm that they do indeed enter the cytoplasm facilitating procession and presentation 
of Listeria-derived peptides by H-2Kd MHC class I molecules for cytotoxic T cells that are 
expected to domain the protective immune response (Berche  et al., 1987; Portnoy, 1992; 
Pamer , 1993). Analysis of the specificity of antilisterial cytotoxic cells from Listeria immune 
BALB/c donors has shown a dominant response to an epitope corresponding to amino acids 
91 to 99 of LLO (Busch et al., 1998). Previously, demonstration of antilisterial T cells 
specific to non-LLO-derived epitopes has been difficult to achieve, because of the crucial 
requirement of LLO in facilitating escape of the bacteria to the cytoplasm of the host cell, 
which may be responsible for the apparent dominance of an anti-LLO response in antilisterial 
immunity (Beattie et al., 1990; Pamer et al., 1991; Safley et al., 1991; Harty and Bevan, 
1992). In addition, LLO but not PFO-expressing Bacillus subtilis were able to confer 
immunity against the wild type L. monocytogenes (Bouwer et al., 1992) indicating that anti-
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listerial immunity has specificity to both LLO and non-LLO derived epitopes. Induction of 
P60217-225 specific effector T cells by pneumolysin-expressing strain (Fig.3.31) was also 
supported by the ability of this strain to initiate a successful programming of T cells leaving, 
following a successful eradication of the strain, a significant pool of CD8+ T cells that acquire 
memory cell properties. One of memory cell surface markers is the adhesion molecule, L-
selectin (CD62L), whose expression is upregulated on naïve CD8+ T cells but rapidly down 
regulated upon cell stimulation (Busch and Pamer , 1999). The in vivo growth pattern of  
PLY-expressing strain together with its ability to induce a significant number of 
CD8+CD62Llo T cells (Fig.3.32) was in agreement with the finding that induction of an 
efficient T cell stimulation and  programming is dispensable for duration and severity of in 
vivo bacterial infection (Mercado  et al., 2000). 
L. monocytogenes has been described as a potential vaccine carrier for induction of protective 
cell-mediated immune responses to virus-specific or pathogenic bacterium-specific epitopes 
(Schafer et al., 1992). The premise for this vaccine design is that following uptake by the host 
cell, L. monocytogenes escapes to the cytoplasm of the host cells, thereby introducing 
peptides into the intracellular environment for processing through the endogenous pathway 
for presentation, in association with MHC class I at the cell surface, to reactive cytotoxic 
CD8+ T cell populations. Indeed, the results of this study are consistent with a model in 
which a protective immunity can be specifically induced against non-LLO derived antigens in 
absence of the pore-forming listeriolysin O. 
 
4.4. Cytosolic  localisation  of  L. monocytogenes  is  critical  for  induction  of  protective  
       immunity  
 
Several virulence factors associated with Listeria infection have been identified. One of these 
is listeriolysin O (LLO). LLO is not only required as a virulence factor that enables 
L. monocytogenes to escape  from the vacuole formed upon initial internalization but it is also 
required in the immunization process during infection through generation of a protective T 
lymphocyte response to L. monocytogenes.  
 The critical role of the PEST-like region at the N-terminus of Listeriolysin O in pathogenesis 
of Listeria monocytogenes was previously studied (Decatur and Portnoy, 2000; Lety et al., 
2001; 2002). On the other hand, nothing is known about the role of this motif in the induction 
of a T cell response against Listeria monocytogenes. In this study the critical role of PEST-
like sequence of Listeriolysin O in mediating induction of Th1-type immune response and 
conferring a protective T cell antilisterial immunity was established. The 28 amino acids 
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region at the N-terminus of Listeriolysin O that harbours the PEST-like sequence was deleted 
and the mutant protein was expressed in EGD-e∆hly. As shown by Western blotting with a 
monoclonal anti-LLO antibody (Fig.3.35.A), the mutant protein, designated LLO∆PEST, was 
secreted in comparable amounts in the culture supernatants. The additional recognized bands 
of lower molecular weight in case of the wild type LLO may reflect its instability over the 
mutant protein supporting the earlier prediction of Decatur and Portnoy  that the PEST-like 
sequence may target LLO for degradation (Decatur and Portnoy, 2000). 
 In vitro, the culture supernatants containing the mutant protein (LLO∆PEST) exhibited a 
haemolytic activity comparable to that of the wild type (Fig.3.35.B). This finding was in 
agreement with previous observations (Lety et al., 2002) indicating that modifications in the 
proximal portion of LLO do not affect protein secretion and hemolytic activity. Evidence that 
PEST-like sequence is crucial for mediating the disruption of phagolysosomal membrane and 
the escape of Listeria into the cytosole of phagocytic cells was confirmed by following the in 
vitro growth kinetics and the immunofluorescence microscopy analysis of the LLO∆PEST 
mutant strain in J774 macrophages (Fig.3.36). These data revealed that the escape of the 
LLO∆PEST mutant from the vacuole was severely impaired. This deficiency in growth was 
also manifested in the mouse model of infection where the LLO∆PEST mutant strain was 
rapidly removed from spleens and livers of infected mice up to day 3 post-infection 
(Fig.3.37).  
It is well-known that a Th1-type immune response is induced in mice upon infection with L. 
monocytogenes and that antigen specific T cells play a central role in protective immunity 
against challenge infection (Darji et al., 2003; Kimoto et al., 2003). Day 3 of Listeria 
infection represents the end of the pre-immune phase of host response against L. 
monocytogenes. It is the last day before the expansion of specific T cells in this model 
(Kaufmann, 1986; Ehlers et al., 1992). The presence of viable bacteria on this day has been 
shown to be critical for successful induction of T cell-mediated immunity (North et al., 1981). 
It was recently established that the pathogen specific T lymphocytes are programmed during 
the first day of infection and subsequently undergo proliferation and differentiation into 
effector T cells without further calibration by the progressing inflammatory response but the 
magnitude of the LLO91-99 specific response correlates with the duration of in vivo bacterial 
growth during the first 24 h after infection (Mercado, et al., 2000). 
These findings prompted the analysis of the relation between the in vivo survival of the PEST-
like sequence mutant strain and its ability to induce a protective immunity. The bacterial load 
in spleens and livers of infected mice was measured at certain time points for several days.  
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The ∆PEST mutant strain and the ∆LLO isogenic mutant strain were rapidly cleared from 
spleens and livers although the former showed a slightly more survival than the latter 
(Fig.3.37). The slight increase in survival pattern of ∆PEST mutant strain over the LLO 
lacking strain both in vitro and in vivo suggests that the removal of the PEST-like motif 
extremely inhibit, but not completely abolish, the disruption of phagolysosomal membrane 
and intracellular bacterial survival. Furthermore, either ∆PEST mutant strain or the ∆LLO 
isogenic mutant strain failed to induce any detectable changes in spleen morphology 3 days 
after infection (Fig.3.38) while infection with the wild type and LLO producing mutant 
showed an intensive granuloma and splenomegaly respectively due to induced monocytic 
infiltration which paralleled the level of DTH responses, a reaction mainly associated with 
helper CD4+ T cell activation.  
LLO was shown to possess the ability to induce various cytokines, including IL-1α and IFN- 
γ. The early production of IFN-γ following infection was shown to be important for the 
generation of protective T cells indicating that listeriolysin O is critical for generating a 
protective anti-listerial T lymphocyte response (Nishibori et al., 1995; 1996; Xiong et al., 
1994; 1998). Mitsuyama and co-workers reported that the inability of a LLO-lacking strain or 
killed bacteria to induce the generation of protective T cells is due not to the lack of a central 
T cell epitope(s) but to the lack of ability to induce the production of endogenous cytokines 
during the early stage of immunization (Tanabe et al., 1999). It has been reported that a 
significant level of IFN-γ production in the murine spleen occurred within 24 to 48 h of 
immunization with a virulent strain (Nakane et al., 1989; 1990). Moreover, when endogenous 
IFN-γ was neutralized by administration of anti- IFN-γ  monoclonal antibody for the initial 2 
days in mice immunized with viable L. monocytogenes, the generation of protective T cells on 
day 6 was completely blocked (Yang et al., 1997). As expected, early production of IFN-γ 
was successfully induced by wild type and LLO producing mutant (Fig.3.39.A). On the other 
hand, both ∆PEST mutant strain and the LLO lacking strain were unable to induce IFN-γ in 
mice serum at day 2 post infection indicating that the in vivo growth deficiency of this mutant 
may contribute to its deficiency to induce IFN-γ production. 
In an attempt to confirm this indication, the amount of IFN-γ produced in culture supernatants 
of splenocytes at day 9 post-infection (Fig.3.39.B) as well as the number of specific MHC 
class I restricted effector CD8+ T cells in spleens at either day 9 post-infection or day 5 post-
challenge (Fig.3.41) were estimated. Day 9 post-infection corresponds to the primary immune 
effector phase, that is, acquired resistance. It was found that the ∆PEST as well as the ∆LLO 
mutant strain fails to induce the number of CD8+ T cells, after either the primary infection or 
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the challenge, or to prime splenocytes to produce a detectable level of IFN-γ. So, the removal 
of PEST-like sequence seems to influence the antigen presentation efficiency through the 
MHC class I pathway due to the poor ability of PEST-like sequence lacking strain to gain 
access to the cytosole of the infected cell and to undergo further processing and antigen 
presentation.  
Earlier studies suggested that  differentiation of CD8+ T cells into effector cells during 
primary immune response has important consequences for the development of long-lived 
memory cells (Lauvau et al., 2001) and that the immunization with avirulent Listeria with an 
in vivo persistence of less than 48 hours (Baldridge et al., 1988) or with a heat-killed Listeria 
(Lauvau et al., 2001) induced only low levels of protection. There was a consensus that the 
virulence factors of L. monocytogenes may contribute directly to the induction of protective 
immunity (Xiong et al., 1998). It was previously confirmed that the deletion of both actin 
nucleator (actA) and phospholipase B (plcB) genes from L. monocytogenes  has extremely 
lowered its virulence but had no influence on its ability either to induce and maintain effector 
memory T cells or to confer a long-lasting protective immunity against the wild type L. 
monocytogenes (Darji et al., 2003) whereas the isogenic mutant strain EGD-e∆hly was shown 
to lack the ability to induce a protective immunity (Xiong et al., 1994; Tanabe et al., 1999; 
Peters et al., 2003) indicating that listeriolysin is essential for induction of protection 
mediating T cells. All other virulence factors even if over-expressed cannot compensate for 
the absence of listeriolysin (Marquis et al., 1995). Most noteworthy, the ability to produce 
listeriolysin O was not sufficient to convert L. innocua into a protection inducing bacterial 
vector (Peters et al., 2003). 
 In this study, these findings were extended by testing the effect of PEST-like sequence 
deletion from Listeriolysin O on T cell mediated protection. It was found that mice 
immunization with ∆PEST mutant strain was not protective against a secondary lethal wild 
type listerial infection (Fig.3.40.A). These mice could not control the challenge infection as 
indicated by either  the high bacterial load in their spleens and livers (Fig.3.40.B) or the poor 
induction of  CD8+CD62Llo effector memory splenocytes (Fig.3.42). In contrast, mice that 
were previously primed with mutant strain expressing the intact listeriolysin O as well as the 
wild type L.monocytogenes showed a full survival and an extreme effector memory T cell 
protective response. Hence, these findings confirm the role of PEST-like sequence in 
mediating escape of L. monocytogenes from phagosomal vacuole into the cytosole as well as 
targeting the listeriolysin O for degradation and presentation on MHC I molecules. 
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Collectively, the ability of L. monocytogenes to gain access into the cytosole of antigen 
presenting cells is crucial for protection and for its use as a potential live vaccine vector. 
 
4.5. Outlook 
 
4.5.1. Antibody-mediated immunity against intracellular pathogens 
 
For intracellular bacteria, the role of antibody-mediated immunity is still poorly understood. 
This is due to the fact that the bacteria inside the cell are protected from the serum antibody. 
Indeed, the recognition of some listerial proteins by the immune sera of listeriosis patients 
(Grenningloh et al., 1997) in addition to the recent finding that monoclonal antibody produced 
against LLO can limit the intracellular listerial growth in macrophages (Edelson and Unanue, 
2001) have paved the way for thinking about the contribution of humoral response to Listeria 
infection.  
However, the two-dimensional separation and categorization of microbes as either 
intracellular and extracellular pathogens was never absolute, since tissue examination often 
revealed that pathogens classified as intracellular could be found in the extracellular space and 
vice versa. Furthermore, at some points in the infectious cycle, most intracellular pathogens 
reside in the extracellular space, where they are vulnerable to antibody action, and Fc receptor 
cross-linking can have profound effects in the intracellular milieu through signal transduction. 
Based on these information, it is suggested that  some level of extracellular listerial growth 
early in systemic infection is required for adequate amounts of antigens to be recognised by 
cells regulating the humoral response. Indeed, generation of monoclonal antibodies against 
secreted or surface-exposed listerial antigens like LLO, P60, actA, and irpA will be helpful as 
a therapeutic tool where antibiotic resistance are common or  for infectious listerial diseases 
that could arise in the setting of severe immunosuppression such as during bone marrow and 
organ transplantation, and AIDS. 
 
4.5.2. Requirements  for the creation of novel vaccine vectors 
 
There is a need to develop vaccines with the potential for global use against bacterial 
infectious diseases. These should be inexpensive to produce, stable in the absence of 
refrigeration, safe and efficacious, and able to be given orally or intranasally rather than by 
injection. 
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A vaccine should be sufficiently attenuated through deletion of certain virulence as well as 
metabolic genes. Attenuation should be sufficient to decrease if not eliminate induction of 
undesirable disease symptoms. In this regard, the nutritional status and health of the 
population to be vaccinated should be considered. The attenuation should be an inherent 
property of the bacterial vaccine and not be dependent on fully functional host defences and 
immune response capabilities. The attenuation should not be reversible by diet or by host 
modification of diet constituents, including by host-resident microbial flora. The attenuation 
should not lead to the development of a persistent carrier state for the vaccine. The attenuated 
vaccine should be sufficiently invasive and persistent to stimulate both strong primary and 
lasting memory immune responses.  
A vaccine should also be designed to minimize tissue damage that is not needed to induce an 
effective immune response. For example, vaccines for enteric pathogens must access the gut-
associated lymphoid tissue (GALT) via invasion and transcytosis through M cells. However, 
attachment to and invasion into enterocytes can lead to undesirable diarrhoeal episodes that do 
not contribute to the desired immune response. As even attenuated vaccine strains may cause 
disease in a few unlucky individuals, safety considerations dictate that any live bacterial 
vaccine should be susceptible to all clinically useful antibiotics. Lastly, the attenuated vaccine 
should possess some containment features to reduce its shedding and/or survival in nature to 
preclude vaccination of individuals who did not elect to be vaccinated. However, persistence 
of a live vaccine with potential for individual-to-individual spread could have a positive 
public health benefit, as is probably the case for vaccination against polio. 
When such an attenuated bacterial mutant is used as a delivery carrier for heterologous 
antigens, the plasmid vector component has to be optimised. Indeed, stability of protective 
antigen expression in vivo is essential for recombinant vaccine efficacy. Insertion of genes 
into the chromosome can increase stability, but the level of antigen expression is generally too 
low to stimulate an adequate immune response. Since the level of protein synthesis in bacteria 
is very much dependent upon gene copy number, antigen production can be vastly increased 
by use of multicopy plasmid vectors. In this case, the use of a balanced-lethal host-vector 
system wherein the plasmid possesses a gene complementing a chromosomal deletion 
mutation of a vital gene, such as for cell wall synthesis or DNA stability or replication, 
ensures that the plasmid is maintained (Nakayama et al., 1988). An alternate approach to 
ensuring retention of the plasmid vector is the "Hok-Sok" strategy, which also results in 
bacterial cell death if the plasmid is lost (Galen et al., 1999). When a plasmid vector with a 
high copy number is used, the level of expression of the gene encoding the vector-selective 
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marker can be far in excess of that necessary for maintenance of the vector. In these instances, 
overexpression of such a gene product further attenuates the vaccine, presumably due to the 
added energy drain on the recombinant vaccine. To address this problem, the selective marker 
gene can be designed to include a ribosome-binding recognition sequence but no promoter 
(Kang et al., 2002). As a safety consideration, it is desirable that plasmid vectors possess some 
containment features to minimize the possibility of transfer to and maintenance in other 
bacterial species. The vector should therefore be non-conjugative, should preferably be non-
mobilizable, should possess a narrow replicon host range, and should not specify resistance to 
any antibiotic. 
 
4.5.3. Role of Listeriolysin O in Listeria monocytogenes  infection 
 
In spite of the great number of studies dealing with the role of LLO in pathogenesis of 
Listeria monocytogenes, more researches have to be conducted to understand how LLO 
interacts with phagolysosmal membranes and allows bacterial phagosomal escape. The patch 
clamp technique may be helpful to elucidate the precise molecular mechanisms by which the 
PEST-like sequence participates in the opening of the vacuole. Indeed, the role of the PEST-
like sequence in mediating escape of Listeria monocytogenes into the cytosol can be 
demonstrated through its fusion to the coding sequences of particular proteins like Green 
Fluorescent Protein (GFP). The intracellular localisation of the fusion proteins can be 
followed in phagocytic cells using fluorescent microscopy.  
A potential screening system for the ability of the PEST-like sequence to permit cytosolic 
transfer of LLO could exploit the Cre–lox recombination system. The Cre–lox recombination 
system has the potential to become a powerful tool for the conditional and cell-specific 
deletion of genes. The introduction of this system into transgenic mice should facilitate 
studies on the loss of function of genes in a particular cell type. The Cre recombinase from 
bacteriophage P1 (Sternberg and Hamilton, 1981) excises intervening DNA sequences located 
between two unidirectional lox sites positioned on the same linear DNA segment, leaving one 
lox site behind.  Fusion of the PEST-like sequence from listeriolysin O to the sequence 
encoding the Cre recombinase may facilitate its escape from the phagolysosme and  gaining 
access to the  cytosole of eukaryotic cells for further translocation into the nucleus where Cre-
mediated gene deletion takes place. In cells that have previously engineered to express the 
Green Fluorescent Protein (GFP) flanked by lox-sites, facilitation of entry of the Cre 
recombinase by the PEST-like sequence would therefore result in GFP-negative cells. 
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5. Summary 
 
In this study, the cholesterol-binding cytolysins, listeriolysin O (LLO) as well as pneumolysin 
(PLY), were expressed in the non-pathogenic species Listeria innocua. Growth of L. innocua 
recombinant strains in the chemically defined minimal medium resulted in 2-fold increment in 
the expression of both cytolysins. Purification from supernatant fluids was achieved by ion 
exchange chromatography. The procedure resulted in about 75 % (LLO) or 70 % (PLY) yield 
of a hemolytically active, highly purified homogenous 58 (LLO) or 52 (PLY) kDa protein 
which can be used to produce monospecific antibodies as well as in many diagnostic and 
serological procedures including procedures which were examined or developed in this study. 
The identity and role of listerial antigens recognized by antibodies following listerial infection 
is largely unknown. In this study, a new and previously uncharacterized target of the humoral 
immune response, the listerial ferritin protein (Frm), was discovered and characterized. 
Specific antibodies to Frm are detected in antisera of mice infected with the L. monocytogenes 
wild type strain but not in antisera of mice infected with a non-pathogenic L. innocua strain. 
Antibodies raised to purified listerial ferritin allowed demonstration that expression of Frm is 
both growth phase- and temperature- dependent. Using an isogenic ∆frm mutant, ferritin was 
found to be essential for bacterial growth in chemically-defined minimal media but not in 
complex media such as BHI. Mutant bacteria also exhibited a defect in intracellular survival, 
probably in exiting from the phagosomal vacuole to the cytoplasm. The ∆frm strain is 
hypersensitive to hydrogen peroxide indicating that Frm mediates protection to reactive 
oxygen intermediates under various growth conditions. Mouse infection studies revealed that 
the listerial ferritin is required for efficacious bacterial growth early in the infectious process.   
Although attenuated strains of microbial pathogens have triggered vaccine development from 
its origin, the role of virulence factors in determining host immunity has remained largely 
unexplored. In this study, using the murine listeriosis model, it was investigated whether the 
induction and expansion of protective and inflammatory T cell responses may be modified by 
selective manipulation of virulence genes. This was accomplished in two ways; the first was 
through generation of isogenic Listeria monocytogenes mutant strains that harboured either a 
specific deletion within the actin nucleator (actA) and/or multiple deletions within the actA 
and phospholipase B (plcB) genes while the second way was through the complementation of 
the non-pathogenic Listeria innocua strain with the PrfA-dependent virulence gene cluster 
(vgc) of the wild type L. monocytogenes.  In comparison to the wild type L. monocytogenes 
EGD-e strain, the mutant strains were extremely low in virulence and were rapidly eliminated 
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by the host during the first days of infection. Nevertheless, a single immunization with mutant 
strains (EGDe∆actA, EGD-e∆actA∆plcB and L. innocua: :vgc) has efficiently induced and 
maintained effector memory CD8+ T cells and provided animals with a state of long-lasting 
protective immunity against wild type L. monocytogenes. Moreover, these mutants were 
shown to exhibit a significantly reduced ability to induce CD4+ T cell-mediated 
inflammation. Therefore, they can be used as live vaccines against the corresponding virulent 
pathogen and as carriers for introducing heterologous protective antigens into animals and 
humans. Among the three mutants tested, the double-deletion mutant (EGD-e∆actA∆plcB) 
showed, beside its profound ability to induce protective CD8+ T cells, the most significant 
level of in vivo attenuation as well as the lowest ability to induce unfavourable CD4+ T cell-
mediated inflammatory responses. Thus, this mutant, L. monocytogenes ∆actA∆plcB, appears 
to be the most promising mutant as a bacterial vaccine vector. 
In an attempt to address the role of the pore forming listeriolysin O (LLO) in intracellular 
survival of L. monocytogenes as well as in mediating a protective T- cell response against the 
wild type L. monocytogenes strain, two approaches were conducted in this study. Firstly, the 
structural gene for the related cytolysin pneumolysin  (PLY) was cloned on a plasmid vector 
downstream from the promoter and signal peptide sequences of hly, the gene encoding LLO, 
and expressed in the isogenic  EGD-e∆hly mutant strain. The resultant recombinant strain 
secreted active PLY in culture supernatants and was able to escape phagosomes of phagocytic 
cells in vitro and spread from cell to cell to a limited time after which growth was aborted 
because of a cytotoxic effect on the host cell. This strain also showed a restricted in vivo 
survival in a mouse model of listeriosis but was able to protect mice against a lethal dose of 
the wild type L. monocytogenes and induced a specific T-cell responses against Listeria 
derived epitopes other than LLO such as the subdominant P60217-225 epitope indicating that 
during the immune response to L. monocytogenes, immune splenocytes with specificity for 
LLO and other non-LLO-derived epitopes develop. These non-LLO epitopes serve as targets 
for antilisterial cytotoxic cells that confer antilisterial immunity. 
The second approach was to study the role of the  putative PEST-like sequence (P, Pro; E, 
Glu; S, Ser; T, Thr), found near the N-terminus of LLO, in virulence and intracellular 
compartmentalization of the wild type L. monocytogenes strain as well as in induction of a 
strong cell-mediated protective immunity to the wild type L. monocytogenes. Therefore, the 
28 amino acids harbouring the PEST-like sequence at the N-terminus of LLO were deleted 
and the mutant LLO protein was expressed in a hly-negative isogenic mutant of L. 
monocytogenes. The mutant protein was secreted in normal amounts in the culture supernatant 
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and was fully haemolytic. L. monocytogenes expressing this truncated LLO showed a reduced 
capacity to escape the phagosomes of J774 cell line macrophages and showed a 1000-fold 
decrease in virulence in the mouse model. Moreover, the mutant strain showed a low ability to 
induce both an early serum level of gamma interferon and gamma interferon-secreting T cells 
following infection of BALB/c mice and exhibited reduced levels of protection against 
virulent L. monocytogenes. These results suggest that the PEST-like sequence is crucial for 
conferring a long lasting immunity against the wild type Listeria monocytogenes through 
facilitating the bacterial escape into the cytosole of host cells for further processing and 
antigen presentation. 
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6. Zusammenfassung 
 
In der vorliegenden Arbeit wurden die Cholesterin-bindenden Cytolysine, Listeriolysin O 
(LLO) oder Pneumolysin (PLY) in dem apathogenen Stamm L. innocua exprimiert. Die 
Kultivierung von rekombinanter L. innocua-Stämme in einem chemisch definierten 
Minimalmedium führte zu einer zweifachen Steigerung der Expression von beiden 
Cytolysinen. Mit Hilfe der Methode der Ionenaustausch-chromatographie wurden die Proteine 
aus dem Überstand der Kultur aufgereinigt. Damit erhielt man in etwa 75% (LLO) bis 70% 
(PLY) Ausbeute von hämolytisch aktiven, mit hochreinen, homogenen  Proteinen LLO 
(58kDa) und PLY (52kDa), die Verwendung bei der Produktion von spezifischen Antikörpern  
und in der Diagnostik und Serologie haben können.    
Die Identität und Rolle von listeriellen Antigenen, die nach einer Infektion mit L. 
monocyogenes von Antikörpern erkannt werden , ist bisher noch weitgehend unbekannt.  
In dieser Arbeit wurde das listerielle Ferritin (Frm) als neuer Angriffspunkt für die humorale 
Immunantwort nach einer Infektion von Mäusen mit pathogenen L. monocytogenes 
identifiziert. Spezifische Antikörper gegen Frm werden im Antiserum von mit dem Wildtyp 
L. monocytogenes infizierten Mäusen nachgewiesen, nicht aber im Antiserum von Mäusen, 
die mit dem apathogenen Stamm L. inoccua infiziert wurden.  Antikörper, die aus 
aufgereinigtem Ferritin aus Listeria gewonnen wurden, zeigten, dass die Expression von Frm 
sowohl von Wachstumsphase als auch von  Temperaturbedingungen abhängt. Bei der 
Verwendung einer isogenen Mutante ∆frm  stellte sich heraus, dass Ferritin für das 
Bakterienwachstum in einem chemisch–definierten Minimalmedium essentiell ist, nicht aber 
in Komplexmedium wie z. B. BHI. Die Deletionsmutante wies außerdem einen Defekt im 
Überleben innerhalb der Wirtszelle auf, wahrscheinlich beim Schritt des Austritt aus dem 
Phagosom in das Cytoplasma. Die Mutante ∆frm  ist hypersensitiv gegenüber 
Wasserstoffperoxid, was darauf schließen lässt, dass Frm für den Schutz gegen reaktive 
Sauerstoff-Intermediate unter unterschiedlichen Wachstumsbedingungen sorgt. Versuche am 
Mausmodell zeigten, dass das listerielle Ferritin für ein effizientes Bakterienwachstum in der 
frühen Infektionsphase notwendig ist. 
Obwohl attenuierte Stämme pathogener Mikroorganismen die Entwicklung von Impfstoffen 
schon zu ihrem Beginn anführte, ist die Rolle von Virulenzfaktoren in Hinblick auf die 
Immunität des Wirtes größtenteils noch immer nicht erforscht. In dieser Arbeit wurde, mit 
Hilfe eines  Listeriose-Mausmodells, untersucht, ob die Auslösung einer schützenden oder 
inflammatorischen T-Zell-Antwort durch die selektive Manipulierung von Virulenzgenen 
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modifiziert werden kann. Dies wurde auf zwei Wegen erreicht: Zum Einen erfolgte durch die 
Herstellung von isogenen Listeria monocytogenes Mutanten, die entweder eine spezifische 
Deletion im Gen für das Aktin-akkumulierende Protein (actA) und/oder multiple Deletionen 
im actA Gen und Phospholipase B (plcB) Gen trugen. Zum Anderen erfolgte eine 
Komplementierung eines nicht-pathogenen Stammes Listeria inoccua mit dem PrfA-
abhängigen Virulenzgencluster (vgc) eines Wildtyps von L. monocytogenes.  
Im Vergleich zum wildtypischen  L. monocytogenes EGD-e waren die Virulenz der Mutanten 
extrem herabgesetzt, und sie wurden während der ersten Tage der Infektion rasch von Wirt 
eliminiert. Dagegen wurde durch die einmalige Immunisierung mit den Mutanten 
(EGDe∆actA, EGD-e∆actA ∆plcB and L. innocua: :vgc) sehr effizient eine Gedächtnis  T-
Zell-Antwort (CD8+) ausgelöst, die die Tiere mit einem lang-anhaltenden Immunschutz 
gegen den Wildtyp L. monocytogenes ausstattete. Darüber hinaus war die Fähigkeit der 
Mutanten  signifikant reduziert, eine CD4+- T-Zell- vermittelte Inflammation zu stimulieren. 
Daher können sie als Lebendimpfstoff gegen die entsprechenden Erreger verwendet werden, 
und als Träger für die Bildung heterologer schützender Antikörper in Tier und Mensch 
dienen. 
Unter den drei Mutanten, die getestet wurden, zeigte die Doppelmutante (EGD-
e∆actA∆plcB), neben seiner ausgeprägten Fähigkeit, schützende CD8+-T-Zellen zu 
induzieren, den signifikantesten Grad an Attenuierung  in vivo  als auch die geringste 
Fähigkeit, eine ungewollte CD4+- T-Zell-vermittelte inflammatorische Antwort auszulösen.  
Daher wird diese Mutante L. monocytogenes ∆actA ∆plcB zur Zeit als die vielversprochenste 
Mutante  für einen bakteriellen Impf-Vektor angesehen.  
In einem Versuch, die Rolle des Poren-bildenden Listeriolysin O (LLO) beim Überleben von 
L. monocytogenes in der Zelle  als auch bei der Vermittlung einer schützende T-Zell-Antwort 
gegen den Wildtyp L. monocytogenes zu bestimmen, wurden in dieser Arbeit zwei Ansätze 
verfolgt. Erstens, wurde das Strukturgen für das ähnliche Cytolysin Pneumolysin (PLY) in ein 
Plasmid kloniert,  downstream vom Promoter und der Sequenz des Signalpeptids von hly, 
dem für das LLO codierenden Gen, und das Konstrukt wurde in der isogenen EGD-e∆hly 
Mutante exprimiert. Der resultierende rekombinante Bakterienstamm sezernierte aktiv PLY in 
den Kulturüberstand und war im in-vitro Experiment befähigt, den Phagosomen  
phagozytierender Zellen zu entkommen. Er konnte sich außerdem von Zelle zu Zelle 
ausbreiten. Der Stamm zeigte zudem im in vivo Versuch mit einem Listeriose-Mausmodell 
eine verringerte Überlebensrate, er war jedoch zugleich dazu in der Lage, Mäuse gegen eine 
letale Dosis des Wildtyps von L. monocytogenes zu schützen. In der Maus induzierte der 
6. Zusammenfassung                                                                                                               166                        
 
rekombinante Bakterienstamm eine spezifische T-Zellantwort gegen von Listeria-stammende 
Epitope, und zwar nicht gegen Epitope von  LLO sondern solche wie das subdominante 
p60217-225 Epitop.  Dies lässt darauf schließen, dass sich während der Immunantwort auf L. 
monocytogenes, immungewordene Milzzellen mit Spezifität für LLO und andere nicht-LLO 
Epitope bilden. Diese nicht-LLO Epitope dienen als Angriffspunkte für anti-listerielle 
cytotoxische Zellen die zur Immunität gegen Listerien beitragen. 
Der zweite Ansatz war die Untersuchung der Rolle der putativen PEST-ähnlichen Sequenz, 
die sich nahe des N-Terminus des LLO-Proteins befindet, in Bezug auf die Virulenz und auf 
die intrazelluläre kompartimentierung des Wildtyps L. monocytogenes, sowohl in Bezug auf 
die Induktion einer starken zell-vermittelten Immunität gegen den Erreger. Die 28 
Aminosäuren am N-Terminus von LLO, die die PEST-ähnliche Sequenz beinhalteten wurden 
somit deletiert und die LLO Variante wurde in einer hly-negativen  isogenen Mutante 
exprimiert. Das mutierte Protein wurde in normalen Mengen in den Kulturüberstand 
sezerniert und war in vollem Maße hämolytisch. Der Listerienstamm, der dieses veränderte 
LLO exprimierte, zeigte eine reduzierte Kapazität den Phagsosomen von J774 Makrophagen 
zu entkommen, und wies eine tausendfache Senkung der Virulenz im Mausmodell auf. 
Darüber hinaus zeigte die Mutante eine herabgesetzte Fähigkeit, sowohl ein frühes 
Serumlevel an γ-Interferon als auch an γ-Interferon-sezernierenden T-Zellen nach der 
Infektion von BALB/c Mäusen zu induzieren, und dadurch kam es zu einem reduzierten 
Schutz gegen den virulenten Stamm L. monocytogenes. Diese Ergebnisse weisen darauf hin, 
dass die PEST-ähnliche Sequenz des reifen LLO entscheidend für die Erhaltung einer lang 
anhaltenden Immunität gegen den Wildtyp L. monocytogenes ist.  
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